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Summary
Background: Deep Brain Stimulation (DBS) is a well established surgical treat-
ment for Parkinson's Disease (PD) and Essential Tremor (ET). Electrical leads
are surgically implanted in the deeply seated structures in the brain and chron-
ically stimulated. The location of the lead with respect to the anatomy is
very important for optimal treatment. Therefore, clinicians carefully plan the
surgery, record electrophysiological signals from the region of interest and per-
form stimulation tests to identify the best location to permanently place the
leads. Nevertheless, there are certain aspects of the surgery that can still be
improved. Firstly, therapeutic eects of stimulation are estimated by visually
evaluating changes in tremor or passively moving patient's limb to evaluate
changes in rigidity. These methods are subjective and depend heavily on the
experience of the evaluator. Secondly, a signicant amount of patient data is
collected before and during the surgery like various CT and MR images, surgical
planning information, electrophysiological recordings and results of stimulation
tests. These are not fully utilized at the time of choosing the position for lead
placement as they are either not available or acquired on separate systems or
in the form of paper notes only. Thirdly, studies have shown that the current
target structures to implant the leads (Subthalamic Nucleus (STN) for PD and
Ventral Intermediate Nucleus (VIM) for ET) may not be the only ones responsi-
ble for the therapeutic eects. The objective of this doctoral work is to develop
new methods that help clinicians subdue the above limitations which could in
the long term improve the DBS therapy.
Method: After a thorough review of the existing literature, specically cus-
tomized solutions were designed for the shortcomings described above. A new
method to quantitatively evaluate tremor during DBS surgery using acceleration
sensor was developed. The method was then adapted to measure acceleration of
passive movements and to evaluate changes in rigidity through it. Data from 30
DBS surgeries was collected by applying these methods in two clinical studies:
one in Centre Hospitalier Universitaire (CHU), Clermont-Ferrand and another
multi-center study in Universitaspital Basel and Inselspital Bern in Switzerland.
To study the role of dierent anatomical structures in the therapeutic and ad-
verse eects of stimulation, the data collected during the study was analysed
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using two methods. The rst classical approach was to classify the data based
on the anatomical structure in which the stimulating contact of the electrode
was located. The second advanced approach was to use patient-specic Finite
Element Method (FEM) simulations of the Electric Field (EF) to estimate the
spatial distribution of stimulation in the structures surrounding the electrode.
Such simulations of the adverse eect inducing stimulation current amplitudes
are used to visualize the boundaries of safe stimulation and identify structures
that could be responsible for these eects. In addition, the patient-specic sim-
ulations are also used to develop a new method called "Improvement Maps" to
generate 2D and 3D visualization of intra operative stimulation test results with
the patient images and surgical planning. This visualization summarized the
stimulation test results by dividing the explored area into multiple regions based
on the improvement in symptoms as measured by the accelerometric methods.
Results: The accelerometric method successfully measured changes in tremor
and rigidity. Standard deviation, signal energy and spectral amplitude of domi-
nant frequency correlated with changes in the symptoms. Symptom suppressing
stimulation current amplitudes identied through quantitative methods were
lower than those identied through the subjective methods. Comparison of
anatomical targets using the accelerometric data showed that to suppress rigid-
ity in PD patients, stimulation current needed was marginally higher for Fields
of Forel (FF) and Zona Incerta (ZI) compared to STN. On the other hand, the
adverse eect occurrence rate was signicantly lower in ZI and FF, indicating
them to be better targets compared to STN. Similarly, for ET patients, other
thalamic nuclei like the Intermediolateral (InL) and Ventro-Oral (VO) as well
as the Pre-Lemniscal Radiations (PLR) are as ecient in suppressing tremor
as the VIM but have lower occurrence of adverse eects. Volumetric analysis
of spatial distribution of stimulation agreed with these results suggesting that
the structures other than the VIM could also play a role in therapeutic eects
of stimulation. The visualization of the adverse eect simulations clearly show
the structures which could be responsible for such eects e.g. stimulation in
the internal capsula induced pyramidal eects. These ndings concur with the
published literature. With regard to the improvement maps, the clinicians found
them intuitive and easy to use to identify the optimal position for lead place-
ment. If the maps were available during the surgery, the clinicians' choice of
lead placement would have been dierent.
Conclusion: This doctoral work has shown that modern techniques like quanti-
tative symptom evaluation and electric eld simulations can suppress the existing
drawbacks of the DBS surgery. Furthermore, these methods along with 3D vi-
sualization of data can simplify tasks for clinicians of optimizing lead placement.
Better placement of the DBS lead can potentially reduce adverse eects and
increase battery life of implanted pulse generator, resulting in better therapy for
patients.
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Chapter 1
Introduction
Essential Tremor (ET) and Parkinson's Disease (PD) are two of the most
common progressive neurodegenerative movement disorders. For decades, re-
searchers have studied the abnormalities in the human motor circuits of patients
suering from these diseases to pin-point the cause. Through these eorts, some
pathological ndings have been associated with the diseases e.g. dopamine de-
pletion in Substania Nigra pars compacta (SNc) is associated with PD. How-
ever, the precise aetiology of these diseases remains elusive. This may be one
of the reasons that a cure for either of the diseases does not exist. Current
treatments are only symptomatic, i.e. they are designed to suppress the pro-
gressively worsening symptoms. The rst approach to treat the symptoms is to
use pharmaceutical drugs which supplement the loss of necessary compounds
in the brain like dopamine. As the disease progresses, the dosage of the drug is
increased but only till the therapeutic eects outweigh the adverse eects. If the
increased dosage causes severe adverse eects, a surgical treatment called Deep
Brain Stimulation (DBS) is considered to decrease the drug dosage without
worsening the symptoms.
In DBS, electrical leads are implanted in specic regions of the brain and stim-
ulated continuously using a pulse generator implanted in the thoracic or pelvic
cavity. Over the years, certain brain structures have been established as ideal
targets for dierent diseases e.g. Subthalamic Nucleus (STN) for PD. For a suc-
cessful outcome of DBS therapy, the implant location of the lead plays a very
crucial role. Before the surgery, the clinicians use commercial planning software
in combination with Computed Tomography (CT) and/or Magnetic Resonance
(MR) images of the patients' brain to identify the target structure and the best
path to reach it. During the surgery, electrophysiological activity is recorded
using Micro-Electrode Recording (MER) to verify the planned path and validate
the target structure through its typical signal pattern. In addition, to ensure
that the lead is implanted in the optimal location, intraoperative stimulation
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tests are performed at planned locations along the path to check for therapeu-
tic and adverse eects. The lead is implanted at a location where therapeutic
eects are observed at low stimulation current amplitudes and where adverse
eects are not observed or only when stimulating at very high currents.
1.1 Motivation
In the past three decades since DBS has been used as a treatment for movement
disorders, more than 150000 patients have been treated. For a majority of these
patients, the motor symptoms have been signicantly suppressed. But reports
of inadequate therapeutic eects have also been published, some of which have
been attributed to suboptimal placement of the DBS lead. Despite the abundant
tools and techniques available to optimize lead placement, from an engineering
perspective, there are some areas which can be improved.
One area that needs further engineering research is the symptom evaluation
technique used during surgery to estimate the therapeutic eects of stimula-
tion. For patients with ET and tremor-dominant PD, the therapeutic eects
are evaluated by visually observing the changes in tremor. For rigidity-dominant
PD patients, changes in rigidity are measured by passive movements of patient's
limb (mostly upper) about a joint. In most centres, changes in the symptoms
are evaluated in a relative manner, i.e. by comparing the symptom severity
during stimulation to a baseline severity noted before stimulation starts. Such
relative changes can be rated in two ways: i) by direct rating i.e. a score is given
from 0 to 4 where 0 indicates no change and 4 indicates symptom alleviation
or ii) using parts of a clinical scale like the Unied Parkinson's Disease Rating
Scale (UPDRS) for severity evaluation for baseline and during stimulation. In
its current form, the evaluation of therapeutic eects for stimulation is very
subjective i.e. the rating during the surgery depends heavily on the experience
of the evaluator.
Another aspect of DBS surgery that can be improved concerns the management
of data obtained during surgery. The results of stimulation tests i.e. stimulation
parameters resulting in therapeutic and adverse eects are noted using pen and
paper. On completion of the stimulation tests, to optimally place the leads, the
surgical team discusses the results using these notes and "mentally" visualizes
the information with respect to the patient's anatomy. If the software used for
planning the surgery is available for intraoperative use, which is not a typical
case, the clinicians have to manually enter the intraoperative data to visualize
it. Nevertheless, the software packages currently available are not capable of
visualizing all the information obtained during the stimulation tests.
The success of DBS as a therapy for PD and ET has prompted clinicians to
apply it to other neurological diseases. However, one hurdle that they have yet
to overcome is to completely understand the functioning of DBS. Despite the
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application of DBS to so many patients, the mechanisms by which it reduces
the patient's symptoms are still not fully known. Since its rst use, the sci-
entic community has proposed various hypothesis based on dierent research
techniques, but none of these can explain all the eects of DBS on their own.
It is known that stimulation in the brain causes changes in the electrical ac-
tivity of the neurons surrounding the lead, but how these changes aect the
functioning of the brain is only partially understood. Some studies have been
performed where DBS has been applied to other neurological diseases, and while
its application to some e.g. Dystonia has been very successful, application to
other diseases like Alzheimer's has produced mixed results. Information regard-
ing the mechanisms of action of DBS will not only speed-up its application as a
therapy to other neurological diseases, but also result in an optimization of the
commercial DBS devices as well.
1.2 Aims
In the last three decades, since the rst DBS surgery, signicant technical ad-
vancements have been made in the eld of medicine. Clinical engineers and
researchers working in the eld of DBS have observed that DBS has not kept
up with these developments as the fundamental procedure remains the same.
This doctoral work attempts to resolve some practical drawbacks by introducing
modern techniques to the surgical procedure of DBS lead implantation and to
use the data collected to answer theoretical questions pertaining to DBS therapy
in general. This thesis aims to:
Improve intraoperative symptom evaluation Current methods to evaluate
tremor and rigidity during the surgery are adapted from the routine clini-
cal methods which were not designed for intraoperative use. The rst goal
of this thesis is to develop a method using an acceleration sensor to quan-
titatively evaluate the changes in tremor and rigidity during intraoperative
stimulation tests to overcome the limits of the current methods.
Improve target selection The current target structures for DBS lead implan-
tation have been adapted from lesioning surgeries, and researchers are
in search of more ecient and alternative targets. Another goal of this
thesis is to compare the eciency of dierent anatomical structures stim-
ulated during the surgery using the results of the quantitative symptom
evaluation data.
Improve lead placement The nal implant position for the DBS lead is chosen
based on the results of intraoperative stimulation tests that are noted using
pen and paper. These results are mentally visualized by the individual
member of the surgical team and discussed to make the choice. This
thesis aims to assist the surgical team in the decision making process
by visualizing the results of the intraoperative stimulation tests on the
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patient's images and other relevant data.
Further the understanding of mechanisms of action of DBS The mecha-
nisms by which DBS alleviates patient's symptoms are not fully known.
Various hypotheses have been proposed, but none of them are able to
explain all the eects of DBS. All the data collected during this thesis
will also be analysed with the aim to obtain more information about the
eect caused by stimulation of dierent anatomical structures.
1.3 Outline
The contents of the thesis are divided into 9 chapters which also include the
published peer-reviewed articles. The current chapter provides a basic introduc-
tion to this thesis. Chapter 2 contains necessary background information about
the anatomy and physiology of the human motor circuit, PD, ET and DBS. This
section also provides details about the dierent shortcomings of DBS that this
doctoral work attempts to overcome. Chapter 3 contains details about the
equipment used to record tremor and rigidity movement data and the clinical
studies conducted to collect data from DBS surgeries. Chapter 4 describes the
method developed for quantitative tremor evaluation during DBS and the re-
sults obtained by applying it in 15 surgeries. This is followed by the description
of method to evaluate rigidity during surgery using an acceleration sensor and
its application for 9 patients in Chapter 5.
Chapter 6 introduces the "classical" approach to compare the therapeutic ef-
fect of stimulation in dierent anatomical structures, i.e. based on the position
of the stimulating contact with respect to these structures. The application of
this method to 5 ET patients and the results are also described in this chapter.
Chapter 7 describes the limitations of using the classical approach and intro-
duces a method to overcome them by estimating the spatial eects stimulation
using patient-specic simulations. This is followed by the details of the applica-
tion of this method to the same Electric Field (EF) patients and the consequent
results.
Chapter 8 describes the various data that is collected for one DBS surgery and
introduces a new data visualization method called improvement maps developed
to improve lead placement. The details of the method and its application to
5 patients are also included in the chapter. Chapter 9 summarizes the main
results of this doctoral work with respect to the aims set forth in the section
above. This is followed by further discussion of the results in the context of
current DBS practice as well as the main advantages and the limitations of each
of the methods. It also contains details about the immediate follow-up tasks as
well as the long term projections of this doctoral work. Chapter 10 concludes
this thesis.
Chapter 2
Background
2.1 Basal ganglia and motor circuit
Human motor control is regulated through various structures in the brain in-
cluding parts of the cortex, thalamus, basal ganglia and the cerebellum.
2.1.1 Motor Cortex
There are three areas in the frontal lobe of the cortex which are associated with
motor function (Figure 2.1). The Primary Motor Cortex (PMC) is in the dorsal
region of the frontal lobe, just anterior to the central sulcus. Its histological
composition is similar to other parts of cortex apart from the distinctively giant
pyramidal neurons called Betz cells.27 It has well dened somatotopy i.e. point-
for-point correspondence of specic area of the structure to an area of the body.
The Premotor Cortex (preMC) and the Supplementary Motor Area (SMA) are
located anteriorly to the PMC but are structurally dierent as the Betz cells
are less common and smaller. Their somatotopical organization is not as well
dened as that of the PMC. These three areas directly innervate the synapse
in the brain stem for control of the head and face movements and in the spinal
cord for the rest of the body. They are also connected to other cortical areas,
basal ganglia nuclei, thalamus, red nucleus and cerebellum.
The dierent areas of the motor cortex are responsible for dierent aspects of
motor physiology. Signals of the PMC encode movement related information like
the force, speed, direction and extent. The preMC is associated with preparation
of a movement based on the sensory and behavioural information. The SMA
is associated with relating a movement to spatial dimensions acquired from
sensory organs, bilateral and mental exercise of movements. All the three areas
in conjunction with other sensory parts of the brain plan and execute movements
of the human body.
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Figure 2.1: Approximate locations of the dierent areas of the motor cortex and the
cerebellum in humans.
2.1.2 Cerebellum and Inferior Olivary Nucleus
The cerebellum (Figure 2.1) is a part of the metencephalon located below
the cerebral hemispheres behind the fourth ventricle, pons and medulla. It is
mostly built up of neurons and contains 3.6 times the number of neurons in
the neocortex.145 It receives inputs from motor and sensory part of the brain
as well as the spinal cord through the inferior olivary nucleus. As a part of
the motor circuit, it helps in coordination and timing of the movements but
does not initiate any movements by itself.110 Apart from its clearly established
role in motor function, the cerebellum has also been associated with cognitive
functions like attention and language.287
The inferior olivary nucleus is located in the medulla oblongata in the brain-
stem, anterior to the cerebellum (Figure 2.1). Distinct bers from the inferior
olivary nucleus called "climbing bers" form a major input to the neurons of the
cerebellum. One neuron is innervated with only one climbing ber, but it makes
contact on multiple sites by wrapping around the dendrite.225 The inferior oli-
vary nucleus is believed to act as a lter in providing sensory information to the
cerebellum.69 It has also been shown to play a role in learning and coordinating
movements along with the cerebellum.313
2.1.3 Thalamus
The thalamus is located at the center of a brain hemisphere in the forebrain
and is the largest part of the diencephalon. It is made up of a group of gray
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Figure 2.2: The thalamus and its nuclei represented in three regions: ante-
rior, medial and lateral (yellow). LP: Lateral posterior nucleus; LD: Lateral
dorsal nucleus; VA: Ventral anterior nucleus; VL: Ventral lateral nucleus; VP:
Ventral posterior nucleus VIM:Ventral intermediate nucleus; VPM: Ventral pos-
teromedial nucleus; VPL: Ventral posterolateral nucleus. Modied from Wiki-
media (Madhero88 https://commons.wikimedia.org/wiki/File:Thalmus.png, "Thal-
mus\, VI renamed to VIM, without legend) under the CC BY-SA 3.0 license
(https://creativecommons.org/licenses/by-sa/3.0/legalcode)
matter nuclei which can be separated using a longitudinal thin sheet of white
matter called internal medullary lamina (Figure 2.2). The thalamus has con-
nections to most of the cerebral cortex, some basal ganglia nuclei, cerebellum,
spinal cord and various other nuclei in the brain.108 Most of the connections
are bidirectional while some are unidirectional. Physiologically, the thalamus is
believed to act as a relay station responsible for transferring information from
other parts of the brain to the cortex.149 The ventral lateral (VL) thalamic
nucleus receives input signals from the basal ganglia and cerebellum and has
bidirectional connections to all the three motor areas of the cortex. The ventral
anterior (VA) thalamic nuclei also receives input signals from the basal ganglia
and has bidirectional communication with the preMC. Through these connec-
tions (Figure 2.3), the thalamus provides feedback for motor control and may
also be involved in planning and initiating movements.34
2.1.4 Basal Ganglia
The substantia nigra (pars compacta: SNc and pars reticulata: SNr), along
with the striatum (caudate nucleus, putamen, nucleus accumbens), the STN,
the globus pallidus (internal: GPi and external: GPe) and the ventral pallidum,
collectively form the Basal Ganglia (BG) (Figure 2.4). The BG were tradition-
ally thought to be involved only in the motor functions of the brain, but recent
research has shown that they are involved in various functions like attention,
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Figure 2.3: A diagrammatic representation of the connections between the dierent
structures involved in the motor function. Arrow heads indicate signal direction.
learning, habit formation, etc.148,314,315,374 Along with the thalamus and the
cortex, the BG form 3 segregated circuits for motor, associative and limbic func-
tions.4,249 Striatum and STN are the input nuclei of BG while GPi and SNr are
the output nuclei projecting into the thalamus.
Figure 2.4: Anatomical location of the basal ganglia nuclei along with other deep
brain structures. Reproduced from Leisman et al.185 under the CC BY 3.0 license
(https://creativecommons.org/licenses/by/3.0/).
There are two pathways in BG between the input and the output nuclei62 (Fig-
ure 2.5a):
i) the direct pathway in which the striatal neurons project directly into the
GPi and
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ii) the indirect pathway where striatal signal passes through GPe and STN
to reach GPi and SNr.
The direct and indirect pathways have opposing eects on movements (via
the thalamus). The stimulation of direct pathway reduces inhibitory output
of the GPi to the thalamus and facilitates movement. The indirect pathway,
on the other hand, increases GPi/SNr activity inhibiting the thalamocortical
system and reducing movement. Neurons of both the pathways have dopamine
receptors, but of dierent kinds. The receptors on the direct pathway are of
D1 type which facilitate the activation of the pathway in presence of dopamine
and the receptors on the indirect pathway are of D2 type which inhibit the
activation of the pathway in presence of dopamine109 (Figure 2.5b). In addition
to these two pathways within the BG, the direct input from cortex to the STN
forms the hyperdirect pathway245 (Figure 2.5a). While its existence has been
acknowledged for some time, its anatomical organization and functional role in
BG physiology including motor control is not completely known.224
Figure 2.5: (a) The three pathways playing a role in motor function: direct (blue),
indirect (red) and hyperdirect. (b) The inuence of dopamine on the motor function
through the thalamus.
2.2 Parkinson's Disease (PD)
Parkinson's Disease (PD) is one of the most common neurodegenerative move-
ment disorders .276 Some well-known people like Michael J. Fox and Davis
Phinney who have been diagnosed with PD have used their image to create
signicant public awareness and support for research in PD through their foun-
dations. Description of PD like symptoms can be found in various texts since
biblical times. In 1817, James Parkinson published his essay titled "An essay on
the Shaking Palsy" where he describes 6 patients having PD symptoms (Figure
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Figure 2.6: The early sketch of a Parkinson's patient by Sir William Richard Gowers.
Public domain image reproduced from Wikimedia Commons369
2.6) and how their disease progressed with age.265 The French Neurologist
Jean-Martin Charcot, known as the father of modern neurology, was the rst to
term the disease as "la maladie de Parkinson" (Parkinson's disease) because he
noted that tremor is not always present in human PD.293 A signicant contri-
bution that he made towards PD was distinguishing between rigidity, weakness
and bradykynesia.184
Based on literature published in PD epidemiology, there are approximately 7
million people in the world suering from PD.16 The prevalence (proportion of a
population at any given time) for PD is about 0.3% across ages, increases to 1%
for people over 60 and to 4% for population over 80.348 The median age of onset
of the disease is 60 years and the mean duration of the disease (from diagnosis
to death) is 15 years.182 About 5-10% of PD cases are classied as young onset
PD where the age of diagnosis is between 20 to 50 years.304 Studies show
men have higher chances of PD and at slightly younger (average) age compared
to women.182 The number of PD patients in Switzerland is estimated to be
about 18,000.217 Additionally, studies estimate that the incidence (number of
new cases per year) of PD is between 8 and 18 per 100,000 person-years.348
Economic burden of PD varies from country to country e.g. $23 billion in USA in
2010332 and about $449 million in UK in 2006,97 but researchers agree that the
cost of PD increases signicantly as the disease progresses,175 mostly because
of increasing cost of institutional care.295 With increasing quality of life and life
expectancy, the PD related costs are expected to increase in the future.
2.2. PARKINSON'S DISEASE (PD) 11
In most PD patients, there is no external identiable cause of the disease and
such PD is termed as primary or idiopathic. Research has identied several
risk factors like pesticides, dairy products, alcohol etc. and some protective
factors like tobacco, caeine, exercise etc. associated with PD. Ascherio et al.9
describes the various risk and protective factors of PD and studies their eect on
the epidemiology of PD. A small percentage of PD cases have been associated
to genetic factors and are classied as familial or hereditary PD. In recent years,
researchers have identied several genes whose mutations have been associated
to PD which has led them to believe that all forms of PD are caused by a
variable combination of environmental and genetic factors.327 Of the dierent
genes associated with PD, mutations in alpha-synuclein (-Syn, SCNA274) and
leucine-rich repeat kinase 2 (LRRK2381) cause autosomal-dominant form of
PD while mutations in PRKN (parkin, PARK2), PINK1 (PARK6), and DJ-1
(PARK7), cause autosomal-recessive forms of PD.190
PD is diagnosed based on the symptoms observed in the patients.340 The di-
agnostic criteria for PD have been changed over the years based on various
research studies. At present, the UK brain bank criteria156 are the most com-
monly used. The Movement disorder's society has revised these criteria once in
2003115 and very recently in 2016.113 Based on the latest revision, the diagnosis
of PD is still centered on the motor symptoms viz. bradykinesia (slowness of
movement) and akinesia/hypokinesia (decreased movement amplitude), rigidity
and rest tremor.277 Elaborate details about tremor and rigidity are provided
below due to their relevance to this doctoral work. In addition, certain "abso-
lute exclusion" criteria are also dened like medical history of diseases known
to cause PD secondarily (Alzheimer's disease). Studies show that accuracy of
diagnosis (conrmation only through autopsy) is 75-90% depending on the du-
ration of the disease and experience of the clinician.254 PD patients also exhibit
other motor symptoms like gait and postural instability and speech disturbances.
In addition, various non-motor symptoms like sleep disturbances,229 autonomic
and sensory dysfunction165 are also observed, some of which may be present
before the diagnosis of the disease.310
Tremor
Tremor is dened as the rhythmic oscillation of a body part.202 Tremor is
observed in 80%340 of the PD patients. The following characteristics of PD
tremor help clinicians to distinguish it from other types of tremor:5
 Tremor onset is unilateral, but with disease progression can become bilat-
eral.
 Most patients present with upper limb tremor.
 PD patients have rest tremor which is attenuated by voluntary movement.
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 It is often called pill-rolling because the thumb and the index nger tend
to get into contact and perform circular movement.159
 Tremor has a tendency to increase with cognitive tasks or walking.
 The amplitude of tremor is moderate at onset and tends to increase with
time.
 The age of onset for PD tremor is mostly after 60.
 Frequency of tremor is between 3-4 Hz which is lower compared to other
types.
 Idiopathic PD patients tend to be more tremulous than other parkinsonian
conditions.
Rigidity
Rigidity is dened as resistance to passive movement caused by an involuntary
increase in muscle tone and can aect all muscle groups.355 PD patients de-
scribe rigidity as muscle stiness or sometimes pain. The severity of rigidity is
evaluated passively by repeated exion and extension of the respective muscle
about the corresponding joint. Based on the resistance observed by the clini-
cians, rigidity is described as either "lead-pipe" (smooth; constant resistance)
or "cog-wheel" (jerky; potentially because of tremor).355 Rigidity of a limb
increases when patients are asked to perform movements on the contralateral
limb (Froment's maneuver100). To distinguish between the two types, they are
termed as "rest rigidity" and "activated rigidity."365
2.2.1 PD Rating Scales
The symptoms of PD worsen with the progression as it is a neurodegenerative
disease. To study the progression of the disease in general and in each patient
individually, clinical scales that assign numbers to the severity of the symptoms
are necessary. Currently, there are two rating scales that are widely used in
clinical practice: i) Unied Parkinson's Disease Rating Scale (UPDRS)89 and
ii) Hoehn and Yahr Stage Scale.152
Unied Parkinson's Disease Rating Scale (UPDRS)
The UPDRS is the most widely used clinical rating scale for PD and is the
international gold standard.162 It was proposed in 1995 as a collaborative eort
to provide an ecient and comprehensive scale to evaluate PD and related
disorders.89 The scale consists of 4 parts:115
Part I Mentation, Behaviour and Mood has 4 items to evaluate the mental
dysfunction and mood of the patient.
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Part II Activities of Daily Living has 13 items related to the disability that
patients face in daily tasks due to the motor symptoms
Part III Motor has 14 items to evaluate the severity of the motor symptoms.
Some items are divided further to evaluate the severity of each limb (Fig-
ure 2.7 and 2.8).
Part IV Complications is to be used to assess any motor or non-motor com-
plications that arise due to medication.
Each item of the scale is rated between 0 (normal) and 4 (severe). Some items
in the scale are rated by interviewing the patient while others are rated by
examining the symptoms. The ratings of each part are summed to estimate the
severity and to evaluate the progression of the disease with time (longitudinal
evaluation). The average time taken by clinicians to administer the full UPDRS
test is between 10 and 20 minutes.223 The wide usage of UPDRS can be
attributed to the availability of a teaching tape.116 This tape provides examples
of rating the motor symptoms of PD patients by a panel of 3 movement disorder
specialists having extensive experience of using the scale. It also includes some
UPDRS motor examinations that trainees can self-administer and compare the
results with that of the panel.
UPDRS has also been extensively tested from a clinimetric point of view due to
its wide usage. It is the most used scale in various clinical research studies and
is relied upon by the US and European87 regulatory agencies. Various studies
have found that the UPDRS as a whole has good intra-rater (reproducibility
of the same evaluators rating on dierent occasions/test-retest) and inter-rater
(reproducibility of ratings by multiple evaluators of the same patient) reliability.
However, Post et al275 showed that the ratings depend heavily on the experience
of the evaluator. Other studies have shown that some items of the motor part
including speech, facial expression, posture, body bradykinesia, action tremor
and rigidity have comparatively lower inter-rater reliability.223,278,289 Other
shortcomings of UPDRS include redundancy of items in Part II and Part III,223
inconsistencies in item allocation115 and cultural bias in Part II.113
The Movement Disorder Society (MDS) sponsored a think-tank to evaluate the
limitations of UPDRS and propose the necessary steps to overcome them.117
This revised version of the UPDRS known as MDS-UPDRS was proposed in
2008. It retains the number of parts and the 5-point rating system of the original
UPDRS but the titles, items and their number for each parts have been altered.
Part I has 13 items related to the non-motor experiences of daily living, Part
II has 13 items related to the motor experiences of daily living, Part III has 18
items, some with sub-items, related to motor symptoms evaluation and Part IV
has 6 items to describe complications arising due to medication. The time taken
to administer the test is about 30 minutes. Compared to UPDRS, the MDS-
UPDRS emphasized the non-motor components of PD, increased emphasis on
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Tremor At Rest Severity
Body Part 0 1 2 3 4
Face     
Right Upper Extremity     
Left Upper Extremity     
Right Lower Extremity     
Left Lower Extremity     
Guidelines:
0 = Absent.
1 = Slight and infrequently present
2 = Mild in amplitude and persistent. Or moderate in amplitude, but only inter-
mittently present.
3 = Moderate in amplitude and present most of the time.
4 = Marked in amplitude and present most of the time.
Action or Postural Tremor of hands Severity
Body Part 0 1 2 3 4
Right Upper Extremity     
Left Upper Extremity     
Guidelines:
0 = Absent.
1 = Slight, present with action.
2 = Moderate in amplitude with action.
3 = Moderate in amplitude with posture holding as well as action.
4 = Marked, interferes with feeding.
Figure 2.7: The gure shows the questions in UPDRS related to evaluation of tremor.
2.2. PARKINSON'S DISEASE (PD) 15
Rigidity Severity
Body Part 0 1 2 3 4
Neck     
Right Upper Extremity     
Left Upper Extremity     
Right Lower Extremity     
Left Lower Extremity     
Guidelines:
Judged on passive movement of major joints with patient relaxed in sitting position.
Cogwheeling to be ignored.
0 = Absent.
1 = Slight or detectable only when activated by mirror or other movements.
2 = Mild to moderate.
3 = Marked, but full range of motion easily achieved.
4 = Severe, range of motion achieved with diculty.
Figure 2.8: The gure shows the questions in UPDRS related to evaluation of rigidity.
mild impairments and disabilities, increased cultural sensitivity,113 improved the
wordings of the dierent items, and resolved other ambiguities. The MDS also
provides a teaching-tape which can be used to train clinicians in rating PD
patients using the scale to increase reliability.
Hoehn and Yahr Stage Scale
The Hoehn and Yahr Stage scale for PD was proposed in 1967 by Melvin Yahr
and Margaret Hoehn.152 It combines functional decits (disability) and objective
signs (impairment) in a descriptive form to estimate PD severity. It was originally
designed as a ve point scale (0-5), to which 0.5 increments were added in 1990
for some clinical trials.161 The scale describes PD symptoms in ve stages i.e.
from unilateral (Stage 1) to bilateral (Stage 2), followed by presence of postural
instability (Stage 3), loss of independence (Stage 4) and being wheelchair- or
bed-bound (Stage 5). This scale was used to report the longitudinal eects of
drugs on PD patients in various clinical studies between 1967 and 1998. In 2004,
MDS also set up a task force to evaluate the Hoehn and Yahr scale.114 They
reported that the simplicity of the scale allows it to be used even by non-clinical
people. However, they also point to the issues of the scale like neglect of upper
limb disability, lack of assessment of some motor and non-motor impairments
(tremor, depression), absence of teaching tape, etc.
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Figure 2.9: The Braak stages in dierent areas of the brain. Reproduced with permis-
sion from Halliday et al.130
2.2.2 Pathology
Besides being classied as a movement disorder, PD is also a neurodegenerative
disease because of pathology. The symptoms of the patient worsen with increas-
ing duration of the disease due to progressive and selective death of neurons in
dierent parts of the brain. A pathological indication of PD is the presence of
Lewy bodies (insoluble proteinaceous structures) in the neurons that survived
until post-mortem.254 Brack et al.35 studied 168 brains obtained at autopsy
(41 with clinical PD diagnosis, 69 without PD diagnosis and 58 age-matched
controls) and proposed that the neuronal damage follows a specic sequence
(Brack Staging, Figure 2.9) starting from motor nuclei in brain stem and the
anterior olfactory nucleus (Stages 1 and 2) moving upwards to substantia ni-
gra (Stage 3), mesocortex (Stage 4), neocortex (Stage 5) and terminating in
premotor areas (Stage 6). However, the deposition of Lewy bodies does not
correlate with neuronal cell loss and in turn with the progressing clinical severity
of PD.163 Traditionally, it was believed that the accumulation of Lewy bodies
results in neuronal death, but, further research has led to a growing consen-
sus that mechanisms taking place inside as well as originating from outside the
neuron result in their death.151 Researchers have proposed other hypotheses
like mitochondrial dysfunction,309 neuroinammation,279 etc. for the neuronal
cell death in PD, but a complete explanation is yet to be established. Further
discussion about the histo-pathology of PD will deviate from the topic of this
thesis as its relevance is limited. On the other hand, a detailed introduction to
the pathophysiology of PD is necessary for discussing the mechanisms of action
of DBS.
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Pathophysiology
Neuronal degeneration in dierent areas of the brain causes dierent symptoms
of PD. Studies have shown that
i) degeneration of dopaminergic neurons in the pars compacta of substania
nigra results in the cardinal symptoms (bradykinesia/akinesia, rigidity and
tremor) of PD142,293
ii) degeneration of cholinergic neurons in nucleus basalis is associated to
cognitive dysfunction and hallucinations19
iii) gait disturbances may be a result of damage in pedunculopontine nucleus
(PPN).258
Pathophysiology resulting due to the death of non-dopaminergic neurons is not
well-understood due to lack of an animal model while the eects of dopaminergic
degeneration can be modeled in animals using toxins like 1-methyl-4-phenyl-
1, 2, 3,6-tetrahydropyridine (MPTP180), or 6-hydroxydopamine (6-OHDA350).
Therefore, studies of pathophysiology of PD have vastly concentrated on the
eects caused by degeneration of dopaminergic neurons.
Over the years, various models have been suggested for the pathophysiology of
PD. The earliest model3,161 (also referred to as classical or rate model) suggests
that the depletion of dopamine in the brain has a two-fold eect on BG: reduced
activation of the direct pathway resulting in lower movement initiation and dis-
inhibition of the indirect pathway resulting in higher opposition to movement
(Figure 2.10). Proof of this model can be obtained from animal and patient
studies of eects of STN or GPi inactivation.6,15,18,24,129,178,358 Despite the
appeal of this model due to its simplicity, it only serves as a starting point
because it provides no explanation for some motor and non-motor symptoms.
Electrophysiological studies have revealed abnormalities in the ring activity of
neurons in PD patients and animals. The most notable pattern is the increase
of burst discharges in extrastriatal BG25,36,368 and thalamus.126,236,268 Another
observed pattern is abnormal oscillations in alpha and beta frequency ranges in
the GPe, GPi and STN.107,192,293 Graybiel120 suggests that in a normal func-
tioning BG, the subcircuits do not have any correlation in their ring patterns
and activities. Hammond134 revealed that, due to depletion of dopamine, cross
connections are developed in the subcircuits of BG causing unwanted synchro-
nization in their ring activity. Other researchers have used Positron Emission
Tomography (PET) and Functional Magnetic Resonance Imaging (fMRI) to
show that parts of BG that are normally used in only one subcircuit are also
active during activities of other subcircuits in PD patients.172,215
Abnormal synchronization and oscillations are not just limited to BG in PD
patients. Such patterns are also found in recordings of the cortex and the tha-
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Figure 2.10: The inuence of loss of dopamine in the basal ganglia on the circuits
with respect to motor function. Activation of the direct pathway is reduced (indicated
by dashed line) while that of the indirect pathway is increased (indicated by thick solid
line). For comparison with normal circuit functions check Figure 2.5.
lamus.38,39,118,325,361 Helmich142 proposed a "dimmer-switch model" saying
that tremor in PD is a resultant of combined actions from the BG and the
cerebello-thalamo-cortical circuit. In addition, researchers have also shown that
lesions in the Pedunculopontine Nucleus (PPN) in the brainstem of monkeys
produce akinesia173,246 suggesting its involvement in PD. Studies of blood ow
and metabolism in the motor cortex report dierences in PD patients compared
to healthy subjects during movements: increased activity in the PMC has been
repeatedly shown138,299,377 whereas reports of activity in the preMC138,299 and
SMA272,377 show dierent results. Studies have also shown impaired motor
learning ability in PD patients78,98 which agrees with the understanding that
dopamine in motor cortex facilitates motor learning skills. Others have shown
that the well-dened somatotopy of the motor cortex is blurred in PD96 and
restored through treatment37,354 indicating it to be essential for alleviating PD
symptoms. Nevertheless, it is still unclear if abnormal cortical activities are due
to dopamine depletion in the BG only or also because of dopamine depletion
in the cortex itself.193 Further research is necessary to completely understand
changes in the brain of PD patients to develop a comprehensive model of patho-
physiology of PD.
2.2.3 Treatments
A cure for PD does not exist and so current treatments of PD aim to main-
tain independence of patients as long as possible by treating the motor and
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non-motor symptoms (symptomatic treatments). Treatments have to be indi-
vidualized for each patient based on the symptoms and their severity, patient's
response to medication and other conditions. The dopamine depletion cannot
be treated directly with dopamine based drugs because it cannot cross the blood
brain barrier. However, its precursor, levodopa (L-Dopa) can. Since Cotzias55,88
showed levodopa's capability to treat PD, it has been the most eective oral
treatment. To prevent peripheral breakdown of levodopa, it is administered
with dopadecarboxylase inhibitors (carbidopa or benerazide), allowing upto 4
fold reduction in levodopa dosage for the same eect. In addition, patients
are also given catechol-O-methyltransferase (COMT) inhibitors to completely
suppress the peripheral breakdown of levodopa. For patients with tremor dom-
inant Parkinson's disease, if the levodopa treatment does not suppress tremor,
anticholinergic drugs are used in addition.
High doses of levodopa are known to induce dyskinesias. With the worsening of
symptoms, the therapeutic benet of higher doses of levodopa are surpassed by
the adverse eects. PD patients may be treated with dopamine agonists or other
drugs in the early stages of the disease to delay the use of levodopa and in-turn
levodopa induced dyskinesias. For patients with advanced PD, complimentary
treatments are used to reduce the levodopa dosage while still retaining similar
therapeutic eect. Continuous subcutaneous apomorphine infusion is one such
therapy where apomorphine is delivered via a pump through a catheter with a
subcutaneous needle in the abdominal wall or thigh. Symptoms that respond to
levodopa improve allowing for a typical reduction in levodopa dosage of 50%.
Another option is to administer levodopa in gel form (duodopa) by a tube placed
in the jejunum allowing similar reductions in oral levodopa.
Before levodopa was introduced, surgical ablation of parts of thalamus (thalamo-
tomy) or sub-thalamic nucleus (subthalamotomy) or the pallidum (pallidotomy)
were used to treat PD patients. Thalamotomy was the most preferred due to
lower adverse eects compared to others. These procedures have been largely
replaced by their electrical stimulation through a neurostimulator via surgically
implanted electrodes collectively known as DBS (Section 2.4). Bilateral stim-
ulation of the subthalamic nucleus is currently the most used treatment for
advanced PD patients. Apart from reducing levodopa-responsive symptoms, it
also reduces tremor. Lower number of adverse eects, adaptability to worsening
disease and reversibility compared to thalamotomy makes it a very compelling
choice for treating advanced PD patients.
2.3 Essential Tremor (ET)
Essential tremor (ET) is one of the most common neurological diseases and the
most common form of pathological tremor.200 An Italian professor of medicine,
Pietro Burresi, was the rst to use the term "essential tremor" in 1847 to
20 CHAPTER 2. BACKGROUND
describe a 18 year old man with severe, isolated action tremor.44,205 The tra-
ditional image of ET as a benign, monosymtomatic (action tremor) condition
has changed signicantly since then.82 It is now considered to be a progressive
neurological disease with action tremor as a primary symptom and other motor
and non-motor symptoms often disabling for the patients.203 The expression of
the disease varies signicantly among patients in terms of evolution and severity
of the symptoms. In addition, postmortem studies have shown dierent struc-
tural changes in the brains of ET patients raising concerns that ET could be a
family of diseases.23,199
Epidemiological studies of ET report signicant variations in data because of
variations in the denition of ET among other things. Prevalence of the disease
across all ages has been reported at 1% which rises to 4-5% for patients above
4073 and between 6-9% for population above 60.73,200 Studies concur that the
prevalence rises rapidly with age.73,200 In population based studies the age of
onset was found to be 60 years,206 while that in studies based on tertiary referrals
was found to peak at 20 years and 60 years.206 The onset of clinical symptoms of
ET in childhood have been frequently reported with studies estimating between
5 and 15% of ET cases occurring during childhood.206,288 ET occurrence does
not vary with gender, but ethnic variations have been reported.204,212
Research has shown that ET patients have rst and second-degree relatives suf-
fering from the disease, indicating that ET has genetic causes and autosomal-
dominant inheritance pattern. Studies have linked ET and regions on chromo-
somes 2p,147 3q127 and 6p,322 but have not been successfully replicated.8,65,174,216
ET genes are yet to be identied, but polymorphisms in certain genes like
LINGO1,52,64,334,356 dopamine receptor D3,64 etc. have been linked to ET.
On the other hand, in ET twin studies, concordance in monozygotic twins was
found to be about 60%,197,345 suggesting role of environmental causes in ET.
Familial aggregation studies have reported that more than 50% of ET patients
do not have aected rst or second-degree relatives.71,209,303 Several studies
have identied -carboline alkaloids (e.g. harmine) and lead as environmental
factors in ET.72,198 Ongoing research in the eld of etiology of ET will provide
more details in the future.
The diagnosis of ET is made by history and physical examination.210 Three
diagnostic clinical criteria have been proposed that are similar and focus mainly
on the severity and characteristics of the kinetic tremor.67,81,211 ET is one of the
most commonly misdiagnosed neurological disease with 30-50% of ET patients
having other diseases.157,311,312 Family history of ET and tremor response to
alcohol are supportive features for diagnosis of ET. It is important to distinguish
ET from other tremor disorders like PD, enhanced physiological tremor, dystonic
tremor, etc. by careful physical examination.210 Caeine, cigarettes and some
medications can alter other tremor conditions to resemble ET which necessitates
through investigation of patient's history. Certain laboratory evaluations like
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thyroid function tests to eliminate signs of hyperthyroidism, serum ceruloplamin
level for Wilson's disease etc. are useful to ensure correct diagnosis of ET.210
Action tremor of the hands is the hallmark of ET. It has the following charac-
teristics:
 It is symmetric or only mildly asymmetric.
 It is kinetic (occurs during guided voluntary movements) or postural (dur-
ing a position against gravity).
 The frequency of tremor is between 4 and 12 Hz and is inversely related
to age.
 It is most common in the arms, but head tremor is also observed in patients
(higher tendency in women).
 Amplitude of kinetic tremor increases with age and patient with longer
duration of disease may also present rest tremor.
 Tremor causes exion extension of the wrists, and/or abduction movement
of the ngers.
Recent studies have observed other motor symptoms like postural instability and
ataxic gait in ET patients93,336 Minor abnormalities in the eye movements have
also been described.141 Some non-motor symptoms have also been identied.
Social phobia,329 depressive symptoms,183 anxiety,49 etc. were noted in few
studies. It is not uncommon that ET patients later develop PD,201 and recent
studies have shown increased risk of Alzheimer's type dementia.158
2.3.1 ET Rating Scales
Clinicians use dierent rating scales to evaluate patients and estimate the sever-
ity of the disease. In clinical literature, the Fahn-Tolosa-Marin90 scale is the
most widely used(Figure 2.11). The scale was designed to rate tremor due
to any disease. It has 10 items to rate tremor in dierent body parts (part
A), 5 items to rate tremor during movement (part B) and 8 items to evaluate
activities of daily living (part C). Another scale designed specically for ET is
termed as Tremor Research Group Essential Tremor Rating Assessment Scale
(TETRAS).80 Its motor part has 9 items to rate tremor severity in 9 levels from
0 to 4 (0.5 intervals) and its second part has 12 items to evaluate activities of
daily living. A third rating scale specially developed for ET is called the Wash-
ington Heights-Inwood Genetic Study of Essential Tremor (WHIGET)211 rating
scale. It is used to examine the upper extremities during rest and some other
specic activities with a rating from 0 to 3 or 0 to 4.
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Tremor Guidelines:
1) at REST (in repose.) For head and trunk, when lying down.
2) with posture holding (upper extremities (UE): arms outstretched, wrists mildly
extended, ngers spread apart; lower extremities (LE): legs exed at hips and
knees, foot dorsiexed; tongue: when protruded; head and trunk: when sitting or
standing)
3) with Action and Intention (upper extremities: nger to nose and other actions;
lower extremities: toe to nger in a exed posture)
NA = Not applicable
0 = None
1 = Slight (amplitude <0.5 cm). May be intermittent.
2 = Moderate amplitude (0.5 - 1 cm). May be intermittent.
3 = Marked amplitude (1 - 2 cm)
4 = Severe amplitude (> 2 cm)
Body Part Rest Posture Act./Int. Total
Face tremor NA
Tongue tremor NA
Voice tremor NA NA
Head tremor NA
Right upper extremity tremor
Left upper extremity tremor
Trunk tremor NA
Right lower extremity tremor
Left lower extremity tremor
Figure 2.11: The rst 9 questions of the Fahn-Tolosa-Marin Tremor rating scale that
is widely used to evaluate ET patients.
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2.3.2 Pathology
Unlike PD, the pathology of ET has not been extensively researched and many
questions remain unanswered.207,213 Some postmortem studies in ET patients
have identied dierences in Purkinjee cells when compared to control samples
like reduction in number of cells, thickening of the cell axon, etc.207 These
dierences, however, are only seen in some of the ET patients and were not
observed in other postmortem studies.285 Nonetheless, researchers suggest that
cerebellar abnormalities may be secondary pathology of ET.323 Researchers in-
vestigated the presence of Lewy bodies in ET patients and did not nd an
increase unless patients had additional parkinsonism symptoms. Louis et al208
performed postmortem study of ET patients and did nd an increase in Lewy
bodies in locus ceruleus in ET patients who did not later develop PD. However,
the frequency of these patients mimics that of the incidental Lewy body disease
cases in large autopsy series. Rajput et al.283 showed in their study that there
may be other reasons for ET patients that may be developing PD. Another hy-
pothesis that has recently been proposed is that alterations in the LINGO-1 gene
may alter the synaptic density in the cerebellum resulting in synchronization of
its activity creating tremor.68
Pathophysiology
Tremor physiology has been the center point of all discussion about the mech-
anisms of the disease61 in most of the disease's research history. With the
support from animal model of action tremor using harmaline (neurotoxin), it
was proposed that a disturbance in the routine oscillatory-pacemaking proper-
ties of the inferior olivary nucleus would be the main reason behind ET.176,221
However, unlike animal models, cortico-muscular coherence studies indicated
presence of several rather than one central pacemaker in ET.196,281 In addition,
PET studies did not show any involvement of the inferior olivary nucleus in
ET370 and postmortem studies did not show any structural changes.200 Thus,
although physiological studies proposed the involvement of inferior olivary nu-
cleus, empirical proof was not available. On the other hand, clinical research
studies of ET indicated the involvement of cerebellum in ET. Symptoms like
abnormalities in gait and balance, oculumotor decits, etc. which are related
to the cerebellum have been reported in ET patients.155,169,263,286,336 Studies
have also reported that unilateral cerebellar stroke abruptly terminates ipsilateral
arm tremor in ET patients.79,284 In addition, neuroimaging studies including
functional magnetic resonance imaging (fMRI,41,375 PET,370 DTI170) of ET pa-
tients suggest functional, metabolic and structural abnormalities in cerebellar
gray and white matter. Research thus far suggests that ET is a neurodegen-
erative disorder which involves oscillatory activity in many parts of the motor
circuit and pathological changes in the cerebellum for some patients. However,
extensive research is necessary to identify the primary pathogenesis of ET.
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2.3.3 Treatments
Like PD, clinicians aim to suppress the symptoms with various treatments as
there is no cure. Alcohol is known to reduce tremor for a limited time and
may be used by patients with mild tremors before social events, but not for
long term treatment. First approach to treat ET is using pharmacological drugs
propranolol and primidone. Propranolol is one of the best beta blockers and
suppresses tremor by antagonism of peripheral beta adrenergic receptors. It is
eective against limb tremor and is known to reduce tremor amplitude by 50%.
Primidone is a GABA agonist and suppresses tremor by enhancing GABAergic
tones in the central nervous system. Studies show that it reduces tremor by
at least 50%. Many patients have a strong feeling of being unwell and some
even stop using it for this reason. Other drugs like topiramate (sodium channel
blocker) gabapentine (calcium channel blocker), etc. are also used to treat ET
patients.
When ET patients do not respond to pharmacological treatments, clinicians
may also consider surgical options. Thalamotomy, surgical destruction of part
of the thalamus, is known to suppress tremor in ET patients. Thalamotomy
has till date been performed using stereotactical procedures to target and ab-
late the tissue. Newer techniques that are being investigated like Gamma knife
therapy and Magnetic Resonance Imaging (MRI)-guided focused ultrasound al-
low for non-invasive thalamotomy. Currently, the most used surgical treatment
for ET patients is DBS (Section 2.4). Electrodes are implanted in the ventro-
intermediate nucleus (VIM) of the thalamus and stimulated continuously via a
neurostimulator. Stimulation parameters can be adapted to worsening symp-
toms and, if needed, electrodes can be removed if severe adverse eects are
observed. Adaptability and reversibility of DBS are two of its advantages over
thalamotomy that make it the preferred clinical choice.
2.4 Deep Brain Stimulation (DBS)
DBS is a surgical procedure in which electrodes are implanted in the deep-seated
structures of the brain and stimulated using a neurostimulator implanted in the
thoracic cavity or the pelvic region. It is approved by the Food and Drug Admin-
istration (FDA) to treat PD and ET patients who do not respond to medications
or are having severe adverse eects due to high drug dosage. It is also approved
by the FDA under humanitarian device exemption rules for treating dystonia and
obsessive compulsive disorder.75 Since it was rst performed in 1987, more than
150000 patients have been treated with this procedure worldwide.301 Research
is being carried out to use DBS to treat diseases like Alzheimer's, depression,
epilepsy and other neurological disorders, but the adoption has been slow.
The roots of DBS can be found in ablative surgeries that were performed to
treat PD and ET patients before the availability of pharmaceutical drugs. The
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Figure 2.12: The components of a DBS system implanted in a pa-
tient. Adapted from Shamir et al.320 under the CC BY license
(https://creativecommons.org/licenses/by/4.0/).
ablative surgery of the thalamus (thalamotomy) was known to suppress mo-
tor symptoms of PD and ET. However, it was necessary to identify the exact
location of ablation to avoid severe adverse eects to the patient. To do so,
electrical stimulation in the thalamus allowed the clinicians to distinguish be-
tween the sensory and motor parts based on the response of stimulation. It was
observed that high frequency electrical stimulation in the motor parts of the
thalamus suppressed tremor. In 1991, Benabid et al.22 published their study
of 26 PD patients and 6 ET patients treated with chronic electrical stimula-
tion in the thalamus and reported major improvement in PD and mild to major
improvement in ET. This was followed by various clinical studies with similar
promising results which began the steep rise of DBS surgeries since then.
From the hardware perspective, DBS consists of three components (Figure
2.12) that have to be implanted in the patient, DBS lead(s), connecting cables
and the implantable pulse generator (IPG). The DBS leads (Figure 2.13) are
exible electrodes with variable number (4 or more) and type (non-directional
and directional) of contacts on one end to deliver the stimulation in the desired
target. The IPG has an inbuilt battery which makes it large and cannot be im-
planted in the skull region. It is therefore implanted in the thoracic (or pelvic)
cavity and connected to the electrode via subcutaneous connecting cables. The
stimulation parameters of the IPG are altered by an external programmer with
wireless communication through the skin. Currently, DBS systems are manu-
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factured by Medtronic, St Jude Medical (now Abott) and Boston Scientic with
variable regional availability.
Figure 2.13: Commercially available DBS leads from various companies and their
schematic. BSN: Boston Scientic, STJ: Saint Jude Medical (Now Abott) and MDT:
Medtronic. Reproduced with permission from Rossi et al.297 under the CC BY license
(https://creativecommons.org/licenses/by/4.0/).
The size of the electrode and the anatomical structures in which they are im-
planted is in the range of millimetres. Therefore, the optimal outcome of DBS
depends heavily on the implant location of the electrode. Over the years, mostly
through trial and error and through the results of ablative surgeries, dierent
anatomical structures in the basal ganglia have been identied as regions of
interest for DBS for dierent diseases. For example, stimulation in the STN
is highly eective in reducing PD symptoms, while the stimulation of VIM in
the thalamus has been used to treat ET patients. The commercially available
DBS leads have a minimum of 4 contacts resulting in a tolerance in the infero-
superior direction. However, no tolerance is available in the antero-posterior
and latero-medial directions which makes lead implantation in the right region
a complex task.
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Figure 2.14: The iPlan Stereotaxy 3.0 R from Brainlab, Munich, Germany is one of
the many surgical planning software available for DBS. Figure shows the planning of
patient operated in Centre Hospitalier Universitaire (CHU), Clermont-Ferrand.
The DBS therapy consists of two parts: a surgical intervention to implant
the electrodes and the pulse-generator and post-operative control sessions to
adapt the stimulation to symptom worsening due to increasing degeneration of
neurons. The aim of the surgical intervention is to implant the DBS leads in the
optimal location such that the patient's symptoms are alleviated with minimum
stimulation energy and without inducing any adverse eects. While the aim
of the surgery remains the same, the procedure followed for the surgery varies
from center to center. A typical surgical procedure can be divided into 3 basic
parts : a) Planning b) Lead implantation c) Implanted Pulse Generator (IPG)
implantation.144 Some centers perform the complete procedure on the same day
while others may spread it out over 2 weeks. After the surgery, post-operative
setup of the IPG (programming) is performed by a neurologist. The following
sections describe the DBS procedure in general.
2.4.1 Surgical Procedure
Planning
The rst step that clinicians perform to ensure that the lead is implanted in
the optimal location is extensive surgical planning. Multiple radiological (CT
and MRI) image sets of patients are acquired and imported into one of various
commercial software systems (Figure 2.14) that are available to facilitate the
planning process. The desired target may not always be discernible based on
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spontaneous contrast alone and so, to localize the target in the patient images,
clinicians use direct visualization targeting56,135 or landmark based indirect tar-
geting or a combination of both. Researchers have developed anatomical atlases
of the sub-cortical region using the known landmarks of anterior commissure
(AC) and the posterior commissure (PC). To identify the target area in pa-
tient images, clinicians identify the AC and PC points in these images and then
scale the atlas in the antero-posterior direction using the AC-PC length and in
medio-lateral direction using the distance to the edge of the thalamus. This
method of identifying a target location is termed as "indirect targeting". In the
"direct visualization targeting", clinicians rst outline those sub-cortical struc-
tures that are easily identiable using spontaneous contrast and/or specic MRI
sequences. The desired target is then localized in relation to these structures
alone or with the help of a commercial atlas or an in-house atlas. Some centers
use a combination of both methods as well.
In order to be able to reach the desired target with least amount of damage to
the brain, the surgery is performed stereotactically.333 Commercial stereotactic
frames are used to assign a 3D co-ordinate system to the human brain. To
recognize this co-ordinate system in the digital images of the patient, a localizer
box (Figure 2.15) is used which transfers the physical coordinates of the frame
to a digital one. The planning software identies various ducials of this localizer
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Figure 2.15: The Leksell Stereotactic System R and corresponding localizer box from
Elekta, Stockholm, Sweden is an example of the commercially available stereotactic
frames. Reproduced from their website(www.elekta.com) for non-commercial purpose.
box in the images and can reconstruct the stereotactic frame's coordinate system
in a digital form. The desired target structure is thus assigned coordinates in the
stereotactic reference system. An entry point near the skull and the best path
to reach the target are identied such that no critical anatomical structures or
blood vessels are penetrated.
The surgical equipment allows insertion of up to 5 electrodes in parallel along
the planned path; the number of electrodes used during the surgery depends
on the surgical team. The planned trajectories of these electrodes (parallel to
the best path) is veried to avoid penetration of blood vessels. The team then
identies a number of positions along these trajectories at dierent depths to
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Figure 2.16: The neurosurgeon is inserting one of the intraoperative electrodes for
recording electrophysiological activity and performing stimulation tests. Photo taken
during a surgery at Inselspital Bern.
record neurophysiological data and to test the response to stimulation. For
bilateral implantation, the procedure is repeated for the other hemisphere.
Lead Implantation
The second step to DBS is the electrode implantation. The time between plan-
ning and surgery varies from center to center and can be from few minutes to
few days. The implantation procedure can be performed using local or gen-
eral anesthesia; the choice is dependent on the disease of the patient and the
clinicians preference and expertise. On conrmation of the eect of anesthesia,
the surgeon mounts the stereotactic frame on the patient using head-holding
clamps. The frame is then adjusted to the co-ordinates provided by the planning
system which aligns it to the planned entry point and trajectory. After opening
the head tissue near the entry point, a burr-hole is drilled and electrodes are
inserted as per the pre-determined number of trajectories (Figure 2.16).
In order to conrm that the electrodes are inserted along the planned trajecto-
ries, some clinicians record electrophysiological activity using micro-electrodes
at pre-determined positions.66,136 The electrodes are pushed till the depth of
the rst planned Micro-Electrode Recording (MER) position. MER and Local
Field Potential (LFP) (Figure 2.17) data is recorded and visualized using com-
mercially available systems, some of which also perform real time analysis for
checking neuronal response. Researchers have identied typical neuronal ring
pattern for some of the structures which can be used to verify their presence
along the trajectory.324 A typical trajectory for Ventral Intermediate Nucleus
(VIM) implantation would pass through the dorsal thalamus, into the ventro-
lateral nucleus including the VIM, followed by the caudal thalamus and ending
in the Posterior Sub-thalamic Area (PSA)305 containing the Zona Incerta (ZI),
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Figure 2.17: An example of MER (Electrode 1 and 2) and LFP (LFP 1 and 2) data
recorded during a DBS surgery along two parallel trajectories
Pre-Lemniscal Radiations (PLR) and the Fields of Forel (FF). Signal pattern
changes when entering the VIM with an increase in ring rate compared to
dorsal thalamus.282 In some cases, tremor cells can be found ring at twice
the tremor frequency.189 Inferior to the VIM, an increase in ring rate and
amplitude with altered background activity would suggest ventro-caudal thala-
mus which also responds to sensory phenomena.188 A decrease in background
activity would suggest exiting the thalamus and entering the ZI.106 For STN
implantation, a typical trajectory would pass through the thalamus, ZI and FF,
STN and end in the SNr. MER ring rates are slow and asynchronous and back-
ground activity is less in ZI or FF compared to the thalamus, but the distinction
is not always clear.324 In the STN, cellular ring rate and background activity
increase and sometimes tremor cells can be observed.247 A signicant rise in
ring rates would indicate entrance into the SNr.247
Planning and MER (Figure 2.18) establish that the region being explored is
right for treating the disease in question. Clinicians still need to decide where
to implant the DBS lead. Therefore, stimulation tests are performed during the
surgery either at all the predetermined positions or only some positions that are
chosen based on MER data. Unlike MER, stimulation tests can be performed
at only one position on one trajectory. Tests start at the highest position for
a preferred trajectory, followed by the same position on the alternative trajec-
tory/trajectories and then moving progressively deeper. During each test, one
stimulation parameter (current or voltage) is stepwise increased from 0 to a xed
upper limit. Before the start of stimulation the severity of the patient's symp-
toms are noted (baseline). For each increment in the stimulation parameter,
changes in the symptoms are evaluated (Section 2.5)compared to the baseline
and the patient is observed for any noticeable adverse eects. Some clinical
centers note the observed changes for all increments of stimulation parameter
while others note only for the ones where the maximum improvement in symp-
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Figure 2.18: The steps that are taken to implant the DBS leads at the optimal
location. After surgical planning and target selection, MER is performed to record
brain activity. This is followed by stimulation tests to determine therapeutic and adverse
eect inducing stimulation parameters. Finally DBS lead is placed at the location with
the best results obtained from stimulation tests.
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toms is observed (Figure 2.19). If severe adverse eects are observed at low
values of stimulation current or voltage, stimulation tests are aborted.
Figure 2.19: The observed changes in patient's symptoms and the corresponding
stimulation test parameters are noted by the neurologist using pen and paper for later
reference. Photo taken during a surgery in Inselspital Bern.
On completion of the stimulation tests, the surgical team must choose the
trajectory and the position at which a particular contact of the electrode should
be implanted. For each stimulation test position, the team mentally calculates
the therapeutic window i.e. the dierence between the stimulation parameter
where largest therapeutic eects were observed and either the parameter where
the rst adverse eects were observed or the xed upper limit of stimulation.
To implant the DBS lead, clinicians choose the trajectory that has the most
number of positions with large therapeutic window and is closer to the desired
target structure. For lead placement, i.e. choosing the position and the contact
of the lead for chronic stimulation, the surgical team tries to match most of
the stimulation test positions with large therapeutic windows to the stimulating
contact of the lead`. One of the many ways to achieve this is to implant the
lowest (distal) contact of the DBS lead at the deepest position with a large
therapeutic window. Any higher positions with large therapeutic windows can
then be stimulated with proximal contacts. Once the decision is made, the
neurosurgeon implants the DBS lead (Figure 2.18), secures it into position
and places the connector between the skin and the skull to connect to the IPG.
Implantation of Pulse Generator
Depending on unilateral or bilateral DBS, one or two IPGs are implanted in
the subclavicular area in a subcutaneous pouch. The implantation is performed
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under general anesthesia. Some clinical centers implant the IPG on the same
day while others do it the next day or a few days after. The extension cables to
connect the IPG to the DBS leads are implanted deep under the skip to prevent
adhesion to the subdermal area. Once the IPG is connected to the DBS leads
via the extension cables, tests are performed to ensure proper connections. All
the incisions are then sutured to complete the procedure.
2.4.2 Risks and Complications
DBS is regarded to be a relatively safe and eective procedure, but it is not
absolutely free of risks and complications.
Stimulation induced Adverse Eects
The complexity of the surgical procedure of DBS results in causing undesired
eects of stimulation due to unplanned position of the DBS lead or due to stim-
ulation spreading into tissue surrounding the planned target. Naturally these
eects vary based on the planned target structure. The most common adverse
eect of GPi DBS is dysarthria, perhaps due to stimulation of the cortico-
bulbar tract in the internal capsule.342 Other adverse eects of GPi DBS in-
clude headache, nausea, muscle contractions of face and limbs, numbness and
abnormal eye movements. In case of STN DBS, adverse eects caused by the
stimulation of third nerve or rostral interstitial nucleus like motor contractions
and dysarthria, paresthesia and oculomotor eects are observed.21,344 Other
eects like nausea, heat sensation and sweating are also common.239 Flora et
al.60 performed a systematic review for a collective of 430 patients of VIM
DBS and found adverse eects like paraesthesia (18.84%), dysarthria (8.84%)
and headache (7.21%) among others. These may be a result of stimulation
spreading posteriorly into the Ventro-caudal (Vc) nucleus, medially into the
medial lemniscus242 or laterally into the internal capsule.16,102,344 These symp-
toms are usually temporary, occurring during intraoperative stimulation tests or
immediately after stimulation and wearing o with time. In case they persist
afterwards, they can still be controlled by adjusting stimulation parameters.
Apart from these acute adverse eects of stimulation, reports of chronic ad-
verse eects aecting the cognitive and psychiatric status of the patients have
also been reported. Verbal uency has been reported to decrease after STN-
DBS.111,252,328 Studies have compared cognitive function of PD patients after
STN-DBS with GPi-DBS and have reported that STN-DBS patients showed
greater decline.364 This decline however, is not very large and it cannot be said
for certain if it is an adverse eect of DBS or signs of worsening disease. Mood
variations have also been reported in relation to STN-DBS, Berney et al.26 re-
porting a decline while Daniele et al.58 reporting an improvement. Takeshita et
al.343 have reported an incidence rate of mania between 4.2% and 8.1% as well
as of depression between 2 and 33%. Depression is an important psychiatric
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symptom in terms of patient management as it relates to suicide risks. Reported
incidence rate of minor depression (31.4%) are much higher compared to major
depression (1.6%).99 History of depression and excessive tapering of levodopa
after DBS have been reported as risk factors of depression.363,371 In another
study, Witt et al.372 reported that STN-DBS eects on cognitive function could
be avoided by ensuring that the stimulating contact is in the STN and the DBS
lead does not pass through the head of the caudate nucleus.
Suicide risks have been reported in relation to DBS. In a multicentre study
consisting of 5311 patients, 24 (0.45%) committed suicide while 48 attempted
suicide (0.90%).360 The researchers also identied 3 risk factors for suicide:
i) relatively younger age, ii) early onset of PD and iii) a preoperative suicide
attempt. Other studies have reported dierent incidence rates of suicide risks
between 0 and 5%.42,99 But, like adverse cognitive function, incidence rates of
suicide are higher in PD patients than in the world population as reported by
the World Health Organization.243 In addition, PD patients who undergo DBS
have higher severity of the disease and usually are on their limits for treatment
through medication. Thus, in absence of any studies comparing the suicide
risks between advance PD patients with and without DBS, it is not possible to
attribute higher suicide rates to STN-DBS alone.
Other Complications
A critical surgical complication of DBS is intracranial haemorrhage i.e. bursting
of blood vessels due to insertion of DBS leads or microelectrodes. The reported
incidence rate in clinical studies varies from 1 to 25%.94 Older patients and
patients with high blood pressure are at a higher risk of having haemorrhage
during DBS. The use of multiple MER electrodes has also been associated
with higher occurrence of haemorrhages, and studies have suggested to use few
MER electrodes and only when necessary.383 Another way to reduce chances of
haemorrhages would be to use contrast based MRI images during the planning
to identify the blood vessels and avoid them along the trajectory. Other surgical
complications with lower incidence rates include confusion, anxiety and seizure
as well as hypotension and arrhythmia.94
Continuous chronic stimulation may be halted due to hardware failures like
cable breakage or malfunctioning IPG. Incidence rates for electro-mechanical
failures including failure of IPG, electrode displacement and breakage as well as
breakage of extension cords range from 4 to 9.7%.338 One study also reported
2 patients having allergic reactions to DBS systems.259 The connection area
between the DBS lead and the extension cord is the most frequent place for
breakage.95 Chances of equipment failure can be reduced by avoiding wiring at
sharp angles and not implanting the IPG in the pectoral region for patients with
well-developed muscles in that region. Another hardware related adverse event
is infection with incidence rates ranging from 2.9 to 7.7%338 with an average
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infection rate of 4.7%.29 Risk factors include age of the patients (younger than
58 years or older than 65 years) among others.28 Sugiyama338 suggests exten-
sive patient management (bathing, etc), precautionary handling of DBS device
(using surgical instruments) and other surgical precautions to limit chances of
infection during DBS surgeries.
2.4.3 Mechanism of Action
The widespread adoption of DBS for the treatment of diseases like PD and ET
clearly indicate its success in suppressing the patient's symptoms. Neverthe-
less, the mechanisms that bring about these therapeutic (or adverse) eects
in patients are still unclear. In order to clearly understand these mechanisms,
information with respect to the following topics have to be obtained.164,237
Eects on neurons What happens to the soma of neurons (cell body, Figure
2.20) in the vicinity of the stimulating electrode? Are they excited and
transmit signals or are they inhibited from performing their designated
tasks?
Eects on axons What happens to axons (Figure 2.20) that are located in
the vicinity of the stimulating electrode but have their soma outside of this
region? do these axons get activated and transmit information towards
(antidromic) or away (orthodromic) from the soma?
Eect on functional circuit The neurons and axons surrounding the stimu-
lating electrode are part of a larger functional circuit performing a cer-
tain task. For example, the STN neurons are part of the cortico-basal
ganglia-thalamic circuit which is responsible for various tasks including
movement. With this regards, what changes are seen in this cortico-basal
ganglia-thalamic circuit during STN DBS? In general, are the eects of
DBS on neurons and axons changing the functional circuit?
Acute and chronic eects The amount of time between stimulation and its
eect varies based on the dierent symptoms and the disease. For ex-
ample, DBS for PD patients immediately improves tremor but gait im-
provements can take days.125,154 Are these dierences in time because of
changes in the functional circuits fo the brain or because the brain adapts
to stimulation through physical changes (plasticity)?
Researchers have performed various experiments studying the eects of DBS
at the cellular, tissue and system levels to get more information about these
topics. According to Udupa,349 these experiments can be roughly classied
into electrophysiological, imaging, biochemical and molecular methods. The
initial hypothesis of the mechanisms of action of DBS was based on the sim-
ilarities between therapeutic eects of DBS and ablative surgeries indicating
that electrical stimulation inhibited the neurons in the vicinity of the electrode.
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Figure 2.20: A rough representation of a neuron with its relevant parts
This hypothesis also supported the classical model of PD i.e. stimulation in the
STN or GPi would decrease the GPi output to thalamus, in turn, promoting
movement. In vitro experiments have shown that high frequency DBS prevents
initiation and propagation of action potential through sustained depolarization
of neuronal membranes218 and perhaps through release of inhibitory neurotrans-
mitters.76 Experiments which recorded activity in the GPI76 and STN367 during
stimulation provided further evidence in support of this hypothesis.
In animal model studies, Hashimoto et al.137 found that during eective STN
stimulation, neuronal activity in the GPe and GPi increased in contrast to ex-
pectations based on the inhibition hypothesis. Further research to understand
the eect of stimulation on neurons revealed that the neuronal projections in
the stimulated region were activated resulting in increased frequency of action
potentials from the region.76,226,357 Computational models revealed that high
frequency stimulation aects the projections more than the soma because of
their lower stimulation thresholds. Larger axons that are perpendicular to the
electric eld in the stimulated region are activated easily compared to others
which may result in a neuron with its axon only in the stimulation region being
activated.227 Results of the optogenetic experiments by Gradinaru et. al.119
further supported this idea as activation of bers in STN of rat models resulted
in therapeutic eects but inhibition of STN neurons did not. Experiments mea-
suring the extracellular Cyclic guanosine monophosphate (cGMP) levels (an in-
direct marker for neuronal activity) in humans undergoing DBS showed increase
in levels in putamen, GPi and SNr during eective stimulation in STN, concur-
ring with the results of computational and animal models. Grill et. al.122 argue
that the increase in action potentials due to stimulation may restrict passing
of information that is coded in the time-varying neuronal activity resulting in
an "informational lesion." Some animal model studies have provided supporting
results2,51 while others have suggested that information transfer decreases in
parkinsonian state and is partially recovered through stimulation.74
Another hypothesis for the mechanisms of actions of DBS is the disruption of
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oscillations. Experiments measuring LFP in PD patients and animal models
have shown that, compared to healthy brains, beta band (12-30Hz) oscillations
in PD become more coherent between dierent neuronal circuits, especially in
the sensorimotor basal ganglia.77,194,257 Additionally, while the beta oscillations
in healthy brain disappear during movement, they persist for PD patients. In
patients treated with levodopa, the beta-band power in STN and GPI decreases
in correlation with the magnitude of clinical improvement in bradykinesia and
rigidity.40 Experimental evidence is available to support the idea that ther-
apeutic eects of DBS are due to disruption in the beta-band oscillations.59
Researchers have also found that stimulation in the STN at beta frequencies
worsens bradykinesia.50
DBS also causes neurochemical changes in the vicinity of the electrode. Micro-
dialysis studies in human brains222,384 have shown that STN or GPi DBS can
induce dopamine release. However, this may play no signicant role or only a
supportive role in the mechanisms of action269 because tremor and dyskinesias
worsen or do not change with dopamine medication, but respond to DBS. Nev-
ertheless, for other diseases like cervical dystonia or OCD, these eects of DBS
may be relevant.219,255 Studies report only short term neurochemical eects of
DBS, but with advancing technology, designs for long term experiments should
be possible in the near future. The application of DBS to diseases other than
PD and ET have led to the idea that only some therapeutic eects of DBS
are due to neuromodulation. Based on the dierence in time that symptoms
take to respond to DBS, some eects may be also due to synaptic plasiticity
and network reorganization. The suppression of motor tics in Tourette's syn-
drome through DBS can take months.300,318 While phasic dystonic movements
improve immediately through GPi DBS, tonic symptoms require months. Imag-
ing studies using fMRI, PET and Single-photon emission computed tomography
(SPECT) have also shown that DBS causes global and long-term changes in
the network activity.171
The above mentioned hypotheses of mechanisms of DBS were proposed based
on research studying a particular pathology or target nuclei. It is clear that
none of the hypotheses proposed for the mechanisms of DBS can explain all
the observed eects in dierent pathologies and targets. Therefore, further
research is necessary to obtain information about how the mechanisms of DBS
vary between dierent pathologies and to nd out if any similarities exist.
2.5 Symptom Evaluation During DBS Surgery
DBS for PD and ET is widely performed under local anaesthesia1 to observe the
eects of stimulation on the symptoms of the patient. During the intraoperative
stimulation tests, the therapeutic eects of stimulation are evaluated based on
these observed changes in the patient's symptoms. In case of ET patients or
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PD patients with severe tremor, the baseline severity in tremor and any changes
during stimulation are estimated by visual observation. When DBS is used to
treat PD patients with rigidity, the therapeutic eects during intraoperative
stimulation tests are evaluated by estimating changes in it. While tremor is
an active symptom, rigidity is dened as a passive symptom and can only be
observed through external intervention. Therefore, to estimate rigidity and its
changes during the surgery, passive movements of the patient's arm or the wrist
joint are performed (Figure 2.21). Other motor symptoms of PD patients like
bradykinesia and akinesia also improve through DBS. But studies have shown
that the latency for tremor and rigidity suppression after stimulation is within
seconds while that for bradykinesia is longer. Therefore, during intraoperative
stimulation tests, changes in these symptoms are either not evaluated or only
evaluated after tremor and/or rigidity have been considerably suppressed. Thus,
this section concentrates on tremor and rigidity evaluation.
Figure 2.21: A neurologist is performing passive movements to evaluate the changes in
patient's rigidity with changing stimulation parameters. Photo taken during a surgery
in Inselspital Bern.
In various DBS centers around the world, while the method of symptom evalua-
tion remains the same, the rating scales used during intraoperative stimulation
tests vary. In some centers, clinical rating scales like UPDRS are used to eval-
uate the baseline symptom and then again the changes at each step of varying
stimulation parameter(s). In other centers, clinicians use a direct rating system
where the baseline severity of the symptom is assigned 0 and any improvement
is rated between 1 (low improvement) to 4 (symptom suppressed) in steps of
0.5. The method and rating system of symptom evaluation during intraopera-
tive stimulation test are minor modications of those used for routine clinical
evaluation. The rating systems in particular were designed to be used to evalu-
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ate symptoms over longer periods of time rather than continuous evaluation.10
Hence, to adapt the rating system to intraoperative use, clinicians would intro-
duce intermediate steps for each rating level177 e.g. for UPDRS instead of just
0,1,2,3 and 4, they would use 0, 0+, 1-, 1, 1+,... 4. Studies have shown that
these methods and rating systems have low inter-rater260,275 and intra-rater
reliability275 as they depend signicantly on the evaluator's experience.121 Us-
ing these relatively subjective symptom evaluations during DBS thwarts other
eorts to implant leads at the best possible location with millimeter precision.
In addition to the variations associated with the rating scales, the passive na-
ture of rigidity evaluation introduces other challenges. Passive movements to
estimate rigidity can be performed about the elbow or the wrist joint with move-
ment patterns being extension-exion, rotational or a combination of both. In
routine clinical evaluation, neurologists tend to check rigidity for dierent joints
and with dierent movements. Additionally, the evaluating neurologist may not
be the same between dierent clinical visits. In contrast, rigidity evaluation
during DBS is performed by only one neurologist and most often only about
his/her preferred joint to reduce surgical time and in-turn patient stress.
The connement of passive movements during DBS surgery to one neurologist
and one joint is advantageous for the goal of this thesis as it limits the variations
that have to be considered. Another advantage that is presented by the nature
of intraoperative evaluation is the duration i.e. the movement pattern and its
variations have to be analysed for the duration of a stimulation test at one po-
sition (1-5 minutes) independently of the previous stimulation test. In addition,
as the passive movements are continuous for one stimulation test (from baseline
to stimulation), the intra-rater variations are also reduced. Nevertheless, it is
important that the evaluating neurologist has direct access to the patient's arm
to perform passive movements as his experience plays an important role in the
evaluation. Therefore, most centers ask experienced neurologists or movement
disorder specialists to assist during the surgery for rigidity evaluation.
2.5.1 Quantitative tremor evaluation
Various techniques have been proposed by researchers to evaluate rigidity and
tremor in a more quantitative fashion for the clinical assessment outside the
operating room.84,139 Tremor, for example, has been studied using various
sensors like Electromyography (EMG),10,167,181,256,330 spirograms,85,292 gyro-
scopes238,294 and accelerometers.233,291,337 Some early propositions were based
on mechanical setups which have largely been converted to electronic systems.
Two of the most common techniques used to measure tremor are EMG and in-
ertial sensors (Figure 2.22). EMG estimates muscle activity by measuring the
electrical potential generated across them when they are activated using intra-
muscular electrodes (invasive) or surface electrodes (non-invasive). Researchers
have used EMG to measure activity of tremor patients to characterize tremor in
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Figure 2.22: The gure shows tremor recorded by an accelerometer mounted to the
extremity of the index nger on channel 2 and by surface EMG electrodes placed at
the exor and extensor muscles of the radial bone on channels 5 and 6 respectively.
Reproduced from Grimaldi et al.123 for non-commercial use under the CC BY-NC-SA
3.0 (https://creativecommons.org/licenses/by-nc-sa/3.0/) license.
terms of time-frequency parameters,256 to distinguish between dierent types
of tremor43,153,230 and also to evaluate the therapeutic eect of drugs273 and
DBS.291,337 A major drawback of EMG is patient discomfort: intramuscular
electrodes are invasive and surface electrodes require good contact with the
skin to record good quality data.91 This prevents the use of EMG to measure
tremor for extended periods of time.
Inertial sensors (Figure 2.23) are a group of sensors that measure movement of
a certain object by measuring its acceleration (accelerometer, Figure 2.23a),
angular velocity (gyroscope, Figure 2.23b) or magnetic eld (magnetometer,
Figure 2.23c). Inertial sensors were designed to assist in the navigation of vehi-
cles in areas where a Global Positioning System (GPS) signal was not available.
Due to advancing technology, new inertial sensors are made using Micro Electro
Mechanical Systems (MEMS) reducing their size to micrometers. These minia-
turized sensors are now used in mobile devices, game controllers and tness
trackers to track movements of the user. These sensors provide an excellent op-
portunity to measure tremor. Early MEMS based inertial sensors were only able
to measure acceleration along a single axis (uniaxial). Researchers used multiple
uniaxial accelerometers to measure tremor in dierent directions and combined
the signal to get an estimate of the tremor severity. Currently, MEMS units
with triaxial accelerometers, triaxial gyroscopes and triaxial magnetometers are
available providing the ability to track movements with 9 degrees of freedom.
These advancements have made the inertial sensors a favourite among tremor
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Figure 2.23: The three types of inertial sensors (a) Accelerometers measure the accel-
eration (b) Gyroscopes measure the angular velocity and (c) Magnetometers measure
the magnetic eld. New devices capable of measuring all three quantities are also
available
investigators.
Over the years, many studies have been published where accelerometers have
been used to measure tremor. Characterizing pathological tremor104,160 and
comparing it with physiological tremor,231,290,291 measuring the changes in
tremor with worsening disease262,266,316 or to evaluate the eects of therapy
on tremor233,291,337 are few examples where accelerometers have been used.
Accelerometers have also been used during post-operative programming for the
IPG.233,280 Apart from these research based uses of accelerometers, inertial sen-
sors are also used in commercial systems to evaluate motor symptoms including
tremor, bradykinesia and akinesia. The Kinesia system (Great Lakes Neurotech-
nologies, Cleveland, USA) can measure tremor, bradykinesia and dyskinesia in
PD patients using an accelerometer mounted on a nger and transfer the data
to the clinician providing a telemedicine tool to evaluate symptoms. The PKG
system (Global Kinetics Corporation, Melbourne, Australia) is another similar
telemedicine device which tracks the same symptoms through an accelerometer
based wrist watch.
Despite these commercial and research systems mentioned above, intraopera-
tive use of systems to quantify tremor has been very limited. To the best of my
knowledge, there is no commercial system that allows for intraoperative evalu-
ation of movement disorder symptoms. On the other hand, some researchers
have proposed methods to quantitatively evaluate tremor during surgery. Eects
of dierent temporal pattern of DBS signal on tremor was studied intraoper-
atively using an accelerometer.30 MER signals were correlated to goniometer
signals to identify the target structure.319 An acceleromter was once used dur-
ing thalamotomy as well.232 Journee et. al.166 used two uniaxial accelerometers
during DBS surgery to evaluate tremor as well as nger tapping while stimulat-
ing through the DBS lead to identify the best contact. They however, used only
spectral parameters to identify changes in tremor without applying any lters to
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the raw data, thus not suppressing the inuence of noise and gravity. They also
only recorded the baseline before inserting the lead, thus unable to dierentiate
the eect of tissue damage due to lead insertion from the eect of stimulation
on tremor. Another study used a commercial system designed for quantifying
tremor called CATSYS 2000 (Danish Product Development Ltd, Snekkersten,
Denmark) after implanting the DBS lead to identify the best stimulation pa-
rameters during the surgery.261 This system uses a tremor pen containing a
biaxial accelerometer which the patient has to hold in a certain position to
record the best data. As patients were given time to familiarize themselves with
the system, the surgical procedure was elongated and the data recorded was
also aected by varying levels of familiarity. Neither of the two studies provided
a detailed comparison of the accelerometer based results with the clinical eval-
uation. These inadequate and partial techniques gave the push to design a new
technique to evaluate changes in tremor during intraoperative stimulation tests
for DBS surgery and test it by applying it in more than one clinical center.
2.5.2 Quantitative rigidity evaluation
Rigidity evaluation has received less attention from researchers compared to
tremor in terms of number of publications proposing methods for quantitative
evaluation. Researchers have proposed methods using EMG to continuously
monitor changes in rigidity,10 to dierentiate between PD rigidity and health
subjects86,373 and also to estimate changes in rigidity with and without DBS.191
Others have used specially designed mechanical apparatus (Figure 2.24) to
measure changes in rigidity by measuring parameters like angular impulse.101 It
has been shown that parameters representing viscous properties of rigidity cor-
relate better with clinical scores than those measuring elastic properties.264,317
Shapiro et. al321 used a custom made mechanical setup to show that STN-DBS
was better at reducing rigidity compared to drug therapy only.
The use of these techniques in the OR would be very cumbersome and could
cause discomfort to the patient. At the beginning of this doctoral work, a
literature search for rigidity evaluation during DBS surgery came up empty. The
absence of any such literature motivated us to accommodate rigidity evaluation
during DBS using an accelerometer. During the time-course of this work, to
the best of my knowledge, only one other research group published a method to
evaluate rigidity intraoperatively.177 They used a mechanical setup which could
only evaluate rigidity through the wrist joint. The use of their system during
the surgery resulted in less number of stimulation tests than usual due to time
constraints.
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Figure 2.24: The mechanical setup used by Park et al.264 to measure the viscoelas-
tic properties of rigidity in Parkinsonian patients. Reproduced from their paper with
permission c2011 IEEE.
2.6 Anatomical Targets for DBS Lead Implantation
The current anatomical targets for PD (STN and GPi) and ET (VIM) were
identied from lesioning surgeries. Various long term clinical studies have shown
that stimulation through DBS leads in these structures suppresses the patients
symptoms, albeit to a variable degree. But existing knowledge of the patho-
physiology of the diseases and the mechanisms of action of DBS is limited and
some contradictory reports have also been published where desired improvement
was not achieved by stimulation of these structures. Therefore, further research
is necessary to identify anatomical structures that are more ecient and reliable
DBS targets.
2.6.1 Identifying structures
It is necessary to know the anatomical structures surrounding the intraoperative
electrode or the DBS lead to analyse which structures play a role in the thera-
peutic eect of stimulation. In a recent review study, Caire et al.47 identied
many techniques with which this task can be achieved. These include projection
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of active contact(s) on anatomical images,353 on anatomical atlas302,306 or even
probabilistic functional atlas.179 MER results alone382 or in combination with
imaging366 and white matter tracking54 can also be used for this purpose.
2.6.2 STN implantation
The STN is surrounded by other structures like the ZI, SNr and the thalamus as
well as bre tracts like FF and Internal Capsule (IC) (Figure 2.25). Trajectories
Figure 2.25: The structures surrounding the Subthalamic Nucleus (STN), some of
which are along the trajectories used for STN-DBS implantation. AL = ansa lenticularis;
CP = cerebral peduncle; FF = Fields of Forel; GPe = globus pallidus externus; GPi =
globus pallidus internus; H1 = H1 Field of Forel (thalamic fasciculus); IC = internal
capsule; LF = lenticular fasciculus (H2); PPN = pedunculopontine nucleus; Put =
putamen; SN = substantia nigra; Thal = thalamus; ZI = zona incerta. Reproduced
with permission from Hamani et al.131
to implant a lead in the STN will pass through some of the structures and
stimulation in the STN at higher amplitudes will spread into these neighbouring
structures. Zheng et. al.380 analysed the position of the DBS lead in 40
cases using post-operative MR images in relation to the position of STN which
was identied through a combination of intraoperative MER and post-operative
MRI. He found that the most eective contact on the DBS lead was located in
the sensorimotor region of the STN or dorsal to it in the ZI or FF. Other studies
have also reported similar results.112,132,302
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2.6.3 VIM implantation
In the vicinity of the VIM, apart from other thalamic nuclei (Figure 2.26), there
are the bre tracts like the Dentato-Rubro Thalamic Tract (DRTT) and PLR
and other structures like the ZI. Other thalamic nuclei like the Intermediolateral
(InL)150 and the Ventro-Oral (VO)48,352 have already been shown to have a role
in the therapeutic eects of DBS. Lesioning studies have reported targeting the
PLR241 and some researchers have also implanted DBS leads close to it.331,352
Others have targeted the DRTT124 and some have suggested that ZI could also
play a role for ET patients.103
Figure 2.26: The dierent thalamic nuclei around the Ventral Intermediate Nucleus
(VIM) which are traversed through during VIM-DBS implantations. AL = AnteroLat-
eral; VO = Ventro-oral; InL = Intermediolateral; VCM = Ventrocaudal medial; VCL
= Ventrocaudal lateral and PLR = prelemniscale radiations. For comparison to other
nomenclatures of thalamic nuclei, refer to Lemaire et al.187
2.7 Data Management and Visualization for DBS Lead
Placement
The use of software in the eld of medicine has increased signicantly in recent
years. As computational power increases, the abilities of software to simplify
tasks of clinicians has also increased. For DBS as well, software is used for all
phases i.e. from planning to post-operative follow up. Nevertheless, one area
where software can further assist the clinicians is at the time of placing the
lead for optimal chronic stimulation. Stimulation at the optimal position should
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have the maximal reduction in patient symptoms with minimal energy consump-
tion without inducing any adverse eects. To achieve this, the team identies
positions with large therapeutic windows, mentally visualizes the anatomy sur-
rounding these positions and identies one as an optimal position. The surgical
planning software can assist the team by visualizing the anatomy, but not all
centres have access to it in the OR room.
During a typical DBS surgery, a large amount of data is collected from the
patient to optimize DBS leads implantation viz. pre-operative CT and/or MR
images, intraoperative MER and response to stimulation tests. In addition, the
surgical team spends signicant time during surgical planning generating more
information by combining their anatomical knowledge and patient images. At
the time of identifying the optimal position to implant the DBS lead, all of this
information is considered. These data are however, either available on dierent
computer systems or only in the form of paper based notes (Figure 2.27).
Clearly, the decision making process can be simplied through a tool that would
consolidate all the relevant information, process it and visualize it together.
An absence of such a software provided the impetus to further investigate and
develop a solution to ll up this void during this doctoral work.
There are a few commercial software systems available that surgical teams can
use during a DBS surgery. Software designed to assist during surgical planning
can import, register and visualize image data, localize stereotactic frames, out-
line and label anatomical structures, plan trajectories and generate co-ordinates
for the frame. Systems designed for intraoperative use are able to record and
analyse MER data in real time and assist during stimulation tests. But most
of these single-purpose systems have proprietary data formats hindering data
consolidation. While some planning systems accept MER and stimulation test
results, these have to be entered manually. Doing so during the surgery would
heavily burden the stressed surgical sta. Additionally, no commercial sys-
tem exists that automatically calculates the results of intraoperative stimulation
tests.
Scientic literature describing software for DBS are also plentiful, most of which
aim to automate certain tasks related to DBS. D'Albis et al.57 have developed
a tool called PyDBS that allows identication of AC-PC points, automatically
identies the frame in stereotactic images and automatically segments and reg-
isters patient images (pre- and post-operative). Qualitative assessment showed
its ability to assist clinicians in planning and post-operative phases. Another
software called StimExplorer46 allows manual alignment of patient images with
anatomical atlas and place the post operative DBS leads. It predicts the Volume
of Tissue Activated (VTA) in homogeneous tissue based on the stimulation pa-
rameters (not patient-specic) which can assist clinicians during postoperative
IPG programming. However, neither of these systems were designed to be used
during intraoperative stimulation tests.
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Figure 2.27: An extract of the noted MER data and the changes in patient's symptoms
during intraoperative stimulation tests. Courtesy of PD Dr. med. Michael Schupbach.
48 CHAPTER 2. BACKGROUND
Guo et al.128 developed a tool to visualize a database of their previously op-
erated patients consisting of electrophysiological information, segmented deep-
brain nuclei and previously chosen targets on images of prospective patients
using non-rigid registration. The results of their retrospective and prospective
study showed that using their software system would reduce the duration of
surgical planning and intraoperative exploration without aecting surgical out-
come. However, their software was not patient-specic as it did not visualize
the results of the intraoperative stimulation tests of the patient being operated.
Cranial Vault is another repository of DBS patients which can be accessed
through software modules called CRAVE.70 This tool had various algorithms to
automate image processing tasks to reduce duration of surgical planning. It
could be used intraoperatively to visualize manually entered therapeutic and
adverse eects of stimulation tests. On testing the system in a clinical study, it
was observed that the task of manually entering information to be tedious for
the surgical sta.
Chapter 3
Clinical Data Acquisition
An important aspect of this doctoral work is the acquisition of clinical data,
i.e. acceleration data during DBS surgery. The approach to use acceleration
sensors during a DBS surgery to evaluate tremor and rigidity may not seem
complicated at rst, but the restrictions and requirements of the surgical room
act as signicant deterrents. This chapter describes these requirements and
the specications of the equipment that was developed to satisfy them. It also
provides the details of two clinical studies that were undertaken to acquire data,
including the details of the participating patients.
3.1 Accelerometer Data Recording Setup
3.1.1 Technical Requirements
A review of the published literature as described in Section 2.5 shows that
an accelerometer would be a good option to evaluate changes in tremor and
rigidity during DBS surgery. In order to choose an accelerometer, it is necessary
to identify the parameters of the movement that have to be measured. Tremor
is a rhythmic movement and thus can be modelled by a sinusoidal function
described by the following equation:84
T = A sin(2ft) (3.1)
where T is the tremor, A is the peak to peak distance moved by the tremulous
limb, f is the frequency of tremor and t is the duration of time for which tremor
is measured. The acceleration of tremor would be the second derivative of
equation 3.1 and can be described by the equation:84
Tacc =  A(2f)2 sin(2ft) (3.2)
where Tacc is the acceleration of tremor. This equation can be used to calcu-
late the range that an acceleration sensor should have to successfully measure
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tremor. For a tremor of 6 Hz having a peak to peak distance of 10 cm, the am-
plitude can be calculated using A(2f)2 to be approximately 14212.23 cm=s2
or 14.5 g (1g = 9:8m=s2 i.e. acceleration due to gravity). Therefore, a uniaxial
accelerometer must have a range higher than this to measure tremor along its
axis. Another factor to consider for choosing the acceleration sensor is the sam-
pling frequency, which according to the Nyquist theorem, must be more than
twice the frequency of the data that has to be measured.
Passive movements for rigidity evaluation (Section 2.2) are also rhythmic in
nature and thus can also be modelled by the equation 3.1 and 3.2. The dif-
ference between the two however is that the peak to peak amplitude (A) can
be signicantly larger (upto 50 cm) while the frequency (f ) of movement is
lower (less than 2 Hz228,278). Based on these values the required range for an
accelerometer is 8g. Considering the denition of rigidity as the resistance to
passive movement, any improvement in rigidity would decrease the resistance
and instantaneously increase the speed of the movement. Combining this in-
formation with the scenario of intraoperative evaluation of rigidity described in
Section 2.5.2, it can be hypothesized that any change in rigidity due to stim-
ulation could be detected by using an acceleration sensor. Contrary to tremor
evaluation though, the acceleration sensor should be attached to the evalua-
tors wrist (Figure 3.1) instead of the patient. This counter-intuitive approach
is based on the thinking that such a setup would result in better recording of
passive movements of the wrist joint.
The above estimation of accelerometer range assumes that tremor or passive
movements are uniaxial, which in reality is not the case. Therefore, in practice,
a triaxial accelerometer is necessary to record these movements. Commercial
accelerometers record inertial acceleration and are inuenced by the acceleration
due to gravity (1g).83 This inuence will vary on individual axis based on the
orientation of the accelerometer, but will appear as a constant on the vector
magnitude of acceleration. Furthermore, accelerometers by design cannot mea-
sure rotations about their own axis. But the data they record will be inuenced
by the rotational component of pathological tremor as the rotational axis of a
patient's limb does not match the axis of the accelerometer.
3.1.2 Clinical Requirements
Apart from the technical specications necessary for evaluation of tremor and
rigidity, certain constraints are imposed by the environment of the operating
room in which the acceleration sensors would be used. The sensors must be
attached to the patient or the evaluator to record data and therefore should
not cause any allergic reactions. It should also not have electrical leakage or
overheat after long periods of use. In addition, it should be possible to disinfect
the sensor or its housing so as to prevent any hygienic hazards in the operating
room. Sterilization of the equipment was not necessary as it was to be used
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Figure 3.1: The accelerometer sensor mounted on the neurologist's wrist to measure
the acceleration of passive movements to evaluate rigidity.
in the non-sterile area of the operating room. An additional requirement set
by the setup for DBS surgery is in terms of electromagnetic noise. The MER
equipment is very sensitive to external noise due to the small range of electrical
activity that it measures in the patient's brain. For this purpose, before MER is
performed, any devices that could potentially cause electromagnetic interference
are turned o in the operating room. The chosen acceleration sensor should
therefore not create any such interference. In case of unforeseen circumstances,
it should be possible to stop the data recording and detach the acceleration
sensors quickly.
Data collection using the acceleration sensor during DBS surgeries would have
to be approved by the local ethics commission of the surgical center. In Switzer-
land, these commissions are governed by the Federal laws. Based on these laws,
the clinical study for this doctoral work would fall under the Ordinance on Hu-
man Research with the Exception of Clinical Trials (HRO 810.301347). In order
to be categorized as a study with minimal risks and burdens, it would be neces-
sary to use a device certied by governing authority in Switzerland or bears the
Conformite Europeenne (CE) marking.346 Thus, while it would be possible to
acquire commercial sensor modules and connect them to a microcontroller in
house, such a setup would present signicant hurdles in attaining approval from
the ethics commission. On the other hand, commercial accelerometer based
devices which are approved for evaluating tremor use wireless communication
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Figure 3.2: The photo shows the STEVAL-MKI022V1, ST, Geneva, Switzerland sensor
evaluation board placed in a 3D printed case and a Velcro strap that is used to attach
the sensor.
to transfer the data to the recording software. In addition, the analysis of the
data would be done through proprietary algorithms which may or may not be
valid for intraoperative evaluations. Rigidity evaluations with such a system
would not be possible.
3.1.3 Hardware
With regards to all the requirements described above, the commercially avail-
able sensor evaluation board STEVAL-MKI022V1 based on the LIS331DLH ac-
celerometer from ST, Geneva, Switzerland, was chosen. The LIS331DLH is a
triaxial accelerometer with a maximum range of 8g and is coupled with a
ST7-USB microcontroller which can transfer data at a maximum sampling rate
of 400 Hz. This is sucient to record pathological tremor which is known to
have a frequency of less than 10 Hz. It can be connected to a computer using
a USB connection to record data using software from ST or custom made soft-
ware. A case was designed for the board in-house at the Institute for Medical
and Analytical Technologies (IMA) and 3D-printed using non-conductive bio-
compatible material (FullCure 830 VeroWhite, Stratasys, Eden Prairie, USA).
The case could be attached to the patient or evaluator's arm using a hook-and-
loop Velcro strap (Figure 3.2).
3.1.4 Software
Data collection during surgery needs a software tool to complement the ded-
icated hardware. The tool must be able to record acceleration data in quick
succession and save them to allow post-operative analysis. In addition to the
acceleration data, it should also be able to save information pertaining to each
surgical procedure like the position of the electrode and the stimulation parame-
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ters corresponding to the acceleration data collected. Real-time visualization of
the data is necessary to indicate proper functioning. The software provided by
ST for recording the data is useful to test the range of the evaluation board, but
does not satisfy all the above requirements. Therefore, a new software called
LemurDBS (Fachhochschule Nordwestschweiz (FHNW), Muttenz, Switzerland)
capable of recording accelerometer data from the evaluation board was devel-
oped in Java (Oracle, Redwood City, United States). The user interface was
designed to be customized for each surgery based on the planning to simplify
data recording (Figure 3.3). Provisions were made to input other data like the
number of planned trajectories, distance of the stimulation position from the
target, the stimulation current amplitude and therapeutic and adverse eects.
These data were stored for each position in separate les to allow post-operative
analysis. Apart from the modules necessary for accelerometer data recording,
others were also added which could import patient images and visualize them,
identify the stereotactic frame and visualize the planned target in 3D.
3.1.5 Synchronization
An important part of the recording setup was the synchronization with the
equipment used for acquiring MER data and delivering current for stimulation
tests. Such a synchronization between the two systems is necessary to precisely
correlate changes in the symptoms to the stimulation parameters. Various com-
mercial systems are available and can vary from center to center. Provisions for
synchronization were developed for two such systems that were used in the two
clinical centers from where data were acquired for this work: MicroGuide Pro
(Alpha Omega Eng. Nazareth, Israel) and LeadPoint (Medtronic, Minneapolis,
USA). For the MicroGuide Pro, a 5V pulse was sent to one of its input channels
using a USB-TTL cable at the start of accelerometer data acquisition. This
signal was saved by the system in its data which was exported after the surgery
for post-operative analysis. Synchronization with the LeadPoint system was
achieved by acquiring time-stamped analogue stimulation signal. These setups
allowed synchronization of the accelerometer data with the stimulation signal
within millisecond accuracy.
3.1.6 Laboratory tests
The above setup was tested in the laboratory environment for electrical leakage,
temperature changes after prolonged periods of recording, disinfection capabil-
ities and any other potential hazards. No electrical leakage was found in the
hardware setup and, as an additional precaution, a portable computer powered
by its battery only was used to record the accelerometer data during surgery.
Accelerometer data was acquired continuously for 5 hours which slightly raised
the temperature of the sensor by 2:5 C. This increase does not pose a severe
risk because the maximum duration of a recording during the surgery would be
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Figure 3.3: Image of the software LemurDBS (FHNW, Muttenz, Switzerland) designed
to record acceleration data during DBS surgery. The rst panel is used to record pre-op
and post-op baseline and during MER. The other two panels are for recording during
stimulation. The stimulation current amplitude and observed therapeutic and adverse
eects can also be saved. The panel for trajectories are added based on the choices
made during surgical planning. The panel below displays the acceleration data recorded
in real-time.
3.2. CLINICAL STUDIES 55
15 minutes and the case for the board would insulate the patient from the heat.
The case also made it possible to disinfect the hardware before every surgery.
The Velcro strap simplied attaching and detaching the sensor to and from the
patient; the patient could also remove it by his/herself if he/she felt uncomfort-
able wearing it. Apart from these tests, as we aimed to answer a basic research
question and as the sensor evaluation board had CE markings, it was possible
to categorize the study as bearing minimum risks and burdens to the patient
and consequently simplify acquiring approval from the ethics commission.
3.2 Clinical Studies
The accelerometer data recording setup described above had to be used during
DBS surgeries to acquire data. The DBS surgical procedure varies from center
to center and, thus, to test the versatility of the system, two clinical studies were
set up. In comparison to setting up one large multinational multi-center study,
two studies in dierent countries were easier to set up from an administrative
point of view.
3.2.1 Study 1: Clermont-Ferrand
One clinical study was set up at the neurosurgery department of CHU, Clermont-
Ferrand lead by Prof. Jean-Jacques Lemaire. He was the principle investigator
of this study which aimed to used the setup described above as a quantitative
tool to estimate changes in rigidity and tremor and to compare the results to
currently used methods. Other aims include studying the inuence of quanti-
tative symptom evaluation on lead placement, comparing eciency of dierent
anatomical structures in suppressing symptoms and use the data to collect more
information about the mechanisms of action of DBS. The study was designed
to last for 2 years and to collect data from 20 DBS surgeries. The criteria for
selecting patients were:
 age between 18 and 70 years
 absence of cognitive deterioration
 absence of depression
 PD patients with levodopa sensitivity more than 50% in the 6 months
preceding the surgery and presence of disabling adverse eects of levodopa
 ET patients with more than a year old disabling pathology that is refrac-
tory to medical treatment
 absence of lesions of basal ganglia on MRI
 absence of neurosurgical or anaesthetic counter indications to surgery.
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 presence of tremor and/or rigidity
 written consent of patient
The exclusion criteria for the study were:
 patients with cognitive impairment, progressive psychiatric conditions or
at high risk for surgery
 patients whose medical or surgical history is deemed to be incompatible
with the test by the investigator
 pregnant women.
The details of the 20 patients that were recruited in the study are presented in
Table 3.1. To summarize, 6 ET patients underwent VIM-DBS implantation, 2
PD patients underwent VIM-DBS implantation and 12 PD patients underwent
STN-DBS implantation. Data collected from two surgeries were not usable
because one patient took the regular medication before surgery which suppressed
the symptoms and another patient had no tremor during the surgery.
3.2.2 Study 2: Basel and Bern
A multicentre clinical study was undertaken in Switzerland at the Universitatspital
Basel and Inselspital Bern with Dr. Ethan Taub and Dr. med Michael Schupbach
as the primary investigators respectively. The pilot study was undertaken with
the aim to use accelerometry to quantitatively evaluate tremor during DBS
surgery to compare the eciency of dierent structures and identify the one
that signicantly alleviates tremor. The planned duration of the study was 2
years with the goal to include 10 patients. The inclusion criteria for the study
were:
 age 18 or above
 medically intractable tremor
 well-documented clinical diagnosis of PD or ET
 clinical determination by the interdisciplinary DBS team that tremor treat-
ment using DBS is indicated
 informed consent to surgery and to participation in the study
The exclusion criteria for the study were:
 cognitive or emotional impairment that would render the subject unable
to give informed consent to DBS or to participation in the study (this had
to be explicitly assessed by the psychiatrist and neuropsychologist in the
interdisciplinary DBS team)
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Patient Number Disease Symptom Evaluated DBS Target
1 PD Tremor STN
2 ET Tremor VIM
3 PD Rigidity STN
4 ET Tremor VIM
5 PD Tremor STN
6 ET Tremor VIM
7 ET Tremor VIM
8 PD Rigidity STN
9 PD Tremor VIM
10 ET Tremor VIM
11 PD Rigidity STN
12 PD Tremor VIM
13 PD Rigidity STN
14 PD Rigidity STN
15 PD Rigidity STN
16 PD Rigidity STN
17 PD Rigidity STN
18 PD Tremor STN
19 PD Rigidity STN
20 ET Tremor VIM
Table 3.1: The details of the patients that were recruited as a part of the clinical study
in CHU, Clermont-Ferrand, France. The "Symptom Evaluated" columns shows which
symptom was evaluated quantitatively during the surgery. Tremor was evaluated for
tremor-dominant PD and ET patients. Rigidity was evaluated for the PD patients that
presented severe rigidity.
 lessened communicative ability (because of deafness, lack of a common
language with DBS team, or other reasons) that would render the subject
unable to give informed consent or to cooperate with the clinicians and
investigators during the DBS procedure
 major pathological ndings on brain MRI unrelated to PD or ET
 bleeding disorders, therapeutic anticoagulation, infectious conditions, or
other medical factors that would contraindicate surgery because of in-
creased risk
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 pregnancy (which is a temporary contraindication to DBS surgery in gen-
eral, regardless of study participation)
 lack of informed consent to surgery or to participation in the study
Table 3.2 lists the details of the 10 patients that were included in the study.
Seven PD patients underwent STN-DBS while one PD and two ET patients
underwent VIM-DBS. Data collected from 3 surgeries could not be used for
analysis due to suppression of tremor during surgery or failure of synchroniza-
tion between LemurDBS and the MER system. For another 3 patients, data
was recorded only during one implantation as this led to sever suppression of
symptoms on the ipsilateral side.
Patient Number Disease Symptom Evaluated DBS Target
1 PD Tremor STN
2 PD Tremor STN
3 PD Tremor STN
4 ET Tremor VIM
5 PD Tremor STN
6 PD Tremor STN
7 PD Tremor STN
8 ET Tremor VIM
9 PD Tremor STN
10 PD Tremor VIM
Table 3.2: The details of the patients that were recruited as a part of the multicenter
study in Universitatspital Basel and Inselspital Bern in Switzerland
3.2.3 Data Recording Protocol
Data recording during the surgery has to be consistent among patients to per-
form a collective analysis. Therefore, data recording protocols were dened for
tremor and rigidity evaluation. In general, recording must be started before the
stimulation is delivered in order to establish a baseline state of the symptom
severity for every stimulation test. However, the protocol had to be modied to
accommodate variations in tremor and rigidity evaluation as well as evaluation
at dierent clinical centers. The specics of data recording protocols are avail-
able in the relevant sections: Section 4.2 for tremor evaluation and Section 5.1
for rigidity.
Chapter 4
Quantitative Tremor Evaluation
during DBS Surgery
The details of our method to evaluate tremor during DBS surgery using ac-
celerometer have been published in two peer-reviewed papers attached in the
following sections. The rst publication (Section 4.1) is a case-study describing
the method and its application to 2 patients which was presented at the 6th
Annual International IEEE EMBS Conference on Neural Engineering. The sec-
ond publication (Section 4.2) contains the exhaustive details about the method
and its use in two clinical studies.
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4.1 A method to quantitatively evaluate changes in
tremor during deep brain stimulation surgery
Authors: Ashesh Shah, Jero^me Coste, Jean-Jacques Lemaire, Erik Schkom-
modau, and Simone Hemm-Ode
This paper was submitted to the 6th Annual IEEE EMBS conference on neural
engineering which was held in San Diego, California, United States of America
from 6th to 8th November, 2013. The aim of this paper is to demonstrate the
feasibility and advantages of using quantitative tremor evaluation during DBS
surgery.
The paper is available at the address :
https://doi.org/10.1109/NER.2013.6696155
Copyright Notice: c2013 IEEE. Reprinted, with permission, from Ashesh Shah,
Jero^me Coste, Jean-Jacques Lemaire, Erik Schkommodau, and Simone Hemm-
Ode, A method to quantitatively evaluate changes in tremor during deep brain
stimulation surgery, 2013 6th International IEEE/EMBS Conference on Neural
Engineering (NER), November, 2013.
In reference to IEEE copyrighted material which is used with permission in this
thesis, the IEEE does not endorse any of Universitat Basel's products or services.
Internal or personal use of this material is permitted. If interested in reprint-
ing/republishing IEEE copyrighted material for advertising or promotional pur-
poses or for creating new collective works for resale or redistribution, please go to
http://www.ieee.org/publications standards/publications/rights/rights link.html
to learn how to obtain a License from RightsLink.
  
1 
Abstract— Deep Brain Stimulation (DBS) surgery is used 
increasingly as a symptomatic treatment for patients with 
movement related neuro-degenerative disorders. However, the 
method of intraoperative symptom evaluation is subjective. 
This paper proposes a method to quantitatively evaluate 
tremor by measuring the acceleration of the patient's wrist 
during the surgery. The results of applying the method to 2 
patients suggest that the acceleration measurements are very 
sensitive to the change in the tremor and that they can be used 
to identify clinically effective stimulation amplitudes. By 
collecting acceleration data from DBS surgeries for many 
patients, we hope to add more knowledge to the mechanisms of 
deep brain stimulation. 
I. INTRODUCTION 
Essential tremor and particularly Parkinson's disease are 
among the most prevalent neuro-degenerative movement 
related disorders [1]. Although, there are drugs which can be 
used to treat the symptoms, Deep Brain Stimulation (DBS) 
surgery is used as the alternative symptomatic treatment as 
well. For 25 years, DBS has become a commonly performed 
operation for the treatment of such disorders. Nevertheless, 
the mechanism of action of this therapy is so far only 
incompletely understood. 
DBS is a complex surgical treatment in which electrodes 
are implanted in the deep brain structures which are 
stimulated using a neuro-stimulator implanted in the chest. 
Careful planning is done on anatomical images of the 
patient's brain to map out a path to implant the electrodes. In 
order to locate the best position of the electrodes to control 
the symptoms, most centers perform the surgery under local 
anesthesia. Micro-electrodes are used to record the electrical 
activity at previously planned positions to identify the 
location of the deep brain structures (Micro-electrode 
recording MER). This is followed by test stimulation at some 
or all of those locations and changes in the patient's 
symptoms and occurring side effects are observed visually 
and by clinical examination. The electrode is finally 
implanted at the location with the best effect on the 
symptoms and the least side effects.  
One aspect of DBS which needs to be improved is the 
symptom evaluation during the surgery[2]. The current 
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methods are semi-quantitative and the judgment is largely 
based on the experience of the neurologist. Various methods 
to quantitatively evaluate tremor have been proposed using 
different methods like accelerometry, use of gyro meters, and 
EMG recording [3-7] . However, very few methods [8-10] 
are designed to be used in the operating room (OR), while 
none of them have become a part of the routine surgical 
procedure. The method proposed in this paper uses 
accelerometer to quantify the change in the tremor of the 
patient. Compared to the existing methods based on 
accelerometers [11], this method is designed specifically for 
usage during the DBS surgery.  
II. METHOD 
A. Equipment 
The quantitative evaluation of tremor is achieved using an 
accelerometer attached to the patient's wrist. A commercial 
accelerometer system evaluation board (STEVAL-
MKI022V1, ST Micro, Geneva, Switzerland) is used for this 
purpose. The sampling frequency used in this method is 
400 Hz. This evaluation board is placed inside an in-house 
developed, non-conductive printed plastic case (FullCure 830 
Vero White, Objet Geometries Ltd - Belgium) and tied 
behind the wrist using a Velcro strap (Fig. 1). An USB cable 
(along with an extension) is used to interface this board with 
a laptop computer to record data.  
An in-house application (Lemur DBS) has been 
developed using Java (Oracle Corporation, California, USA) 
to record the data during the surgery. The software is 
initialized by interfacing it with the accelerometer board and 
defining the recording protocol (see below). The software 
then opens a recording window tweaked for the defined 
protocol. The software also allows the user to select the 
different parameters (like stimulation position or amplitude, 
for example) during an acceleration recording and stores 
these parameters for referencing at the time of data analysis. 
The recorded acceleration data is also displayed in graphical 
manner in real-time. The software creates a new data file for 
each acceleration recording to simplify the data analysis.  
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Figure 1. A) Accelerometer case B) Accelerometer mounted to patient 
during surgery 
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In order to synchronize the data between acceleration 
measurements and the intraoperative electrophysiological 
system (MicroGuide; Alpha Omega Eng., Israel), an USB-
TTL cable is used. When an acceleration recording is started, 
a TTL signal is sent to the electrophysiology system, which 
stores the signal according to the time, the position, the 
trajectory and the stimulation amplitude.  
A video recording is also made during the surgery for the 
interpretation of unexpected signals. 
C. Surgical Procedure  
The routine surgical procedure at the University Hospital 
in Clermont-Ferrand is distributed over 2 days, planning and 
surgical procedure. For the planning, a stereotactic frame 
(Leksell G frame, Elekta, Sweden), with its repositioning kit, 
is mounted on the patient under the local anesthesia, and 
stereotactic images (CT and MRI) are obtained. The frame is 
then removed during the planning phase and remounted just 
before the surgery. Using the stereotactic planning software 
(Iplan 3, Brainlab, Feldkirchen, Germany) the deep brain 
structures are carefully identified and manually outlined on 
the patient's MRI. The labeling of the different structures is 
performed based on surgical anatomical knowledge and in-
house 3D 4.7-Tesla MRI anatomy software [12]. After 
identifying the target structures, trajectories are planned for 
the patient in a manner to avoid blood vessels and the caudate 
nucleus. On these trajectories, test stimulation locations are 
identified from maximum 10 mm, in steps of 1mm in the 
region of interest.  
The actual DBS surgery is performed on the next day of 
the planning. Before performing test stimulations, micro-
electrode recording (MER) is done at the planned locations to 
confirm the position of the deep brain structures. MER is 
followed by test stimulations at all or most of the planned 
locations. At each location, the neurosurgeon changes the 
stimulation current from 0 to 3mA in steps of 0.2mA and 
identifies the stimulation amplitude at which a considerable 
change is observed in the patient's tremor (subjective 
threshold). The decrease in the tremor amplitude is identified 
in 5 levels (0, 25%, 50%, 75%, and 100%) and is noted along 
with the amplitude. The neurosurgeon also checks for side-
effects of stimulation and the amplitudes at which they are 
first observed (side effect threshold). 
After completion of test stimulation for all the positions, 
the neurosurgeon, mentally visualizes the subjective and the 
side-effect thresholds with reference to the anatomy. The 
final implant location for the optimized DBS electrode 
contact will be the position with the lowest subjective 
threshold on tremor, with the largest difference between the 
latter and side-effect threshold. In the case of bilateral 
implantation, the above procedure is repeated for the second 
brain hemisphere. 
D. Data Recording Protocol 
In order to maximize the acceleration data recording and 
minimize the obstruction to routine surgery, a recording 
protocol has been defined. Before the start of the surgery, a 
baseline recording is performed. The acceleration sensor is 
then disconnected during the remounting of the frame and 
surgical preparations. Acceleration data recording is 
resumed during MER for every pre-planned position. The 
acceleration data recording is started after the start of MER 
recording in the electrophysiological system. After 
completion of MER for all the positions, test stimulations are 
performed at those locations to observe the effects and the 
side-effects. Contrary to MER, acceleration data recording is 
started a few seconds before the test stimulation and is 
continued till the end of test stimulation for every position. 
The data recorded without any stimulation is used as a 
baseline data during the analysis to identify changes in the 
patient's tremor.  
On completion of the surgery, another acceleration 
recording is performed to use as a post-operative baseline.  
E. Data Analysis 
The accelerometer data analysis involves many different 
steps. The data recorded in the electrophysiology system is 
analyzed using Neuroexplorer (Nex Technologies, Madison, 
Alabama, USA).The synchronization time stamps and the 
stimulation amplitude are transferred  to Matlab (Mathwork 
Inc., Massachusetts, USA) for further analysis. A Matlab 
function has been developed to analyze the data recorded for 
one side of the brain.  
As a first step, the synchronization points and the 
stimulation amplitude are extracted from the 
electrophysiology data. This is followed by importing the 
acceleration recording into Matlab. The accelerometer data is 
then synchronized to the time stamps from the 
electrophysiology system and this synchronization is visually 
verified. The data from the 3 different axes of the 
accelerometer, stored in separate columns at first, are 
combined by calculating the RMS value for every sample. In 
case when rigidity and tremor were both present but the 
clinician decided to mainly observe stimulation effects on 
tremor, the data corresponding to the rigidity evaluations 
within the acceleration data were removed. A time varying 
high-pass filter (cut-off 2 Hz) called smoothness priors 
method [13] was used to remove the low-frequency trends 
and acceleration due to gravity. Another low pass 
Butterworth filter (cut-off 10 Hz) is used to filter the noise 
and then statistical features are extracted in a windowed 
manner (Fig 2).  
A non-overlapping window of 2 seconds (795 samples on 
 
Figure 2. A. Raw signal including arm movement in addition to tremor 
(see arrows). B) The signal after application of smoothness priors and 
Butterworth filter. 
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Figure 5. Comparison of thresholds for the posterior trajectory of the 
right hemisphere of patient 2. The highlighted markers indicate the final 
implant location chosen based on subjective data (blue with black 
border) and acceleration data (green with yellow border). 
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Figure 3. Comparison of different thresholds for left hemisphere, central 
trajectory of patient 1. The highlighted markers indicate the final implant 
location chosen based on subjective data (blue with black border) and 
acceleration data (green with yellow border). 
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average) is chosen for optimum analysis based on factors like 
average duration of one stimulation amplitude, sampling rate, 
etc. From the windowed data, the standard deviation, signal 
energy, signal entropy, peak frequency and peak frequency 
amplitude (standard fft function in Matlab) are extracted. 
Thereafter, the baseline data recorded just before the 
corresponding test stimulation is imported into Matlab and 
statistical features are extracted from it in the same way as 
from the test stimulation acceleration data. These statistical 
features are then plotted on a graph and the best baseline 
features are selected for further analysis.   
The statistical features extracted from the acceleration 
data are then normalized to the baseline value. These 
normalized features are used to extract the stimulation 
amplitude at which a change in the tremor is observed, 
referred as acceleration threshold. Three such acceleration 
thresholds are calculated from the normalized parameters 
corresponding to their change as compared to the baseline - 
25% reduced, 50% reduced, and 75% reduced. Such 
acceleration thresholds are extracted for every position on 
each trajectory. These acceleration thresholds are represented 
graphically along with the side-effect thresholds and a final 
implant site is decided as the position which has the lowest 
acceleration threshold and the largest difference between the 
that and the side-effect threshold for every brain side.  
F. Case studies 
Under an ongoing clinical study at the University 
Hospital in Clermont-Ferrand, France, data was recorded 
following the above described protocol on 2 patients being 
good candidates for DBS surgery following the international 
guidelines [14]. No alterations were made to the routine 
surgical procedure. Both patients showed high amplitudes of 
tremor.  
Patient 1included in the study underwent a bilateral DBS 
implantation in the subthalmic nucleus (STN) for the 
treatment of Parkinson's disease. For the left hemisphere, 11 
positions were explored for test stimulation starting from the 
zona incerta to the subthamic nucleus on two parallel 
trajectories (6 on central and 5 on 2mm-posterior). For the 
right hemisphere, 18 positions were explored from the 
thalamus to the subthamic nucleus via the zona incerta on the 
same two trajectories (9 each). Along with high tremor 
patient 1 showed rigidity. 
 Patient 2 underwent bilateral DBS implantation in the 
ventralis intermedius nucleus (Vim) for the treatment of 
Essential tremor. Sixteen test stimulation locations were 
explored for central (8) and posterior (8) trajectories for the 
left hemisphere, while 14 locations were explored for the 
same trajectories (7 each) for the right hemisphere. Both 
trajectories were planned to explore different thalamic 
regions involved in tremor. Patient 2 presented high 
amplitudes of tremor and the neurosurgeon had to stimulate 
till 5.0 mA to observe an effect on the tremor. 
III. RESULTS 
A total of 59 recordings were made during the test 
stimulations for the two patients. Out of the different 
acceleration thresholds identified, 80% of the 75% thresholds 
are lower than the subjective threshold, 90% of the 50% 
threshold are lower than the subjective threshold and 99% of 
the 25% threshold are lower the subjective threshold.  
All of the 3 different acceleration thresholds for patient 1 
are equal to or lower than the subjective threshold suggesting 
that the stimulation location was very effective. Fig 3 shows 
the comparison between different thresholds for right 
hemisphere, central trajectory. The 75% acceleration 
threshold corresponded well with the subjective thresholds. 
The final implant site determined based on acceleration 
thresholds (Fig 3 for left hemisphere only) for both the brain 
sides are the same as the one decided based on the surgery 
(Fig 3 for the left hemisphere only).  
 
Figure 4. Comparison of thresholds for central trajectory of left 
hemisphere of patient 2. Since the stimulation did not cause any effect, 
no thresholds were found. 
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In the case of patient 2, at 14 of the 30 stimulation 
locations the acceleration features changed by less than 50%. 
This suggests that the stimulation effect at this location was 
not very effective. This was also confirmed for the central 
trajectory of the left hemisphere (Fig 4), where 75% 
acceleration thresholds and subjective thresholds could both 
not be found for any position. For the other trajectories, the 
75% acceleration threshold corresponded well with the 
subjective threshold. The final implant site determined based 
on acceleration thresholds (Fig 5 for the right hemisphere 
only) for both the brain sides are the same as the one decided 
based on the surgery (Fig 5 for the right hemisphere only)  
IV. DISCUSSION 
The method described in the paper demonstrates that by 
using acceleration measurements of the patient's wrist it is 
possible to quantify the changes in tremor during DBS 
surgeries without hindering the existing surgical procedure. 
Simple statistical features like standard deviation can be used 
to quantify the changes in the tremor of the patient. From the 
results of the two patients, it is clear that the acceleration 
measurements are very sensitive to the changes in tremor. 
The differences between the subjective and the acceleration 
threshold suggest that by objectively evaluating tremor, target 
selection in DBS can be improved.  
One of the main factors that influence the objective 
evaluation using acceleration data is the baseline data. It is 
very important that during the baseline data recording, the 
patient is in a state of high tremor.  
Although this method can objectively evaluate tremor, it 
has so far only been used for post-operative analysis and not 
yet in the operating room during the target selection 
procedure. Thus, our next step is to implement the data 
analysis in our recording software to extract the statistical 
features in real-time. We intend to visualize these features 
and other information about the surgery on the patient's 
anatomical images so as to support the neurosurgeon during 
target selection. Furthermore, we are also working on a 
method to evaluate rigidity during DBS surgery.  
In addition to the optimization of the targeting procedure, 
the collected acceleration data will be correlated with the 
anatomical structures and electrophysiological signal to get 
more knowledge about the mechanism of action of DBS. 
This is the primary intention why to record acceleration data 
during MER in the clinical study. By collecting data in many 
surgeries and correlating them to different information about 
the deep brain, new information related to the mechanisms of 
DBS may come to light.  
V. CONCLUSION 
The current paper presents a methodology allowing 
intraoperative acceleration measurements for tremor 
evaluation during DBS electrode implantation. First results 
are encouraging but have to be confirmed in further patients 
included in the clinical study. The objectively obtained data 
in correlation with the patient's anatomy might represent an 
interesting approach to further elucidate the mechanism of 
action of DBS.  
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359 stimulation tests were acquired. Our results suggest 
that accelerometric evaluation detects tremor changes more 
sensitively than subjective visual ratings. The effective 
stimulation current amplitudes identified from the quanti-
tative data (1.1 ± 0.8 mA) are lower than those identified 
by visual evaluation (1.7 ± 0.8 mA) for similar improve-
ment in tremor. Additionally, if these data had been used 
to choose the chronic implant position of the DBS lead, 15 
of the 26 choices would have been different. These results 
show that our method of accelerometric evaluation can 
potentially improve DBS targeting.
Keywords Deep brain stimulation · Intraoperative 
monitoring · Acceleration · Tremor · Parkinson’s disease · 
Essential tremor
1 Introduction
Parkinson’s disease (PD) and essential tremor (ET) are 
common movement disorders [46]. Deep brain stimulation 
(DBS), in which electrical leads are surgically implanted in 
the thalamic, subthalamic, or pallidal region of the brain, 
is a highly effective symptomatic treatment of these con-
ditions [12]. The leads are connected to a subcutaneously 
implanted impulse generator (neurostimulator). Unlike 
ablative surgery, DBS is reversible and adaptable in the set-
ting of progressively worsening disease. Over the past three 
decades, more than 100,000 patients have been treated with 
DBS around the world [39].
In many centers, DBS surgery is performed under local 
anesthesia to enable intraoperative stimulation tests [1] 
mostly through a specific exploration electrode, for direct 
observation of the therapeutic effect of stimulation and of 
side effects. The therapeutic effects induced by stimulation 
Abstract Deep brain stimulation (DBS) surgery is exten-
sively used in the treatment of movement disorders. Nev-
ertheless, methods to evaluate the clinical response dur-
ing intraoperative stimulation tests to identify the optimal 
position for the implantation of the chronic DBS lead 
remain subjective. In this paper, we describe a new, ver-
satile method for quantitative intraoperative evaluation of 
improvement in tremor with an acceleration sensor that is 
mounted on the patient’s wrist during surgery. At each ana-
tomical test position, the improvement in tremor compared 
to the initial tremor is estimated on the basis of extracted 
outcome measures. This method was tested on 15 tremor 
patients undergoing DBS surgery in two centers. Data from 
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tests are visually evaluated and rated in different ways by 
different centers, but always with the same underlying con-
cept: either the observer directly rates the improvement 
of a symptom (e.g., tremor) in response to stimulation, or 
the observer rates the severity of the symptom both with-
out and with stimulation using a clinical scale such as the 
Unified Parkinson’s Disease Rating Scale (UPDRS [9]). 
Previous studies have revealed that such ratings have a low 
inter-rater [26, 33] and intra-rater [33] reliability because 
of their subjectivity and their high dependence on the expe-
rience of the evaluating neurologist [11]. Moreover, pen 
and paper are used to note down the subjective ratings of 
the therapeutic effects and side effects that are observed at 
varying stimulation parameters and positions; retrospec-
tive comparisons once the testing is completed are difficult 
and dependent on human memory. If the measurement and 
evaluation of changes in tremor were performed quantita-
tively, these limitations could be overcome.
Numerous methods with different sensors, including 
EMG [2, 15, 17, 25, 44], spirograms [7, 37], and gyro-
scopes [23, 32, 38], have been used to quantify tremor. 
Accelerometers have been applied outside the operating 
room (OR) for a wide variety of purposes, e.g., to charac-
terize pathological tremor [8, 13], to compare it with physi-
ological tremor [20, 35, 36], and to evaluate the severity 
and evolution of tremor [28, 29, 40] and the tremor-allevi-
ating effect of drugs or DBS [22, 36, 47]. Pulliam et al. [34] 
used motion sensors during postoperative DBS pulse gen-
erator programming to develop automated programming 
algorithms and concluded that objective assessment can 
improve patients’ outcomes. These methods, however, were 
developed to evaluate tremor outside the OR and cannot 
be used in their current form during surgery, for multiple 
reasons. The patient has only limited freedom of movement 
during surgery, compared to preoperative or postoperative 
examination; to be useful, intraoperative tremor assessment 
must be performed at many different positions of the test 
electrode and at a variety of stimulation current amplitudes; 
and the surgical team’s access to the patient and the level of 
patient comfort are especially important considerations in 
the design of systems for intraoperative use.
For these reasons, unlike the numerous methods men-
tioned above for tremor assessment outside the OR, intra-
operative quantitative tremor assessment has only rarely 
been described in the literature. These descriptions were 
mostly for research purposes, for example the one-time use 
of inertial sensors during a thalamotomy [21], the evalu-
ation of the effect of non-constant inter-pulse intervals of 
DBS stimulation on tremor [4], or the identification of a 
target structure by spectral correlation of a tremor signal 
from goniometers with the electrophysiological signal from 
microelectrode recording [43]. To our knowledge, only 
Journee et al. [14] and Papapetropoulos et al. [27] evaluated 
tremor intraoperatively in a relatively large patient cohort. 
Their tests, however, seem to have been performed by stim-
ulating through the chronic DBS lead in order to ascertain 
the optimal stimulation parameters, rather than through 
exploratory test electrodes of the type used in most centers 
to find the optimal target site for stimulation. None of these 
methods were used to help determine the best site for DBS 
lead implantation, nor were any of them implemented in 
more than a single surgical center or as a part of the regu-
lar surgical protocol for DBS. Additionally, to the best of 
our knowledge, the correlation between the intraoperative 
visual (subjective) and quantitative evaluations has not yet 
been thoroughly investigated.
This study presents a method designed for the specific 
purpose of quantitatively estimating changes in tremor dur-
ing intraoperative stimulation tests through an exploratory 
electrode to identify the optimal position for implantation 
of the chronic lead in routine DBS surgery. It tries to over-
come the limitations of previous methods by recording data 
in parallel to conventional subjective visual evaluation, by 
recording baseline activity before each stimulation test, 
and by synchronizing the data with the electrophysiology 
system. The aim of the present study was to evaluate the 
feasibility and adaptability of the method by applying it to 
15 patients undergoing DBS surgery in two clinical centers. 
Furthermore, the correlations between the recorded accel-
erometric data and the visual evaluations during surgery 
were studied to better understand the similarities and dif-
ferences of the two evaluation methods.
2  Materials and methods
2.1  Surgical protocol
In order to design a method for intraoperative use, the DBS 
surgical procedure has to be understood, which, in most 
centers, can be summarized in 4 steps as follows: (1) the 
anatomical target and the best path to reach it are defined on 
the patient images during pre-surgical planning. An elec-
trode trajectory or, in many cases, multiple closely spaced 
parallel trajectories through the target region are selected 
for intraoperative testing. (2) At surgery, intraoperative 
exploratory electrodes are inserted along the chosen trajec-
tory or trajectories, and the target region is electrophysi-
ologically mapped with microelectrode recording (MER). 
(3) After MER, stimulation test is administered at various 
locations, and the therapeutic effects and side effects are 
observed. The visually observed improvement in tremor 
(IV), the amplitude of the stimulating current that brought 
about this improvement (AV), and the lowest stimulation 
current amplitude at which a side effect is observed (side-
effect threshold) are noted for each site of stimulation. (4) 
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The site for implantation of the chronic DBS lead is chosen 
to be one with low AV and a large difference (“therapeutic 
window”) between AV and the side-effect threshold. Opti-
mally, the target site should be one among a group of adja-
cently located sites that all have a large therapeutic window.
We aimed to design the acceleration recording system to 
be usable in multiple clinical centers with few or no modi-
fications. Patients from two different clinical centers were 
included: from the University Hospital in Clermont-Fer-
rand, France (Center 1), and from the Inselspital in Bern, 
Switzerland (Center 2). Although the basic surgical steps in 
these centers correspond to the ones described above, there 
are significant differences in how these steps are config-
ured and executed. Table 1 lists the various surgical steps 
and the configuration used in the two centers which were 
considered when developing the quantitative symptom eval-
uation system. In Center 1, stimulation tests are performed 
at various preoperatively chosen positions on the trajectories 
(between 10 and 18 per hemisphere) and only the highest 
improvement in tremor and the corresponding stimulation 
current amplitude are noted for each stimulation position 
(one improvement noted per position). In Center 2, stimu-
lation tests are performed only at a few positions (between 
2 and 6 per hemisphere) chosen on the basis of the elec-
trophysiological activity observed during MER, but the 
improvement in tremor is noted for each stimulation current 
amplitude (between 4 and 8 improvements noted per posi-
tion). In addition, in Center 1, the stimulation current is var-
ied from 0 to 3 mA in steps of 0.2 mA for each stimulation 
test position, whereas, in Center 2, the stimulation current 
Table 1  Details of the configuration and execution of surgical steps in the two clinical centers that were considered when designing the adapt-
able accelerometer recording system
Surgical step Center 1 Center 2
Pre‑surgical planning Direct visual targeting Combination of AC/PC based and direct visual 
targeting
Number of trajectories per hemisphere 2 1 to 2
Intraoperative MER Yes Yes
 No. of explored positions per trajectory 5–10 15 or more
 Distance of first position from target 
(=0 mm)
Based on pre-surgical planning 10 mm
 Distance between positions 1 mm 1 mm (5–10 mm)
0.5 mm (4.5 mm to target)
Intraoperative stimulation tests through 
exploration electrode
Yes Yes
 Test positions All MER positions Chosen based on MER data (2 to 6 per hemi-
sphere)
Stimulation pattern Current-controlled Current-controlled
 Range (mA) 0–3 0–4
 Step size (mA) 0.2 0.5 or 1
Visual evaluation of baseline tremor At every position just before start of test 
stimulation
Before starting test stimulation of each hemi-
sphere.
Documentation of findings of intraoperative 
test stimulation
For each position of test stimulation For each position and amplitude of test stimula-
tion
 Level of improvement Maximum degree of improvement and the 
stimulation amplitude that induced it
The degree of improvement with stimulation at 
that position and amplitude
 Side effects Type and amplitude Type
Rating scale for tremor evaluation Direct relative improvement rating; 0–4 scale, 
worst (0) to best (4)
Absolute rating based on UPDRS; 0–4 scale, 
best (0) to worst (4)
 Before stimulation Baseline tremor defined as 0 Tremor severity based on UPDRS scale
 Tremor arrest 4 0
 Number of intermediate levels (indicated 
using underlining)
1 level (0, 0.5, 1, 1.5…) 2 levels (4, 4−, 3+, 3, 3−…)
Choice of chronic implant position for DBS 
lead
Stimulation test position among a group of 
adjacently located positions all having a 
large therapeutic window
Deepest stimulation test position with a large 
therapeutic window
 Stimulating contact Based on the adjacent positions having large 
therapeutic windows
Distal contact (number 0)
 Contact border Distal border
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range goes up to 4 mA and the step size is decided based on 
the observed response of the patient. These differences sig-
nificantly influence the data recording procedure.
The analysis of the acquired data is also altered because 
of some of the differences in the surgical procedure like 
the rating scales for tremor evaluation and the method used 
for choosing the chronic implant position of the DBS lead. 
‎In Center 1, the chronically stimulating lead is implanted 
at the position having a large therapeutic window itself as 
well as its adjacent positions, and the contact and its bor-
der are chosen in a manner permitting chronic stimulation 
at these adjacent positions if needed. ‎In Center 2, the dis-
tal border of the distal contact is implanted at the deepest 
effective stimulation position making it possible to chroni-
cally stimulate other effective positions located proximally. 
Such differences should be considered when designing a 
method for intraoperative use in multiple clinical centers.
2.2  Acceleration data recording
A commercially available 3-axis acceleration sensor evalu-
ation board (STEVAL-MKI022V1,1 ST Micro, Geneva, 
Switzerland), with a sampling rate of 400 Hz and a range of 
8 g, was used to quantify changes in tremor. To facilitate its 
use in the OR, it was placed in an in-house-developed, non-
conductive printed plastic case (FullCure 830 Vero White, 
Stratasys, Eden Prairie, USA) that can be attached to the 
patient’s wrist with a Velcro strap (Fig. 1). The sensor eval-
uation board was interfaced with and powered by a laptop 
via a USB connection.
The data recording setup was approved for use in clini-
cal studies after multiple tests revealed its harmlessness to 
patients: The chosen 3D printing material was biocompat-
ible. Heating tests performed by continuously recording 
acceleration data for 5 h marginally raised the temperature 
of the case by 2.5 °C; the maximum duration of continu-
ous intraoperative recording was 15 min, which would not 
lead to any degree of heating that would be appreciable by 
the patient. Nevertheless, the Velcro strap made it possible 
to remove the sensor at any time at the patient’s request in 
case wearing it was uncomfortable. All the equipment was 
cleaned with disinfectant wipes before and after each use, 
and a new Velcro strap was used for each patient, to min-
imize potential sources of infection. To lessen the risk of 
leakage currents, the laptop was powered by battery only, 
rather than by line current.
1 STEVAL-MKI022V1 (data sheet: https://www.arrow.com/en/prod-
ucts/steval-mki022v1/stmicroelectronics or at authors) is no longer 
produced by the manufacturer. It has been replaced by STEVAL-
MKI089V1 evaluation board (data sheet: http://www.st.com/content/
st_com/en/products/evaluation-tools/product-evaluation-tools/mems-
motion-sensor-eval-boards/steval-mki089v1.html) which uses the 
same accelerometer (LIS331DLH) as in the present study.
For data recording and visualization, a computer appli-
cation (LemurDBS) has been developed in our laboratory 
in Java (Oracle Corporation, California, USA). In order to 
make the system adaptable to the varying DBS procedures 
in different clinical centers, software profiles can be made 
for individual centers to customize LemurDBS during the 
initiation phase to adapt it to the center’s surgical proce-
dure. In addition, the software can be further adapted for 
individual operations by providing certain details of the 
operation, such as the number of trajectories or number of 
positions at which stimulation tests would be performed. 
The important information to be obtained intraoperatively, 
for example the position and amplitude of the stimulation 
test, any observed side effects, and the threshold ampli-
tudes at which they arose, can be entered manually. Dur-
ing data recording, the acceleration data and extracted 
outcome measures (for details, see data analysis section) 
are visualized online to check the correct functioning 
of the system and to identify any fluctuation of the pre-
stimulation baseline tremor. All data are stored for offline 
analysis.
For data synchronization, the acceleration data record-
ing software was connected to the MicroGuide Pro (Alpha 
Omega Eng., Nazareth, Israel) or LeadPoint (Medtronic, 
Minneapolis, USA) electrophysiology systems that were 
used in the two centers for MER and stimulation tests 
(Fig. 1). A PhidgetInterfaceKit 2/2/2 board (Phidgets Inc. 
Calgary, Alberta, Canada) was used for this purpose. A 5 V 
CMOS signal was sent from LemurDBS to the MicroGuide 
Pro system at the beginning and end of each acceleration 
data recording. For the LeadPoint system, synchronization 
was obtained by acquiring time-stamped analog stimulation 
signal as measured by the non-stimulating electrode 2 mm 
away from the stimulating one.
Fig. 1  Intraoperative data recording setup. The acceleration sensor is 
inside a plastic case (top left), which is mounted on the patient’s wrist 
with a Velcro strap. The sensor is connected to our recording system 
(bottom left), which is also connected to the DBS system (bottom 
right) so that data from the two sources can be synchronized
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As MER recording systems are very sensitive to noise, 
wired connections were used between the laptop, the accel-
eration sensor, and the electrophysiology system. The wire-
less system on the laptop was disabled to ensure that no 
wireless signals were emitted from our recording setup that 
could interfere with other systems in the OR.
No specific instructions were given to the patient or the 
surgical team for the data recording, which did not require 
any conscious effort or participation on their part and there-
fore did not prolong the operations.
2.3  Clinical application
Quantitative evaluation of change in tremor was carried out 
during DBS implantations of 15 patients, 9 in Center 1 and 
6 in Center 2. All patients were good candidates for DBS 
according to the international guidelines [16]. They gave 
written informed consent before surgery, and the experi-
mental procedures were approved by the respective Insti-
tutional Ethics Committee (Center 1: 2011-A00774-37/
AU905; Center 2: 2365—multicenter study together with 
the University Hospital in Basel). The details of surgery for 
each patient, including the number of trajectories explored 
and the number of stimulation tests on each trajectory, are 
provided in Table 2.
In Center 1, for patient 1, rigidity was also evaluated by 
the neurologist for short periods of 2–5 s and subsequently 
recorded during stimulation tests by moving the patient’s 
forearm. However, rigidity was only evaluated at stimu-
lation amplitudes at which the tremor was suppressed by 
Table 2  Details of the included patients and their surgical procedures
STN subthalamic nucleus, VIM ventral intermediate nucleus of the thalamus
Patient Surgical Center Disease Target structure Trajectory position (number of stimulation test positions on this trajectory)
Left side Right side
1 Center 1 PD STN Central (6) Central (9)
Posterolateral (5) Posterior (9)
2 Center 1 ET VIM Central (8) Central (7)
Posterolateral (8) Posterolateral (8)
3 Center 1 ET VIM Central (6) Central (7)
Posterior (6) Posterior (6)
4 Center 1 ET VIM Central (5) Central (7)
Posterior (5) Posterior (7)
5 Center 1 ET VIM Central (8) Central (8)
Posterior (8) Posterior (8)
6 Center 1 ET VIM Central (9) Central (5)
Posterior (9) Posterior (5)
7 Center 1 PD VIM Central (7) Central (7)
Posterior (7) Posterior (7)
8 Center 1 PD STN Central (7) Central (6)
Posterolateral (7) Posterolateral (6)
9 Center 1 ET VIM Central (8) Central (8)
Posterior (8) Posterior (8)
10 Center 2 PD STN Central (2) Central (1)
Lateral (1)
11 Center 2 PD STN Central (2) Central (2)
Medial (2)
12 Center 2 PD STN Central (2) Central (2)
Lateral (1) Lateral (1)
13 Center 2 PD STN Central (2) Central (4)
Medial (2) Medial (4)
Posterior (1) Posterior (2)
14 Center 2 ET VIM Central (2) Central (2)
Medial (2) Medial (2)
15 Center 2 PD STN Central (3) Central (2)
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stimulation. Patient 7 also exhibited rigidity as a symptom. 
However, during surgery, only the tremor was evaluated. 
Because of a software error during the implantation of the 
left hemisphere of patient 7, no synchronization signal was 
sent to the electrophysiology system. Hence, data from the 
left hemisphere could not be analyzed. The problem had no 
influence on the operation itself and was resolved before 
the neurosurgeons proceeded to the right hemisphere.
In Center 2, for patient 10, during the stimulation of the 
right hemisphere, no tremor was observed and rigidity was 
evaluated by a neurologist during the surgery. Patient 12 
had more tremor in the left lower limb than in the left hand; 
therefore, to test the versatility of the method, the accelera-
tion sensor was mounted on the foot in the distal metatarsal 
region. The visual evaluation was also based on rest tremor 
reduction in the patient’s foot. During implantation in the 
right hemisphere of patient 11, the acceleration sensor was 
unintentionally disconnected from the recording software, 
and for the right hemisphere of patient 13, no acceleration 
data were recorded because of waning battery power in the 
recording laptop.
2.4  Data analysis
The raw data recorded during DBS surgery as well as a first 
analysis were visualized in real time in LemurDBS during 
surgery. For ethical reasons, the results of the acceleration 
data analysis were not considered when the chronic implant 
position for the DBS lead was chosen (the study had been 
declared a purely observational study of the potential useful-
ness of a new method, and any influence of the intraopera-
tive accelerometric findings on surgical decision making was 
explicitly ruled out). An exhaustive data analysis was per-
formed postoperatively in MATLAB (Mathwork Inc., Mas-
sachusetts, USA) including a comparison between results of 
the accelerometric and visual evaluations. Statistical analy-
sis was performed with SOFA Statistics (Paton-Simpson & 
Associates Ltd, Auckland, New Zealand) and OriginPro 
(OriginLab Corporation, Massachusetts, USA).
2.4.1  Preprocessing
As a first step, the magnitude (square root of sum of squares) 
of every sample of the 3 different axes of acceleration data 
was calculated. In general, acceleration signals correspond-
ing to movements other than tremor were also present in the 
recorded data and could be clearly identified visually. Large 
movements, like those corresponding to rigidity evaluations, 
were ignored for real-time analysis and were manually elimi-
nated from the data sets during postoperative evaluation [48]. 
It was necessary to filter the acceleration data to extract the 
tremor signal while suppressing the effect of gravity and 
higher-order spectral harmonics. In addition, the filters had to 
be optimized for low computation time to allow for real-time 
evaluation. While previous studies have shown that PD and 
ET have a dominant frequency between 3 and 12 Hz [18], 
our data showed a range of 3–6 Hz. Based on this, a 2-step 
process was employed to filter the data. (1) A time-varying 
high-pass filter called “smoothness priors” [48], with a cutoff 
frequency of 2 Hz [20], was used to remove low-frequency 
trends and the effect of gravity. (2) A second-order Butter-
worth low-pass filter was tested with cutoff frequencies from 
10 to 30 Hz in steps of 5 Hz. In the present study, a cutoff 
frequency of 10 Hz was used because of adequate suppres-
sion of higher-order (2 and more) harmonics and digital noise 
without altering the outcome measures or the calculated 
improvement in tremor. Nevertheless, the cutoff frequency 
can be adapted to accommodate unexpected variations in 
tremor frequency. For postoperative analysis, synchroniza-
tion markers and stimulation amplitude from the data for each 
stimulation test position were imported into MATLAB. For 
data coming from the Alpha Omega system, Neuroexplorer 
(Nex Technologies, Madison, Alabama, USA) was used to 
read the proprietary format. Acceleration data were imported 
Fig. 2  a Raw acceleration data (blue signal) recorded in syn-
chronization with the stimulation amplitude (black stepped line). 
b Improvement in tremor estimated from the outcome measures 
extracted from accelerometer data (IQ) for the different stimulation 
current amplitudes (color figure online)
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and synchronized with the stimulation amplitude (Fig. 2, top). 
Correct synchronization was verified by visual inspection.
2.4.2  Outcome measures
To estimate the changes in tremor during intraoperative 
stimulation tests, the accelerometer data were analyzed in 
a windowed manner. Various factors such as the average 
duration per stimulation amplitude, the sampling rate, and 
the range of tremor frequency had to be taken into account 
in choosing the window length. Based on these factors, 
windows of 1–4 s of time length and 0–50 % overlap were 
tested, and a non-overlapping window of 2 s was found to 
be optimal for data analysis. For each measurement posi-
tion, outcome measures (standard deviation (1), signal 
energy (2), entropy (3), dominant frequency (4), and spec-
tral amplitude of the dominant frequency (5)) were extracted 
from data recorded during baseline and stimulation periods:
However, statistical tests showed that 3 outcome meas-
ures (standard deviation, signal energy, and spectral ampli-
tude of the dominant frequency) were more sensitive 
(1)
Standard deviation =
√√√√ 1
N − 1
N∑
n=1
|xn − µ|
2
with µ =
1
N
N∑
n=1
xn
and N = Total number of samples
(2)Signal energy =
N∑
n=1
|xi|
2
(3)
Entropy = −
N∑
n=1
pn log2 pn where p is
the probability density function
(4)
Dominant frequency = k such that max(Xk) where
Xk =
N−1∑
n=0
xne
−i2pik n
N
and k = 0, . . . ,N − 1
(5)
Spectral amplitude of dominant frequency = max(Xk)
where Xk =
N−1∑
n=0
xne
−i2pik n
N and k = 0, . . . ,N − 1
toward changes in tremor [41], and only they were retained 
for further analysis. The extracted measures were graphi-
cally presented along with the stimulation current ampli-
tude for visual analysis. Once the stimulation test was 
completed, the time window representing the highest 
tremor in the baseline data was identified and selected. The 
measures (a set of all three) extracted from this baseline 
window were used to normalize (6) the respective meas-
ures extracted for the following windows obtained during 
the stimulation test.
Such normalization permitted a relative evaluation of 
tremor with changing stimulation current amplitude. The 
mean (7) of the normalized standard deviation, signal 
energy, and spectral amplitude of dominant frequency for 
any given window was termed as quantitatively calculated 
improvement in tremor or IQ (Fig. 2, bottom).
2.4.3  Comparative postoperative analysis
To establish the benefits of accelerometric tremor evalua-
tion during DBS over visual evaluation, the first step was 
to compare the improvement in tremor identified by the 
two methods. To compare the discrete levels of the rat-
ing scales used for visual evaluations to the continuous 
values of accelerometric evaluation and to eliminate the 
difference between the rating scales used by the two dif-
ferent centers, the improvement values were classified 
in 5 categories as described in Table 3. Since in Center 
1 the relative improvement in tremor was directly visu-
ally rated, the categories were easy to assign. In Center 
2, tremor severity was rated on the UPDRS scale, i.e., 
in absolute rather than relative terms (see Table 1 for 
details). In consequence, the baseline severity had to be 
considered to determine the corresponding improvement 
values. Table 3 shows the baseline-dependent classifica-
tion. As no patient had a baseline rating of 1, it is not 
listed in the table.
The classification of improvement values from visual 
evaluation (IV) was straightforward, as only one IV value was 
(6)
Normalized outcome measure
=
(
Baseline value− current value
Baseline value
)
× 100%
(7)
IQ =
1
3
×
(
Normalized
standard deviation
+
Normalized
signal energy
+
Normalized spectral
amplitude of dominant frequency
)
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available for each stimulation current amplitude. Because the 
quantitative improvement values (IQ) were calculated in a win-
dowed fashion, multiple values were available depending on 
the number of windows that were completely enclosed in the 
period of a given stimulation current amplitude. Therefore, for 
the classification as well as for the comparison with IV at any 
given stimulation current amplitude, the IQ values for the same 
stimulation current amplitude were averaged. To study the 
distribution (pairwise) of IV and IQ values, the Wilcoxon two-
sided signed rank test [50] was used to compare their popula-
tion mean ranks. Also, as IV and IQ are both tremor improve-
ment values, a positive linear correlation should exist between 
these two data sets. To check statistically for such a correla-
tion, Spearman’s test [45] was used.
In addition to comparing the improvement in tremor 
identified by the different methods, the IQ values were also 
used to identify effective stimulation current amplitudes. 
For every stimulation test position, the lowest stimulation 
current amplitude (mA) at which the IQ value was similar 
to the IV value (highest IV value for Center 2) was identified 
and termed as the quantitatively identified effective stimu-
lation current amplitude (AQ). The Wilcoxon two-sided 
signed rank test was used to compare AQ values to the visu-
ally identified effective amplitude (AV) values. To study the 
effect of using accelerometric evaluation of tremor on the 
implant position of the permanent DBS lead, the clinical 
staff was given the AQ values after implantation and asked 
to state where they would have implanted the permanent 
DBS lead on the basis of these values rather than AV values.
3  Results
The presented setup and method were successfully applied 
to the intraoperative stimulation tests in both the clinical 
centers. The data recording setup had certain failures during 
the surgery of 4 patients. While the synchronization failure 
for patient 6 was due to a software error, the loss of battery 
power for patient 13 was due to human error. The disconnec-
tion between the sensor and the software during the surgery 
for patient 11 was rectified after the surgery with the use of 
a cable loop on the plastic case of the sensor board. Also, the 
synchronization with the LeadPoint system highlighted prob-
lems of signal saturation. On the other hand, the data analysis 
techniques were successful in eliminating noise and in extract-
ing relevant information from the raw acceleration data.
In total, from all 15 patients, accelerometry data for 
359 stimulation current amplitudes (223 in Center 1; 136 
in Center 2) and the respective visually observed improve-
ment values in tremor were acquired and analyzed offline. 
The Wilcoxon two-sided signed rank test (p = 0.041) 
showed that for any given improvement in tremor, the IV 
and IQ values are not significantly different. The result of 
the Spearman’s test confirmed that for increasing improve-
ment in tremor, IQ and IV values increase in a correlated 
manner (R = 0.661, p < 0.001).
Figure 3a shows the counts of the quantitatively evalu-
ated improvement IQ as a function of the corresponding 
visually assessed improvement IV in terms of categories as 
defined in Table 3. For example, if for one stimulation cur-
rent amplitude, the change in tremor was visually assessed 
as average improvement (category C) and quantitatively 
as 70 % improvement (category B), then this evaluation 
would fall in the group CB (column 3, row 2) in Fig. 3. 
Ideally, all the evaluations would fall in one of the groups 
on the 45° diagonal, implying that both methods identify 
similar improvement in tremor for all the ranges. In fact, 
only 156 (43.5 %) evaluation pairs fell in the same category 
for both evaluation methods (Fig. 3b). Of the remaining 
203 evaluations, IQ values were lower than IV values for 93 
(26 %) (Fig. 3b, groups below the diagonal) and IQ values 
were higher for 110 (30.5 %) (Fig. 3b, groups above the 
diagonal). Further, 296 (82.5 %) of the evaluations fell in 
the same or adjacent categories (neighborhood, Fig. 3c), 
while the remaining 63 (17.5 %) evaluations showed dif-
ferences of at least 2 categories between the two values 
Table 3  Categories used for classification of tremor improvement for the different rating scales used for visual- and accelerometer-based evalu-
ations
a Details about the two different clinical scales are given in Table 1
Category Descriptive evaluation in 
tremor
Quantitative accelerom-
etry-based evaluation 
(IQ) (%)
Visual evaluation (IV)
a
Center 1: Direct rating Center 2: Rating using absolute UPDRS
Baseline = 4 Baseline = 3 Baseline = 2
A Tremor arrest >87.5 4 0 0 0
B High improvement 75 ± 12.5 3, 3.5 1+,1,1−, 0+ 1−,0+ 0+
C Average improvement 50 ± 12.5 2, 2.5 2+,2,2− 2−,1+,1 1+,1,1−
D Limited improvement 25 ± 12.5 0.5, 1, 1.5 4−,3+, 3, 3− 3−,2+,2 2−
E No improvement/tremor 
worsening
<12.5 0 4 3 2
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(outliers, Fig. 3d). As mentioned in Table 1, in Center 1, 
only the maximum improvement in tremor was noted for 
every stimulation test. This, along with the higher number 
of patients from Center 1, creates a bias in the results as 
evident from the number of evaluations in category A for 
both IV and IQ values (Fig. 3a).
The comparison between effective stimulation cur-
rent amplitudes AV and AQ is depicted in Fig. 4. AQ val-
ues (mean ± SD: 1.1 ± 0.8 mA) were significantly lower 
(p < 0.001) than AV values (1.7 ± 0.8 mA). The considera-
tion of the acceleration data instead of the visual evaluations 
would have affected the choice of the chronic implant posi-
tion for the DBS lead. Out of the 26 (Center 1: 18, Center 2: 
8) choices, 15 (Center 1: 15, Center 2: 0) would have been 
different, and for 2 implantations (Center 1: 2, Center 2: 0), 
a position on a different trajectory would have been chosen.
4  Discussion
The aim of this study was to provide an assistive tool sup-
porting the neurologists in their tremor assessment during 
DBS surgery normally performed by visual inspection (the 
method now used in most centers). With the versatile sys-
tem based on accelerometry, improvement in tremor can 
be measured quantitatively and any evaluation performed 
during DBS surgery can be revisited and visualized. The 
system was specifically designed to be used in the operat-
ing room during stimulation tests through exploration elec-
trodes in different clinical centers, without impeding or 
prolonging the surgical procedure.
Some researchers have performed intraoperative quan-
titative evaluations to identify the best stimulation param-
eters for stimulating through the chronically implanted 
Fig. 3  a 5 × 5 Heatmap illustrating the number of evaluations fall-
ing in each category pair, based on Table 3. The intensity of gray is 
proportional to the number of evaluations. (Right) Subdivision of the 
heatmap of the left into 3 scenarios: b the ideal scenario would be 
that all the evaluations fall along the diagonal meaning that visual 
and quantitative evaluation are equal; c inclusion of the neighborhood 
around the diagonal, i.e., taking account as well variations of one cat-
egory between the two evaluation methods; d considering the outliers 
where the difference between the visual improvement and the quanti-
tative improvement is of at least two categories (color figure online)
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DBS lead. Journee et al. [14] performed intraoperative 
neurophysiological measurements with multiple sensors, 
including two uniaxial accelerometers, on a large patient 
cohort. They evaluated tremor by comparing it with a com-
mon baseline recorded before any incision. This method 
of comparison ignores the improvement in tremor that is 
often observed after insertion of the electrode but before 
any stimulating current is turned on (the so-called micro-
lesional effect [24]). A baseline recording performed before 
each stimulation test, as in the current method, is necessary 
to have an accurate objective evaluation of improvement in 
tremor. Papapetropoulos et al. [27] used the commercially 
available CATSYS system (Danish Product Development 
Ltd., Snekkersten, Denmark) to evaluate the best stimula-
tion parameters for PD patients undergoing DBS immedi-
ately after the DBS lead was placed in the brain. However, 
their method required the active participation of the patient 
by holding the tremor pen in a certain position, and the 
patients were given practice time to familiarize themselves 
with the testing procedure. Varying levels of familiarity 
with the system increase the subjectivity of such evalua-
tions. In the method presented here, the acceleration data 
were recorded passively and in parallel to the routine visual 
evaluation.
Quantitative evaluation of improvement in tremor with 
accelerometers depends heavily on the filtering param-
eters used and the outcome measures extracted from the 
data. Gravity also has an effect on the data measured by 
the accelerometer [30] and therefore has to be corrected for 
before any outcome measures are extracted. In contrast to 
previously proposed methods, in which the effect of grav-
ity was not suppressed, our method uses a cutoff frequency 
of 2 Hz for the smoothness-priors detrending method 
which has been shown to suppress the effect of gravi-
tational acceleration on the raw data [20]. With regard to 
the outcome measures, as Papapetropoulos et al. [27] used 
a commercial system; they were restricted to the outcome 
measures available from it, i.e., tremor intensity, center fre-
quency, its standard deviation, and harmonic index. Journee 
et al. [14] relied on spectral outcome measures without any 
filtering of the data. Additionally, they extracted temporal 
outcome measures from displacement estimated from the 
accelerometer data after double integration, which also 
significantly amplifies the noise in the accelerometer data 
[49]. In contrast, the linear outcome measures (temporal 
and spectral) like the ones proposed in this study have been 
shown to correlate with the UPDRS tremor scores during 
routine non-surgical clinical evaluation [20].
The use of our method in 15 patients in 2 different cent-
ers has already revealed some of its benefits and limita-
tions. The complete setup was initially designed for use 
with the MicroGuide Pro system and later adapted for use 
with the LeadPoint system. Imperfect adaptation might 
underlie the signal saturation that was initially observed 
during synchronization with LeadPoint system but subse-
quently eliminated after the present study was conducted 
by modification of certain parameters in LemurDBS. This 
experience only underscores the need to test any quantita-
tive symptom evaluation method in multiple clinical cent-
ers. A clear advantage of the method is the absence of any 
patient discomfort. The acceleration sensor is easy to attach 
to the patient’s affected (usually upper) limb and to remove 
from it afterward; aside from patient comfort, this also 
ensures that the device does not block the surgical team’s 
access to any part of the patient’s body if needed (for inser-
tion of new intravenous lines, etc.).
The comparison of improvement in tremor identified 
visually (IV) with that calculated from the acceleration data 
(IQ) is shown in Fig. 3. It must be noted, however, that a 
categorization of evaluations based on Table 3 results in 
loss of information, partly because of the large ranges of 
quantitative improvement values for each category and 
also because any worsening in tremor is also categorized 
in E, i.e., “No change/tremor worsening.” Despite this loss 
of information, the number of evaluations in each category 
provides a better understanding of the similarities and dif-
ferences between the two tremor evaluation methods. The 
results show that for 43.5 % of the evaluations, both the 
methods identified similar improvement in tremor, i.e., IV 
and IQ values fell in the same category (Fig. 3b). In prac-
tice, however, minor changes in tremor are difficult to esti-
mate visually, especially when the baseline tremor is small. 
Therefore, it is plausible that IQ values would be in the 
same category as the IV values, or at least in a neighbor-
ing category. In this scenario, 82.5 % of the evaluations are 
Fig. 4  Box plot comparing the effective stimulation current ampli-
tudes identified from visual evaluation (AV) and quantitative evalu-
ation (AQ). The lower whiskers indicate 5th and the upper whiskers 
95th percentile of the values
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either in the same or neighboring categories (Fig. 3c). The 
remaining 17.5 % of evaluations show very large differ-
ences between the visual evaluation and the accelerometric 
evaluation (Fig. 3d).
One of the primary objectives of intraoperative stimula-
tion tests is to identify sites where stimulation suppresses 
tremor. The high number of evaluations in the AA group 
would indicate that both methods can be used for this 
purpose. However, considering that the total number of 
the evaluations where only one of the methods indicated 
tremor arrest (AB, AC, AD, BA, CA, and DA) is 76, it 
seems that a small residual tremor might not always be 
visually identified. As both methods estimate change in 
tremor compared to a baseline condition, the difference in 
estimation by the two methods may be a result of different 
choices of baseline. The visual evaluation is based on the 
complete baseline activity before test stimulation, whereas 
the accelerometric evaluation is based on the worst tremor 
(2 s long) in the whole baseline recording. Further, it may 
be possible that in case of very low baseline tremor, it was 
considered as suppressed by visual estimation, while the 
accelerometric evaluation only measured 50 % improve-
ment. Another possible reason for such differences might 
be that the evaluator did not retain an accurate memory of 
the observed baseline tremor while performing the evalu-
ation. This emphasizes the need of an evaluation system 
that lets the evaluator re-check the severity of tremor at any 
time during the surgery. Previous studies proposing quan-
titative evaluation methods have shown similar findings 
[14, 27, 36] suggesting that the limitations of current visual 
evaluation methods could be overcome by supplementing 
them with quantitative methods.
The impact of quantitative tremor evaluation on the DBS 
surgery can be gauged by its influence on surgical decision 
making, i.e., the choice of the site where the chronic DBS 
lead is finally implanted. One of the factors that influence 
this choice is the therapeutic window, i.e., the difference 
between the amplitude of stimulating current that results 
in an appreciable clinical effect and the side-effect thresh-
old. As evident from Fig. 4, the quantitatively identified 
amplitude for effective stimulation (AQ) tends to be lower 
than the corresponding value obtained by visual evalua-
tion (AV) and is thus associated with a wider therapeutic 
window. The evidence of this expansion in range affecting 
the choice of chronic implant position is provided by the 
results of comparison between clinical choices and choices 
based on quantitative data for the chronic implant position. 
The results show a stark difference in the choices between 
Center 1 and Center 2 because of the differences in the 
method of choosing the chronic implant position (Table 1). 
In Center 1, the stimulation test position among a group 
of adjacently located positions with large therapeutic win-
dow is chosen as opposed to Center 2, where the deepest 
effective stimulation test position is chosen. Also, as the 
number of stimulation tests per hemisphere is lower in 
Center 2, the choice of chronic implant position of the DBS 
lead would be less influenced by the accelerometer-based 
improvement values. A clinical study would be needed 
to determine the impact of different methods of choosing 
the chronic implant site on the ultimate clinical efficacy of 
stimulation.
We infer from our data analysis that the recording of 
a sufficient amount of baseline data is important. In the 
case of insufficient baseline data (<5 s) at a position, the 
analysis has to be done with the baseline from the previ-
ous position. However, this scenario does not significantly 
limit the method. Additionally, as the data analysis is per-
formed with windows of 2 s, each stimulation tests at any 
particular amplitude should be longer than that to increase 
the reliability of the result. A shorter duration might result 
in an incorrect identification of the effective amplitude of 
the stimulating current. Such errors will be smaller if the 
current is raised in smaller increments.
The results of this study show that our quantitative 
tremor evaluation method can help improve the placement 
of the chronic DBS lead. As a next step, a visualization tool 
will also be added to the software to allow the surgical team 
to see the results superimposed on the patients’ brain scans 
(MRI or CT). To allow automatic identification of effective 
stimulation current amplitudes, thresholds for the quantita-
tively calculated improvement in tremor will be identified. 
For patients with Parkinson’s disease, the quantification of 
tremor alone may not be sufficient. Rigidity is also present 
in these patients and is clinically evaluated during DBS sur-
gery. Moreover, rigidity seems to be less affected by other 
factors like psychological stress, pain, alertness, microle-
sioning effects. Thus, in patients with Parkinson’s disease a 
quantitative evaluation of rigidity is also needed for a com-
prehensive quantification of stimulation test results. Rigid-
ity can be measured with intraoperative accelerometry as 
well [42].
Recent years have seen the development and marketing 
of new types of DBS leads. The idea of directional stimula-
tion [5, 19] has been extensively researched, and new leads 
[6, 31] are already undergoing clinical trials. With the aid 
of quantitative methods as proposed in the current study, 
a more robust comparison can be made between different 
stimulation parameters and positions, and the time needed 
for testing may be shortened. Another area of increasing 
research is closed-loop DBS. Closed-loop systems have 
been proposed that are based not only on electrophysiologi-
cal signals [10], but also on EMG and acceleration signals 
of tremor [3]. For such technologies to be practically useful 
and rapidly applicable, intraoperative quantitative evalua-
tions of disease manifestations such as tremor and rigidity 
might play an important role.
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5  Conclusion
In this paper, we describe a new method in which an accel-
eration sensor is used for the quantitative evaluation of 
improvement in tremor in patients undergoing DBS for 
movement disorders. The method can be used in differ-
ent surgical centers with little or no change of the system 
setup. It improves upon the previously proposed methods 
by using better filtering techniques and outcome measures 
that correlate with tremor severity. Accelerometry-based 
tremor evaluation widens the apparent therapeutic window 
of stimulation for tremor; it can therefore alter the explora-
tory test stimulation results and thus affect the choice of site 
for chronic DBS lead implantation. In the present study, 
the site of chronic lead implantation would have been dif-
ferent in 60 % of cases if the surgeons had been allowed 
to consider the accelerometric evaluations instead of the 
subjective visual evaluations of tremor. Our preliminary 
results suggest that the limitations of the current clinical 
rating methods can be overcome by supplementing them 
with objective evaluation methods and, in turn, improve 
the determination of the optimum site for lead placement. 
To confirm the present findings, the method will have to be 
used in more patients undergoing DBS surgery.
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A novel assistive method for rigidity evaluation during 
deep brain stimulation surgery using acceleration sensors
ashesh shah, Msc,1 Jérôme Coste, PhD,2,3 Jean-Jacques lemaire, MD, PhD,2,3  
erik schkommodau, PhD,1 ethan taub, MD,4 raphael guzman, MD,4 Philippe Derost, MD,5,6 and 
simone hemm, PhD1
1Institute for Medical and Analytical Technologies, School of Life Sciences, University of Applied Sciences and Arts Northwestern 
Switzerland, Muttenz; 4Departments of Neurosurgery and Biomedicine, University Hospital of Basel, Switzerland; 2Image-Guided 
Clinical Neuroscience and Connectomics, and 5Neuro-Psycho-Pharmacologie des Systèmes Dopaminergiques Sous-Corticaux, 
Université Clermont Auvergne, Université d’Auvergne; and 3Service de Neurochirurgie and 6Service de Neurologie, CHU 
Clermont-Ferrand, France
obJeCtive Despite the widespread use of deep brain stimulation (DBS) for movement disorders such as Parkinson’s 
disease (PD), the exact anatomical target responsible for the therapeutic effect is still a subject of research. Intraopera-
tive stimulation tests by experts consist of performing passive movements of the patient’s arm or wrist while the ampli-
tude of the stimulation current is increased. At each position, the amplitude that best alleviates rigidity is identified. Intra-
rater and interrater variations due to the subjective and semiquantitative nature of such evaluations have been reported. 
The aim of the present study was to evaluate the use of an acceleration sensor attached to the evaluator’s wrist to 
assess the change in rigidity, hypothesizing that such a change will alter the speed of the passive movements. Further-
more, the combined analysis of such quantitative results with anatomy would generate a more reproducible description 
of the most effective stimulation sites.
MethoDs To test the reliability of the method, it was applied during postoperative follow-up examinations of 3 patients. 
To study the feasibility of intraoperative use, it was used during 9 bilateral DBS operations in patients suffering from PD. 
Changes in rigidity were calculated by extracting relevant outcome measures from the accelerometer data. These values 
were used to identify rigidity-suppressing stimulation current amplitudes, which were statistically compared with the 
amplitudes identified by the neurologist. Positions for the chronic DBS lead implantation that would have been chosen 
based on the acceleration data were compared with clinical choices. The data were also analyzed with respect to the 
anatomical location of the stimulating electrode.
resUlts Outcome measures extracted from the accelerometer data were reproducible for the same evaluator, thus 
providing a reliable assessment of rigidity changes during intraoperative stimulation tests. Of the 188 stimulation sites 
analyzed, the number of sites where rigidity-suppressing amplitudes were found increased from 144 to 170 when the ac-
celerometer evaluations were considered. In general, rigidity release could be observed at significantly lower amplitudes 
with accelerometer evaluation (mean 0.9 ± 0.6 mA) than with subjective evaluation (mean 1.4 ± 0.6 mA) (p < 0.001). Of 
14 choices for the implant location of the DBS lead, only 2 were the same for acceleration-based and subjective evalu-
ations. The comparison across anatomical locations showed that stimulation in the fields of Forel ameliorates rigidity at 
similar amplitudes as stimulation in the subthalamic nucleus, but with fewer side effects.
ConClUsions This article describes and validates a new assistive method for assessing rigidity with acceleration 
sensors during intraoperative stimulation tests in DBS procedures. The initial results indicate that the proposed method 
may be a clinically useful aid for optimal DBS lead placement as well as a new tool in the ongoing scientific search for 
the optimal DBS target for PD.
https://thejns.org/doi/abs/10.3171/2016.8.JNS152770
Key worDs deep brain stimulation; Parkinson’s disease; rigidity; acceleration sensor; quantification; intraoperative; 
subthalamic nucleus; fields of Forel; functional neurosurgery
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Deep brain stimulation (DBS) is a neurosurgical technique in which electrodes are implanted in deep-seated brain structures (e.g., the subthalamic 
nucleus [STN], globus pallidus, or thalamus) so that these 
structures can be stimulated with electrical pulses gener-
ated in an attached, extracranially implanted neurostimu-
lator device. DBS is a highly effective symptomatic treat-
ment for Parkinson’s disease (PD) and other movement 
disorders.25 More than 100,000 patients have been treated 
with DBS in the past 3 decades.23
The current incomplete understanding of the mecha-
nisms of action of DBS and interindividual variation of 
brain anatomy necessitate patient-specific planning. Most 
centers also perform intraoperative stimulation tests un-
der local anesthesia at multiple anatomical locations in the 
vicinity of a preoperatively chosen target1 to evaluate the 
therapeutic effects and side effects of stimulation before 
the DBS lead (permanent electrode) is definitively fixed 
in place. For some patients with PD, the therapeutic ef-
fects of stimulation tests are estimated by assessing the 
changes in rigidity as the stimulation current is increased. 
Expert evaluators (generally a neurologist) perform pas-
sive movements of the patient’s arm continuously to assess 
the changes in rigidity. When either a reduction in rigidity 
or a side effect is observed, the amplitude and the effect of 
stimulation are noted. After completion of all stimulation 
tests, the results are compared to identify the best implant 
position, that is, the one that yields the best improvement 
with the fewest side effects.
Different evaluators assess rigidity during surgery in 
different ways,5 but with the same basic concept: the base-
line rigidity is rated before any stimulation, and the chang-
es in rigidity are assessed in comparison with this baseline 
value. Intraoperatively used rating scales for PD are based 
on those commonly used outside the operating room (OR), 
mainly the Unified Parkinson’s Disease Rating Scale7 and 
the Hoehn and Yahr staging scale.10 Previous studies have 
shown that such rating scales have low interrater16,18 and 
intrarater18 reliability, because they are subjective and de-
pend highly on the experience of the evaluating neurolo-
gist.8 Additionally, these scales have only discrete levels 
and were not designed for continuous rigidity evaluation.2 
To increase the sensitivity for intraoperative use, some 
neurologists add intermediate levels to the existing rating 
scales.12 An alternative way to increase sensitivity is to 
measure movement parameters during passive movement 
with sensors and thereby quantify the change in rigidity.
Various methods have been proposed for quantify-
ing the absolute level of rigidity in patients with PD by 
measuring responses to passive movement.11,17,19 Some re-
searchers have used surface electromyography (S-EMG) 
to measure muscle activity and have shown that the sig-
nals differ between healthy subjects and patients with 
PD.15,26 Other techniques have also been proposed, which 
use a torque-motor setup to perform precise movements of 
a patient’s arm or wrist while measuring joint angle and 
resistance.2,5,21 These studies showed that the features ex-
tracted from such precise movements are more strongly 
correlated with rating scales than those extracted from 
S-EMG signals.4 However, the intraoperative use of such 
techniques to quantify rigidity would be excessively cum-
bersome or impossible. Usable signals from S-EMG elec-
trodes can only be obtained when they are in close contact 
with the skin; the prolonged use of such electrodes might 
cause discomfort. In addition, the mechanical torque-mo-
tor setup limits the evaluation of rigidity to a single joint, 
and the apparatus is typically too large for use in the OR.
Rigidity is defined as the resistance to passive move-
ment; thus, it can be presumed that during stimulation 
tests, the speed of the movement would increase with a 
reduction in rigidity. To the best of our knowledge, no such 
method has been proposed, in which the change in rigidity 
is assessed by measuring the change in speed (accelera-
tion) of the passive movement. One reason for the lack of 
such a method could be the variations associated with the 
passive movements. In general, each expert evaluator has a 
preferred joint (arm/wrist) to perform passive movements 
to evaluate rigidity. Each expert can also choose the pat-
tern of passive movement (extension, flexion, or circular) 
to be performed during a test. An expert may also stop and 
restart passive movements to prevent the patient’s active 
participation in the movements. Therefore, any method for 
assessing rigidity that is based on the speed of movement 
should have robust outcome measures that are not influ-
enced by the intrarater and interrater variability associ-
ated with passive movement.
We previously published a method22 for evaluating 
tremor during DBS surgery by using acceleration sensors. 
In the current study, we present various modifications of 
this method, with the aim of helping the neurologist as-
sess the effect of stimulation on rigidity during intraopera-
tive stimulation tests. Our hypothesis is that the relative 
change in rigidity can be assessed by measuring the accel-
eration of the evaluator’s wrist during passive movement. 
To validate our approach, we studied the intra- and inter-
rater variability of accelerometer measurements of pas-
sive movement in postoperative follow-up examinations 
of patients with PD treated with DBS. We evaluated the 
feasibility of intraoperative use of the system in a total of 9 
DBS operations. The impact that this method would have 
had on the DBS surgery was studied by analyzing differ-
ences in the choice of position for the chronic DBS lead 
implantation (clinical choice vs choice based on acceler-
ometry), a decision that is based on results of intraopera-
tive stimulation tests. In addition, the accelerometry-based 
change in rigidity was correlated with the anatomical lo-
cation of the stimulating electrode to identify the most ef-
fective stimulation sites.
Methods
recording equipment
A commercially available accelerometer sensor evalu-
ation board (STEVAL-MKI022VI, STMicroelectronics) 
was used to measure the acceleration of the passive move-
ments. It was housed inside a printed plastic case (Full-
Cure 830 Vero White, Stratasys) that could be attached to 
the wrist with a Velcro strap (Fig. 1). The sensor board was 
connected through a Universal Serial Bus (USB) cable to 
the laptop running custom-made in-house software (Le-
murDBS). A wireless sensor system was not used to avoid 
any possible interference with the microelectrode record-
rigidity assessment using acceleration sensors during Dbs
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ing (MER) of the signal. Acceleration data were recorded 
and visualized with LemurDBS.
Filtering and outcome Measures
The acceleration data were processed with MATLAB 
version R2015b (MathWorks, Inc.). They were filtered 
with a smoothness priors24 filter to remove the influence 
of gravity. To identify the changes in rigidity during in-
traoperative stimulation tests, the data were analyzed in 
a windowed manner. Various time lengths, ranging from 
1 to 4 seconds with 0%–50% overlap, were tested. On the 
basis of the duration of a single passive movement (ap-
proximately 1 second), the duration of a single stimulation 
current amplitude, and the sampling frequency of the ac-
celerometer, the 4-second window with 50% overlap was 
found to be optimal. To simplify the comparisons between 
various data sets, outcome measures were extracted from 
all windowed data. The measures previously found to be 
correlated with changes in tremor22 (standard deviation, 
signal energy, and spectral amplitude of the dominant 
frequency) were used, along with others (entropy and pri-
mary frequency). For simplicity, these outcome measures 
will be referred to numerically as follows: 1) standard de-
viation, 2) signal energy, 3) spectral amplitude of the dom-
inant frequency, 4) dominant frequency, and 5) entropy.
Data acquisition
Reliability Tests
To study the intra- and interrater variability of the out-
come measures, it was necessary to collect data in a con-
trolled environment. Such data collection during intraoper-
ative stimulation tests would have prolonged the operations 
and put the patients under additional stress. Moreover, be-
cause of restrictions imposed by the OR environment, only 
1 sensor could be used at a time to measure acceleration. 
Theoretically, acceleration of passive movements could be 
measured by attaching the sensor either to the patient or to 
the evaluator. We hypothesized that attaching the sensor to 
the evaluator would record higher-quality data than plac-
ing the sensor on the patient during passive movements of 
the wrist joint. To study this matter further and investigate 
the intra- and interrater variability of accelerometer data 
measured during passive movement, we performed special 
tests during the postoperative follow-up of patients with 
PD treated with DBS.
A specific protocol was set up to be followed by each 
evaluator when obtaining data from a patient. The evalu-
ators were required to perform a set of 4 passive move-
ments (left elbow, left wrist, right elbow, and right wrist) 
twice, with a short pause in between. Data from 2 accel-
eration sensors (1 attached to the patient and 1 attached 
to the evaluator) were recorded simultaneously and in a 
synchronized manner to test the quality of acceleration 
data obtained from the 2 fixation positions during differ-
ent evaluations.
Feasibility of Intraoperative Use
To study the intraoperative feasibility of the system, it 
was used during DBS operations at the University Hospi-
tal in Clermont-Ferrand, France.
Surgical Procedure. The clinical team uses direct tar-
geting on patient-specific imaging data as part of the sur-
gical procedure.14 During the planning session, with the 
aid of a brain atlas developed in-house13 and multiple im-
age sets of the patient (CT scans and MR images), includ-
ing a specific white matter–attenuated inversion recovery 
sequence, the neurosurgeon identified and outlined the 
different deep brain structures in the subthalamic region 
with the iPlan Stereotaxy 3.0 planning software (Brain-
lab). Two trajectories per hemisphere were planned, from 
an entry point in the skull to the target structure, avoiding 
sensitive structures (blood vessels, cerebral ventricles). For 
stimulation tests, multiple positions were identified along 
these trajectories in the region of interest, in 1-mm steps.
The surgery was performed on awake patients. Two 
exploration electrodes (Alpha Omega) were inserted and 
electrophysiological mapping (MER) was performed at 
the preplanned positions in both trajectories simultane-
ously. After MER, stimulation tests were performed at the 
same positions: first in one trajectory, then in the other, 
moving progressively deeper into the brain tissue in steps 
of 1 mm. At each position, the stimulation current was in-
creased from 0 to 3 mA in steps of 0.2 mA. To evaluate 
rigidity, the neurologist first passively moved the patient’s 
arm/wrist to assess baseline rigidity, before any stimula-
tion was delivered. Then, during stimulation, changes in 
rigidity compared with baseline were rated on a scale from 
0 (no change) to 4 (complete suppression of rigidity). Ri-
gidity could be rated multiple times in a single evaluation, 
but only the maximum reduction in rigidity was noted and 
used for comparison with the results at other stimulation 
positions. The evaluator continuously interacted with the 
patient to observe any side effects and to make sure that he 
or she was not actively moving the limb.
At each position, 2 stimulation amplitudes were identi-
fied: 1) the amplitude at which the highest reduction in 
rigidity was observed (subjectively assessed amplitude 
[AmpS]), and 2) the amplitude at which the first side ef-
fect occurred (side-effect threshold). When stimulation 
tests were completed, the surgical team determined the 
best implant position, according to the following crite-
ria: 1) low AmpS value, 2) large difference (“therapeutic 
window”) between AmpS and the side-effect threshold, 3) 
neighboring positions having a comparatively large thera-
peutic window, and 4) anatomical position. Depending on 
the number of preoperatively chosen positions, stimulation 
tests in 1 cerebral hemisphere can take 15–30 minutes.
Intraoperative Protocol for Data Recording. To avoid 
prolonging the surgical procedure while maximizing the 
data recorded during all of the stimulation tests, a system-
atic data-recording procedure was followed. The accelera-
tion sensor was mounted on the evaluator’s wrist during 
the stimulation tests. The strap was tightened snugly, but 
not uncomfortably, to prevent slippage. Data recording 
was started during the baseline evaluation and continued 
until the stimulation test for 1 position was completed. A 
new recording was started in a similar manner for each 
position, and the data were saved in separate files for off-
line analysis.
The stimulation current amplitude was varied in quick 
succession. To identify the exact amplitude responsible for 
a. shah et al.
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the therapeutic effects, recording of acceleration data was 
synchronized with the electrophysiological system. For 
this purpose, the electrophysiology system (Microguide 
Pro, Alpha Omega) was connected to a laptop running Le-
murDBS with a USB–Bayonet Neill–Concelman (USB-
BNC) cable (Fig. 1).
Clinical application
The clinical use of the afore-described data-recording 
system for the purpose of intraoperative and postoperative 
symptom evaluation in the framework of this study was 
approved by the institutional review boards of the Univer-
sity Hospital in Clermont-Ferrand (France) and the Uni-
versity Hospital of Basel (Switzerland).
For the tests of intra- and interrater reliability in post-
operative follow-up, 3 different evaluators were asked to 
perform passive movements to assess rigidity in 3 patients 
with PD, according to a predefined protocol. To simulate 
OR conditions, the tests were done with the patients su-
pine. Each evaluator completed 8 passive movements for 
each patient, yielding a total of 72 evaluations (3 patients × 
3 evaluators × 2 sides × 2 joints × 2 evaluations).
To investigate the feasibility of using the system dur-
ing intraoperative stimulation tests, the recording system 
was used during the DBS operations of 9 patients with PD, 
who had rigidity as their primary symptom. The patients 
gave their written informed consent to participate in the 
study (for details, see Table 1). Four different neurologists 
performed routine passive movements to evaluate rigidity 
while wearing the acceleration sensor on their wrist (each 
patient was evaluated intraoperatively by only 1 neurolo-
gist).
Data analysis Method
The data were analyzed with MATLAB. Statistics 
were performed with SOFA Statistics version 1.4.5 (Pa-
ton-Simpson & Associates Ltd.) and OriginPro (Origin-
Lab Corporation).
Reliability Tests
To validate the outcome measures, they were extracted 
from the acceleration sensors in both positions (attached 
to the patient and to the evaluator, respectively) with the 
MATLAB scripts after verification of synchronization. 
Because these measures were extracted in a windowed 
fashion, multiple sets of measures were available per eval-
uation. The outcome measures extracted from the sensors 
on the patient and on the evaluator would be expected to 
be strongly correlated with each other (pairwise) because 
of the simultaneous synchronized recording of data. An 
absence of correlation would indicate insufficient quality 
of acceleration data. For each evaluation, the multiple sets 
of outcome measures were averaged to create a pairwise 
data set. To confirm our presumption that the sensor on 
Fig. 1. Data recording setup used to assist rigidity evaluations per-
formed during DBS surgery. Figure is available in color online only.
table 1. Details about patients participating in the clinical study and their surgical procedures
Patient  
No.
Age at  
Surgery (yrs)
Preop UPDRS-III  
Scores (medication off)
Evaluator  
ID
Tested Trajectories (no. of stimulation positions)
Lt Rt
1 67 17 E1 Central (9), posterolateral (9) Central (8), posterolateral (8)
2 60 26 E1 Central (8), posterior (8) Central (3), posterior (3)
3 53 39.5 E1 Central (4), posterior (4) Central (8), posterior (8)
4 61 26 E4 Central (8), posterior (8) Central (6), posterior (6)
5 66 35 E3 Central (8), posterior (8) Central (7), posterior (7)
6 69 45 E2 Central (6), posterior (6) Central (6), posterior (6)
7 57 45 E4 Central (8), posterior (8) Central (8), posterior (8)
8 69 27 E2 Central (7), posterior (7) Central (7), posterior (7)
9 53 43 E2 Central (7), posterolateral (7) Central (7), posterolateral (7)
UPDRS = Unified Parkinson’s Disease Rating Scale.
Acceleration data were unavailable for the stimulation tests in boldface type. 
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the patient would not be sensitive enough to detect wrist 
movements, the pairwise correlation of the outcome mea-
sures from the patient’s and the evaluator’s sensors was 
tested for wrist and elbow evaluations separately with the 
Spearman correlation test.
For reliable assessment of changes in rigidity, the out-
come measures of the evaluator’s sensor were checked for 
intrarater variability by comparing data from evaluations 
1 and 2 of each evaluation type. From the data set of av-
eraged outcome measures, only those for the evaluator’s 
sensor were separated into data from evaluations 1 and 2 
for pairwise comparison. The Wilcoxon signed-rank test 
was used to verify similarity between the outcome mea-
sures of these 2 groups.
To study interrater variability, the multiple outcome 
measures per evaluation were compared independently for 
the different evaluators and patients. The data were grouped 
for the 4 different joints (left elbow, left wrist, right elbow, 
and right wrist). The Kruskal-Wallis ANOVA test was used 
for each patient to check for interrater variations.
The different groupings and statistical tests described 
above are summarized in Table 2.
Feasibility of Intraoperative Use
The intraoperatively recorded acceleration data were 
synchronized with the stimulation current amplitude ac-
cording to the time-stamped synchronization signal (Fig. 
2, upper). The repetitive nature of passive movements fa-
cilitated the identification and removal of data correspond-
ing to other movements of the evaluator’s arm. The data 
corresponding to 1 stimulation test were divided into 2 
parts as follows: 1) the data recorded during passive move-
ments without any stimulation were called baseline data, 
and 2) the remaining data were called stimulation data. 
These data were then filtered and outcome measures were 
extracted with the MATLAB scripts as described above. 
Further, to perform comparative analysis in a manner sim-
ilar to the neurologists’ evaluations, the extracted outcome 
measures from the stimulation data were normalized to 
the highest outcome measures at baseline (Fig. 2, lower).
To investigate the pairwise correlation between nor-
malized outcome measures and clinical ratings, Spear-
man’s correlation test was used. Because a neurologist’s 
assessment of change in rigidity was only noted once for 
each stimulation position (change at AmpS), the subjective 
ratings were compared with the normalized outcome mea-
sures at AmpS. Furthermore, the mean of the normalized 
outcome measures that were well correlated was called 
the quantitatively assessed change (QC) in rigidity.
Identification of Rigidity Release Threshold
During subjective evaluations, the AmpS (that is, the 
stimulation current amplitude for the highest change in 
rigidity) was determined by the evaluator for each stimu-
lation position. In addition, the amplitude inducing a QC 
similar to the subjectively assessed reduction at AmpS 
was identified and designated as quantitatively identified 
rigidity-suppressing amplitude (AmpQ). The Wilcoxon 
2-sided signed-rank test was used to compare AmpS and 
Fig. 2. Graphical representation of the recorded acceleration data syn-
chronized with the stimulation current amplitude (upper) for 1 stimula-
tion test, and outcome measures extracted in a windowed manner from 
the recorded signal along with the stimulation current amplitude (lower).
table 2. Categorization, comparison, and statistical tests used for analysis of data collected during reliability tests
Purpose Data Constraints & Groups Comparison Test Result
Patient sensor 
vs evaluator 
sensor
Test 1: elbow movements; 
Test 2: wrist movements
Pairwise correlation of outcome 
measures from patient’s sen-
sor & evaluator’s sensor
Spearman’s cor-
relation test
Correlation for elbow movements (Test 1): 
outcome measures 1, 2, & 3; correlation 
for wrist movements (Test 2): none
Intrarater vari-
ability
Data only from evaluator’s 
sensor
Pairwise comparison btwn out-
come measures of repeated 
evaluation of the same joint
Paired-sample Wil-
coxon signed-
rank test
No change in outcome measures 1, 2, & 3
Interrater vari-
ability
Data only from evaluator’s 
sensor. Comparison per 
patient, side, & joint
Comparison of outcome mea-
sures 1, 2, & 3 btwn different 
evaluators
Kruskal-Wallis 
ANOVA
Interrater variability in outcome measures 
1, 2, & 3
a. shah et al.
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AmpQ for stimulation tests where both the AmpQ and the 
AmpS were identified.
Impact on Surgical Decision Making
During the routine procedure, the surgical team would 
determine the best implant position of the DBS lead on the 
basis of the AmpS, the side-effect threshold, and the anat-
omy, as described above. To study the effect of accelerom-
etry-based rigidity change assessment on the final implant 
position chosen, the clinical staff was asked which final 
implant position they would have chosen if they had consid-
ered the AmpQ rather than the AmpS values. These choices 
were compared with the actual best implant positions cho-
sen after intraoperative stimulation testing for each patient.
Anatomical Analysis
The intraoperative accelerometric assessment of change 
in rigidity was used to study the efficacy of stimulation in 
different anatomical structures as targets for the reduction 
of rigidity. On the basis of the planning data, the surgical 
team postoperatively identified the anatomical structure 
present at the center of the stimulating contact for every 
stimulation position and verified it with the MER data. To 
compare the efficacy of the different anatomical locations 
on the basis of the accelerometric measurements, at each 
stimulation test position the lowest stimulation current am-
plitude at which the QC value increased to more than 75% 
was identified, if it existed (Amp75). The threshold value 
of 75% was chosen to identify only the structures respon-
sible for high reduction of rigidity. We also compared the 
side-effect thresholds and the number of stimulation tests 
where side effects were observed as a percentage of the 
total number of stimulation tests in a particular structure. 
These data sets, composed of Amp75, occurrence of side 
effects, and side-effect thresholds, were used to compare 
the efficacies of different anatomical structures.
results
The accelerometric method could be successfully ap-
plied in the postoperative validation tests and in 9 DBS 
operations without prolonging the procedures. All evalua-
tors and patients were comfortable with wearing the accel-
eration sensor while performing the rigidity evaluations. 
Routine evaluations and routine surgical procedures took 
place as usual, without any interruptions. During implan-
tation in the left hemisphere of Patient 1, the sensor was 
mounted on the patient’s wrist and not on the evaluator’s. 
Data recorded during these stimulation tests were not in-
cluded in the analysis. No electrophysiological data were 
available for implantation in the left hemisphere of Patient 
3. For Patient 7, due to the absence of rigidity, akinesia was 
evaluated during stimulation tests in the left hemisphere.
reliability tests
Figure 3 shows an example of a comparison between 
data sets acquired with acceleration sensors mounted on 
the patient and on the evaluator for elbow and wrist move-
ments. For the elbow tests, of the 5 outcome measures, 
3 showed a strong correlation (outcome measure 1: R = 
0.766, p < 0.001; outcome measure 2: R = 0.756, p < 0.001; 
and outcome measure 3: R = 0.697, p < 0.001) between 
the 2 sensors, whereas the remaining outcome measures (4 
and 5) showed a weak or no correlation. In contrast, none 
of the features exhibited a correlation between patient-
derived and evaluator-derived measurements of passive 
movement of the wrist.
In the analysis of intrarater variability, the results of the 
paired-sample Wilcoxon signed-rank tests showed that 3 
outcome measures did not change (outcome measures 1, 2, 
and 3; p < 0.001) between repeated evaluations of the same 
joint. Therefore, only these 3 outcome measures were re-
tained in the further analysis.
The interrater variability analysis (Kruskal-Wallis 
ANOVA test) for the different joints and for each patient 
showed that outcome measures 1, 2, and 3 were signifi-
cantly different (p < 0.05) among the 3 evaluators. Box 
plots in Fig. 4 represent the interrater variations in out-
come measure 1. They show that for some evaluations (left 
elbow, right elbow, and right wrist of Patient 3), the inter-
rater variability was very low, but for others (left and right 
elbow of Patient 1, and right wrist of Patient 3) there were 
significant interrater differences. Outcome measures 2 and 
3 have similar distributions.
Fig. 3. Filtered acceleration data from the sensors mounted on the eval-
uator (solid gray line) and on the patient (solid black line). The graphs 
show data from the passive movements of the elbow (upper) and wrist 
joint (lower).
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The statistical results of the above tests are summarized 
in Table 2.
Feasibility of intraoperative Use
The comparison between the normalized outcome mea-
sures and the subjectively rated change in rigidity during 
intraoperative stimulation tests indicates a strong correla-
tion for outcome measures 1 (R = 0.308, p < 0.001), 2 (R 
= 0.313, p < 0.001), and 3 (R = 0.237, p < 0.05). Therefore, 
QC (the quantitatively assessed change in rigidity) was 
calculated as the mean of the normalized values of these 
outcome measures.
Identification of Rigidity Release Threshold 
Of 188 stimulation tests during which acceleration data 
were recorded, AmpS and AmpQ were available and could 
be compared for 140 stimulation tests. The other 48 were 
composed of 14 evaluations where neither method identi-
fied any reduction in rigidity, 30 evaluations where the sub-
jective evaluation did not find any threshold, and 4 evalua-
tions where the accelerometric evaluation did not identify 
a threshold. The mean value of AmpQ (0.9 ± 0.6 mA) was 
lower than AmpS (1.4 ± 0.6 mA), and the results of the 
Wilcoxon 2-sided signed-rank test confirmed inequality 
between AmpQ and AmpS values (Fig. 5, p < 0.001). For 
stimulation tests where the value for AmpQ was lower than 
for AmpS, it was observed that the value of QC during 
stimulation was uniform between these 2 amplitudes.
impact on surgical Decision Making
The comparison of choices of the final implant position 
is shown in Table 3. Because of error in the synchroniza-
tion setup, only 2 stimulation tests were analyzed for the 
left implantation in Patient 5, for which data were insuf-
ficient to identify the best implant position for this hemi-
sphere. Of the remaining 14 implantations, for only 2 po-
sitions (rows in boldface type in Table 3), the choice was 
the same when made with AmpS or AmpQ. In 4 cases, a 
position on another trajectory was chosen on the basis of 
the AmpQ compared with the AmpS values.
anatomical analysis
For this analysis, 125 stimulation tests were used for 
which QC values were higher than 75%. Furthermore, 
the number of stimulation tests in the substantia nigra (1 
test) and thalamus (4 tests) were not large enough to pro-
Fig. 4. Box plots showing the interrater variations (E1, E2, E3) for outcome measure 1 for passive movements of the left elbow (a), 
left wrist (b), right elbow (C), and right wrist (D).
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vide statistically significant results. Of the remaining 120 
stimulation tests, 64 were in the STN, 35 were in the zona 
incerta (ZI), and 21 were found in the fields of Forel (FF). 
The results depicted on the left in Fig. 6 show that the STN 
requires lower stimulation current amplitudes than the 
ZI and FF to reduce rigidity by at least 75%. The aver-
age values of side-effect thresholds were similar for all 3 
structures (STN 2.68 ± 0.36 mA, ZI 2.72 ± 0.17 mA, and 
FF 2.5 ± 0.22 mA), but the STN had a significantly higher 
occurrence of side effects (Fig. 6, right).
Discussion
This article describes a novel method of recording 
and analyzing rigidity evaluation during DBS surgery by 
means of an acceleration sensor strapped on the evalua-
tor’s wrist. The aim was to test the hypothesis that changes 
in the patient’s rigidity can be assessed by measuring ac-
celeration during passive movement. Validation tests were 
performed to confirm the optimal mounting position of the 
acceleration sensor, to check for low intrarater variability 
of the outcome measures, and to assess interrater variabil-
ity, before using the system intraoperatively.
reliability tests
The comparison between the data of the sensor on the 
patient’s wrist and the sensor on the evaluator’s wrist (Fig. 
3) and the Spearman’s correlation test confirmed our hy-
pothesis that a fixation on the evaluator’s wrist is more 
robust for measuring passive movements of both joints. 
Therefore, for an intraoperative use without altering the 
existing surgical procedure, the sensor should be mounted 
on the wrist of the evaluator, as done in the current study.
The low intrarater variability in 3 of the 5 outcome 
measures shows that these outcome measures are suffi-
ciently robust for use in the intraoperative environment. 
During our intraoperative stimulation tests, intrarater vari-
ability would not have been relevant because the evaluator 
performs no other activity than passive movement, paus-
ing only between stimulation test positions. In any case, 
even if the evaluator has to stop and then resume passive 
movements, the current method will be able to reliably as-
sess the change in rigidity.
As mentioned previously, the performed passive move-
ments vary between evaluators,27 so interrater variations 
are expected in the accelerometer data. These variations 
also influence the outcome measures, as depicted in the 
box plots in Fig. 4 and as statistically confirmed. It must 
be borne in mind that the results of the Kruskal-Wallis 
ANOVA test are based on a small sample size, thus re-
ducing their power. Because of the high inherent interra-
ter variability of passive movements, the determination of 
the absolute level of rigidity in patients by measuring the 
acceleration is not possible. Thus, the aim of the current 
study was to develop a method for the determination of 
relative changes compared with baseline evaluations.
Feasibility of intraoperative Use
The method proposed in this article is designed to as-
sist the neurologist in estimating the changes in rigidity 
during intraoperative stimulation tests of DBS surgery. 
Considering that in most centers only 1 evaluator is pres-
ent to perform the passive movements, the current method 
will produce reliable results because of the high intrarater 
reliability. Additionally, the technique of normalization 
of the outcome measures used in the current method not 
only mimics the subjective evaluation method (that is, 
assess changes compared with baseline values), but also 
minimizes the effect of any residual intrarater variability 
between different stimulation test positions. The evidence 
is provided by the results of the Spearman’s correlation 
tests between the 3 normalized outcome measures and the 
clinically rated changes in rigidity. 
Moreover, such an evaluation is superior to absolute eval-
uation, because the rigidity of the patient may also change 
due to other factors such as microlesional effects, patient 
stress, and so on. However, it was also noted during the data 
analysis that a minimum recording of 5 seconds of baseline 
evaluation is needed to obtain evaluable results. When such 
data were unavailable, the baseline data from the previous 
stimulation test position (a maximum of 3 minutes before) 
were used. The results of the application of this method in 9 
DBS operations support its future use in the OR.
Quantitative rigidity evaluations have rarely been 
performed during DBS surgery. To our knowledge, only 
Kwon et al.12 have used a mechanical setup to measure 
parameters of rigidity in the wrist joint while the patient 
Fig. 5. Box plot comparing the rigidity-suppressing stimulation current 
amplitudes (n = 140) identified with subjective evaluation (AmpS) and from 
the quantitative data (AmpQ). Upper whiskers are at the 95th percentile 
and lower whiskers are at the 5th percentile. Asterisks represent outliers.
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underwent surgery. An expert evaluator passively moved 
the patient’s wrist around the joint through a handle while 
the input force of the evaluator and the inertia of the move-
ment were measured. Mechanical parameters such as 
work, impulse impedance, and so on were extracted. In 
contrast to our method, their setup enables the measure-
ment of multiple variables simultaneously, but is restricted 
to evaluation of the wrist joint. Moreover, for proper func-
tioning, instructions were given to the evaluator to perform 
a specific movement, which resulted in longer evaluations. 
In addition, the evaluator had to change his or her routine 
evaluation protocol. In order not to prolong the surgical 
procedure, fewer evaluations were performed when their 
setup was used.12 Our system was specifically designed for 
use in routine evaluation; no instructions were given to the 
patient or the evaluator. Because the evaluator could fol-
low his or her usual evaluation protocol, the duration of the 
routine surgery was unaltered.
Identification of Rigidity Release Threshold 
One of the advantages of using our method rather than 
subjective evaluation is in the identification of rigidity re-
lease thresholds. Twenty-six more thresholds were found 
with our data analysis technique. Also, the results of the 
table 3. Choice of best implant position for the Dbs lead
Patient  
No. Hemisphere
Choice Based on Clinical Evaluation Choice Based on Thresholds Extracted From Acceleration Data
Trajectory Distance to Target (mm) Trajectory Distance to Target (mm)
1 Lt Central 0 NA NA
1 Rt Central −1 Central −3
2 Lt Central 0 Posterior −1
2 Rt Central −3.5 Posterior −4
3 Lt Central −4 NA NA
3 rt Central −3 Central −3
4 Lt Central −1 Central −3
4 Rt Central −2 Central −3
5 Lt Central −4.5 NA NA
5 rt Central −1 Central −1
6 Lt Central −3.5 Central −3
6 Rt Central −3.5 Posterolateral −3
7 Rt Central −2 Posterolateral −5
8 Lt Central −2 Central −1
8 Rt Central −2 Central −6
9 Lt Central −2.5 Central −1
9 Rt Central −3.5 Central −8
NA = not available (that is, for stimulation tests in the left hemisphere of Patients 1, 3, and 5, acceleration data were insufficient to make a choice).
The choice of the best implant position was the same for the rows in boldface type.
Fig. 6. left: Column charts comparing the average stimulation current amplitude required to observe at least a 75% reduction 
in the mean of the 3 outcome measures (standard deviation, signal energy, and spectral amplitude of the primary frequency).  
right: Stacked 100% column charts present the number of stimulation tests where side effects were observed (black) as a 
percentage of the total number of stimulation tests in the corresponding structure. The numbers inside the black part of the bars 
indicate the actual count of the side-effect occurrences; the numbers below the bars indicate the total number of stimulation tests.
a. shah et al.
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Wilcoxon 2-sided signed-rank test and the box plot show 
that values tend to be lower for AmpQ than for AmpS. We 
believe that the human evaluator, on observing the change 
in rigidity, may need a few seconds to verify and assess the 
amount of reduction. During this time, the amplitude may 
have already been increased, resulting in higher AmpS 
values. This result suggests that the current setup enhances 
the sensitivity of the subjective rigidity evaluation. On the 
other hand, there were 4 positions where AmpS values, 
but no AmpQ values, were found. On inspection of these 
4 positions, it was observed that the baseline data were 
insufficient to extract outcome measures for normaliza-
tion. Because they were the first positions tested, baseline 
evaluations of previous positions were unavailable to use 
the workaround. This underscores the need for sufficient 
baseline recording for data analysis.
impact on surgical Decision Making
The differences in the rigidity release amplitudes iden-
tified by the 2 methods significantly influenced the choice 
of the best implant position. Only 2 of the 12 choices would 
have been at the same position. This clearly shows the po-
tential of using an assistive method during intraoperative 
symptom evaluation for DBS surgery. From the current 
data, it is not possible to judge which of the 2 choices was 
better. One possible way would be to compare the choice 
of best implant position with the choice of postoperative 
contact; the relative closeness of one or the other choice 
may help to judge whether the assistive evaluation system 
can identify better implant positions. However, such an 
analysis would need a very large data set to result in statis-
tically significant conclusions.
anatomical analysis
The anatomical analysis gives interesting insight into 
the target selection procedure of DBS. It shows that stimu-
lation in the STN requires the lowest current amplitude 
to achieve a 75% reduction in rigidity. However, in view 
of the fact that side effects were observed in nearly 50% 
of stimulations in the STN, it may not be the optimum 
target structure. The FF require an additional 0.3 mA, on 
average, to achieve a comparable reduction in rigidity, but 
have significantly fewer side-effect occurrences. Hence, to 
achieve a better outcome of DBS for patients with rigidity, 
the DBS lead might be placed closer to the FF or the ZI and 
not inside the STN, to avoid side effects. This would be in 
accordance with reported findings3,6,9,20,28 implying that the 
FF and the ZI may also be responsible for the therapeutic 
effects of DBS. However, this analysis has a limitation. It 
only considers the center of the electrode when associating 
a structure with a stimulation test position. Because the ef-
fect of stimulation spreads beyond the center, electric-field 
simulations would be a helpful tool to deepen the analysis 
of the available intraoperative data.
Future work
In its current state, the method proposed in this study 
has various advantages over the existing subjective ratings 
used in the OR. It provides a reproducible assessment of the 
change in rigidity, which can be reviewed at any time dur-
ing surgery without any discomfort to the patient or evalu-
ator, and without prolonging the operation. Nevertheless, 
because the changes in rigidity are assessed indirectly, the 
results produced are only semiquantitative. In the future, 
to make the method a comprehensive evaluation system for 
use in DBS surgery, the current setup will be modified to 
enable data recording and analysis from 2 smaller acceler-
ation sensors simultaneously. By mounting one sensor on 
the evaluator and the other on the patient,23 it will be pos-
sible to evaluate rigidity and tremor at the same time. We 
intend to use the system in more operations (optimally, in 
additional clinical centers as well) so that we can continue 
to adapt it to physicians’ needs. The long-term aim is to 
integrate this method in commercially available and cur-
rently used intraoperative stimulation systems to facilitate 
visualization of the symptom improvement in real time, 
along with other stimulation parameters and anatomical 
data. Such a system would enable the surgical team to in-
terpret the results of intraoperative stimulation tests more 
easily and thus facilitate surgical decision making.
Conclusions
We have described a new way to assess changes in ri-
gidity by measuring the acceleration of the examiner’s 
wrist during passive movement while the patient is un-
dergoing intraoperative stimulation testing in DBS sur-
gery. Outcome measures are reproducible over time but 
are influenced by variations in the passive movements of 
different evaluators. The intraoperatively assessed change 
in rigidity is reliable and is correlated with the subjective 
ratings. The quantitatively identified effective stimulation 
amplitudes show the potential of the method to optimize 
surgical decision making. Moreover, our findings concern-
ing the thresholds for effective stimulation at different ana-
tomical sites suggest that the optimal DBS target may, in 
fact, lie closer to the FF, just dorsal to the STN. The pro-
posed method may be a clinically and scientifically useful 
aid to optimal targeting in DBS.
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Results of reliability tests for validation of acceleration sensors as an 
assistive tool for rigidity evaluation.  
In the manuscript titled "A novel assistive method for rigidity evaluation during deep brain stimu-
lation surgery using acceleration sensors," the authors were asked to add tests to validate their 
method of using acceleration sensors to evaluate rigidity. The aim of these tests was to an-
swer the following questions: 
a) Optimal mount position of the sensor: The acceleration sensor can be attached to the 
patient's wrist or the evaluator's wrist. Which of the two mount positions provides the op-
timum data? 
b) Test-retest reproducibility: Are the outcome measures extracted from the acceleration 
data reproducible over time, i.e. if an evaluator evaluates rigidity of the same patient 
twice, with a brief interval in between?  
c) Inter-rater variations: Do the variations in the passive movements of different evalua-
tors evaluating the same patient affect the outcome measures?  
As described in the manuscript, to answer the above questions, the proposed method was ap-
plied to rigidity evaluations during the post-operative follow-up of 3 patients who had undergone 
STN-DBS surgery. During these sessions, the evaluators were asked to perform passive 
movements in a specific sequence of tests while the stimulators were turned off. To identify 
which of the mount positions of the sensor is better for analysis, data from 2 sensors were rec-
orded simultaneously in a synchronized fashion during the passive movements. Each evaluator 
was asked to perform passive movements on the wrist and elbow joints of both arms. After 
evaluating the elbow joint, the evaluator paused for a short break and repeated the passive 
movements of the elbow joint for the retest. After another short break, passive movements of 
the wrist joint were performed twice. Each evaluator performed 8 tests (two times each for left 
elbow, left wrist, right elbow and right wrist) for each patient. This permitted the study of inter-
rater variations in the outcome measure. As only some of the results could be integrated in 
the manuscript because of restrictions on length and the number of figures, the results 
of these tests are described here for the reviewers in greater detail.  
 
Optimum mount position of the sensor:  
Figure 3 in the paper shows the differences of the acceleration data from the sensor mounted 
on the evaluator and the sensor mounted on the patient. For passive movements of the elbow 
joint, the data from the two sensors are similar. However, for passive movements of the wrist 
joint, the sensor on the patient does not register enough information. The outcome measures 
extracted from the two sensors were checked for correlation and it was noted that they were 
correlated between the sensors for elbow evaluation but not for wrist evaluation.  
Figure A in the present document shows the 6 scatter plots comparing the 3 outcome measures 
(standard deviation, signal energy and spectral amplitude of dominant frequency) obtained from 
a sensor attached to the evaluator with those obtained from a sensor attached to the patient 
during passive elbow and wrist movement. The distribution of  points along the 45° diagonal and 
their relative closeness to it in figures A1, A2 and A3, show that the outcome measures corre-
late across the different evaluators and the patients for passive movements of the elbow joint. 
Yet, as seen in Figures A4, A5 and A6, the measures obtained from a sensor attached to the 
patient's wrist have much lower values than the corresponding measures obtained from a sen-
sor attached to the evaluator's wrist. The outcome measures are not correlated for the passive 
movements of the wrist joint. When the sensor is mounted on the patient’s wrist, the movements 
of the wrist joint are not recorded; therefore, the extracted statistical features are not correlated 
with the passive movements of the evaluator’s arm. One solution would be to mount the sensor 
on the back of the patient's hand, but this would tend to get in the way of the grip of the evalua-
tor. We therefore decided to mount the sensor on the evaluator, rather than the patient, during 
the surgery.  
 
Test-retest reproducibility:  
The paired-sample Wilcoxon signed-rank test reported in the manuscript revealed that the out-
come measures used to assess changes in rigidity are reproducible over time. Figure B shows 
the scatter plots of the outcome measures (test vs. retest) obtained with the sensor mounted on 
the evaluator. The type of marker indicates the patient, while the gray scale of the marker indi-
 
Figure A: Scatter plots for outcome measures extracted from passive movements of elbow (left col-
umn) and the wrist (right column) joints for all three evaluators together. 
cates the evaluator. The graph shows that the test and retest values are similar for nearly all 
evaluators and all patients, with only a few exceptions. Overall, for all the data combined, the 
three outcome measures (standard deviation, signal energy, and spectral amplitude of the pri-
mary frequency) are reproducible over time for each patient and evaluator. This is indicated by 
the angle of the trend-line (close to 45 degrees) and its r2 value (points do not lie too far away 
from the trend-line).  
 
Inter-rater variations:  
The Kruskal-Wallis ANOVA test reported in the manuscript revealed variations between the out-
come measures extracted from the same patient by different evaluators. As each evaluator has 
his/her specific pattern of passive movements to estimate rigidity, the signal recorded by the 
accelerometer will be different for each. As a result, the outcome measures will also vary. To 
suppress these variations, it would be necessary to instruct and train the evaluators to use a 
single, standardized type of passive movement, which might not be comfortable for and accept-
ed by all the evaluators. More importantly, for intraoperative use of the system, these variations 
do not influence the result of the data analysis, because, in most clinical centers, one expert is 
responsible for all of the rigidity evaluations in each operation. Moreover, the purpose of the 
method is to identify the changes in rigidity by comparing passive movements of the same eval-
uator over different time periods, and not the absolute amount of rigidity in a patient.   
In any case, in view of the inherently indirect nature of this technique for assessing changes in 
rigidity, and the observed inter-rater variability, the authors propose the method only as an as-
sistive tool, rather than a quantitative one.  The intention is to enable evaluators to assess 
changes in rigidity more reliably and confidently and to permit the review of any evaluation dur-
ing the course of the operation or afterward.  
 
 
Figure B. Scatter plots showing pairwise comparison of outcome measures 
from test data against retest data 1) Standard deviation 2) Signal Energy 
and 3) Spectral amplitude of primary frequency.  
Chapter 6
Quantitative Target Selection
The previously published eorts to improve target selection for DBS have relied
on data collected from chronic stimulation through the DBS lead. In contrast,
the large number of positions that are stimulated during the surgery may be
better suited to study the eciency of dierent structures. Planned surgical
trajectories for a target structure traverse through neighbouring structures and
in some cases, structures inferior to the target. In addition, use of intraoperative
data also eliminates any eect of plasticity or post-operative adaptations in the
patients brain that are observed for chronic stimulation. Furthermore, the setup
of this study adds another benet in terms of sensitivity to symptom changes
due to the use of quantitative evaluation.
The surgical team in CHU, Clermont-Ferrand uses a direct targeting method
with the help of an in-house developed microscopic 4.7 T 3D T1 MRI atlas.186
For each patient, they carefully outline the anatomical structures (Figure 6.1)
in the region of interest in the commercial surgical planning software called iPlan
Stereotaxy (Brainlab, Munich, Germany).The necessary structures are identied
based on the MRI tissue contrasts on 1.5T White Matter Attenuated Inversion
Recovery (WAIR) images and the relative positions of these structures with
respect to one another.379 They use a previously published nomenclature187
for the dierent thalamic nuclei for VIM-DBS implantations. In addition to the
manual outlining and labelling, the surgical team also veries the location of
these structures with respect to the trajectory through MER.
In our clinical study in CHU, Clermont-Ferrand, a total of 20 patients had
participated to use the quantitative symptom evaluation (Table 3.1). Out of
these patients, 6 ET patients underwent VIM-DBS implantation, 2 PD patients
underwent VIM-DBS implantation and 12 PD patients underwent STN-DBS
implantation. These patients were categorized based on the disease, target and
the symptom to analyze the data in terms of anatomy. This resulted in a group
of 9 PD STN-DBS patients with rigidity, 3 PD STN-DBS patients with tremor,
96
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Figure 6.1: A screenshot of the iPlan Stereotaxy software showing the relevant struc-
tures for the DBS implantation. Courtesy of Prof. Jean-Jacques Lemaire, CHU,
Clermont-Ferrand.
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2 PD VIM-DBS patients with tremor and 6 ET VIM-DBS patients with tremor.
One PD VIM-DBS patient took the regular medication before surgery which
suppressed the symptoms and one PD STN-DBS patient had no tremor during
the surgery. Due to these exclusions, anatomical analysis of the data was only
possible for two groups - rigidity PD patients with STN-DBS implantation and
ET patients with VIM-DBS implantation.
In accordance with the published literature, our rst approach towards analysing
intraoperative stimulation test data in terms of anatomy was to use the location
of the stimulating contact of the electrode. For each stimulation test position,
the anatomical structure surrounding the stimulating contact was identied us-
ing the pre-operative planning and veried using MER data. Using the ac-
celerometer data, the stimulation current resulting in 75% improvement in the
symptom was identied for each stimulation test. This data was classied based
on the anatomical structures and compared. The details about the analysis, the
results and the discussion for PD-rigidity patients with STN-DBS implantation
can be found in the previous chapter (Section 5.1). Data collected from VIM-
DBS implantations for ET patients are available below in the current chapter
(Section 6.1).
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6.1 Use of quantitative tremor evaluation to enhance
target selection during deep brain stimulation surgery
for essential tremor
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Use of quantitative tremor evaluation to enhance
target selection during deep brain stimulation
surgery for essential tremor
Abstract:Deep brain stimulation (DBS), an eective surgi-
cal treatment for Essential Tremor (ET), requires test stim-
ulations in the thalamus to nd the optimum site for per-
manent electrode implantation. During these test stimula-
tions, the changes in tremor are only visually evaluated.
This, along with other parameters, increases the subjec-
tivity when comparing the ecacy of dierent thalamic
nuclei. We developed a method to quantitatively evaluate
tremor during the test stimulations of DBS surgery and ap-
plied to 6 ET patients undergoing this treatment. From the
quantitative data collected, we identied eective stimu-
lation amplitudes for every test stimulation position and
compared it with the ones identied visually during the
surgery. We also classied the data based on the thalamic
nuclei in which the center of the stimulating contact was
present during test stimulations. Results indicate that, to
achieve the same reduction in tremor, onaverage, the stim-
ulation amplitude identied by our method was 0.6 mA
lower than those identied by visual evaluation. The com-
parison of the dierent thalamic nuclei showed that stim-
ulations in the Ventro-oral and the Intermediolateral nu-
clei of the thalamus result in higher reduction in tremor for
similar stimulation amplitudes as the frequently targeted
Ventrointermediate nucleus. We conclude that our quan-
titative tremor evaluation method is more sensitive than
thewidely used visual evaluation. Using such quantitative
methods will aid in identifying the optimum target struc-
ture for patients undergoing DBS.
Keywords: deep brain stimulation; essential tremor; ac-
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1 Background
Deep Brain Stimulation (DBS) is now a routinely used
surgical treatment for movement disorders like Essential
Tremor (ET) [1]. Electrical stimulation of certain brain
structures is performed by implanting electrodes and
connecting them to a subcutaneously implanted neuro-
stimulator. Although the use of DBS is increasing, the op-
timum target structure is still debated. The limited knowl-
edge of the mechanisms of action of DBS being one of
the reasons, we believe the under-utilization of intra-
operatively obtained data is another.
A typical DBS surgery is preceded by a planning ses-
sion during which a trajectory is planned from an entry
point in the skull to the target structure on the patient’s
anatomical images using stereotactic planning software.
With the aid of stereotactic equipment, this trajectory is
then explored during the surgery. In most of the surgeries,
neuronal activity is recorded and test stimulations are per-
formed at pre-planned positions on this trajectory while
the patient is awake. The nal implant position is decided
after comparing the reduction in tremor, needed stimula-
tion current for inducing those reductions and the side ef-
fects observed during the test stimulations.
In the routing clinical practice, the symptom evalua-
tionmethods are subjective [2]. Tremor is evaluated by a vi-
sual rating of the change compared to its level observedbe-
fore stimulation.Wehavepreviouslydescribed themethod
of evaluating tremor during DBS quantitatively by using
accelerometers [3]. We used this method to intraopera-
tively evaluate tremor from 6 ET patients who participated
in a clinical study in the University Hospital in Clermont-
Ferrand, France. In the current paper, we describe the re-
sult of the comparison between visual and quantitative
evaluations. Further, we classied the results based on the
anatomical location of the electrode and compared them
to identify the target structure which is the most eective
in reducing tremor.
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2 Method
2.1 Surgical protocol
The primary goal of the DBS surgery remains the same
for all surgical centres: to determine the optimal implan-
tation position. However, the actual procedure may dif-
fer signicantly. Lemaire et al have described, in detail,
the routine surgical procedure at the University Hospi-
tal in Clermont-Ferrand [4]. For treating ET patients using
DBS, the primary target structure is the Ventrointermedius
nucleus (VIM) of the thalamus. At the University Hospi-
tal in Clermont-Ferrand, during the planning session on
patient’s images using a commercial stereotactic surgery
planning software (iPlan Stereotaxy, Brainlab, Germany),
the surgical team identies and outlines dierent nuclei
in the thalamus using MRI images of the patient [5]. Af-
ter the denition of target and entry point, test stimula-
tion positions are planned on the resulting trajectory. After
performingmicro-electrode recording (MER) at these posi-
tions, test stimulations are performed. For each test stim-
ulation, the stimulation current is varied from 0 to 3mA in
steps of 0.2 mA and the changes in tremor are observed vi-
sually. The highest reduction in tremor (Visually identied
Change, VC) and the corresponding stimulation amplitude
(Visually identied Amplitude, VA) at which it was ob-
served are noted for every test stimulation location. Along
with these, the occurrence of side-eects, their type and
their corresponding amplitudes are also noted. On com-
pletion of all test stimulations, these data are discussed
upon by the surgical team and a position is determined as
the “nal implant location” for the chronic DBS electrode.
2.2 Acceleration data recording
Tremor was quantied during the surgery using a com-
mercial acceleration sensor evaluation board (STEVAL-
MKI022VI, ST Micro, Switzerland). Time-stamped acceler-
ation values from 3 axes were obtained at a frequency of
400 Hz and a range of 8 g. The evaluation board was xed
in an in-house developed non-conductive printed plastic
case which was attached to the patient’s wrist using a Vel-
cro strap. The acceleration datawere recorded by in-house
developed software installed on a laptop that was inter-
faced with the sensor via an USB cable. Furthermore, the
recording software was also interfaced with the electro-
physiology system to synchronize the acceleration data
recording with the test stimulation data.
For the simplication of acceleration data recording
and analysis, a data recording protocol was dened for all
the surgeries. Acceleration data recording is started before
the beginning of the test stimulation to record the data rep-
resenting the baseline tremor for that test stimulation, and
is continued till all the stimulation amplitudes are tested.
The acceleration data and the related information about
the test stimulation position and amplitude were saved in
data les for oine analysis [3].
2.3 Post-operative data analysis
Acceleration data were analysed post-operatively using
Matlab (Mathwork, USA). In brief, the resultant acceler-
ation was calculated from the three axes and ltered to
remove low frequency (2 Hz) movements and high fre-
quency noise (10 Hz). Statistical features were extracted
from these ltered acceleration data and the features from
dierent stimulation amplitudes were normalized (%) us-
ing the features from the baseline data. These normalized
features were used to identify a dataset of 2 values for each
test stimulation: 1.) The change in acceleration features
(Quantitatively identied Change, QC) at the visually iden-
tied best stimulation amplitude VA and 2.) The stimula-
tion amplitude (Quantitatively equivalent Amplitude, QA)
at which the quantitative change QC was similar to VC.
These data were then statistically compared to the corre-
sponding values from the visual evaluation (VC vs QC and
VA vs QA) using the Wilcoxon two-sided signed rank test.
In order to analyse the correlationwith the anatomical
position of the electrode, the anatomical structure present
at the centre of the stimulating electrode was determined.
Data were then grouped based on the thalamic nucleus
attributed to the test stimulation position. Furthermore,
from the acceleration data of every test stimulation, we
also calculated the minimum stimulation amplitude re-
quired to obtain a 75% reduction in the statistical features
compared to baseline (Amp75). These data along with the
occurrence of side-eects were used to compare the ef-
ciency of dierent structures in reducing the patient’s
tremor by a xed amount.
2.4 Patients
The above method was applied to 6 ET patients under
a clinical study at the University Hospital in Clermont-
Ferrand (2011-A00774-37 / AU905). Out of the 167 test stim-
ulations that were performed, 148 positions were found
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where both evaluation methods identied a reduction in
tremor.
3 Results
The Wilcoxon signed rank test revealed a statistically sig-
nicant dierence between VA and QA (W=4256, p< 0.001,
alpha = 0.001) which can also be observed in the box plot
of the twodata sets (Figure 1). On theother hand, thedier-
ence between VC and QC at the visually identied ampli-
tude VAwas not statistically signicant (W = 3004, p=0.72,
alpha = 0.001).
Figure 1: Box plot comparing visually identied eective stimula-
tion amplitude VA to quantitatively identied eective stimulation
amplitude QA for the same clinical improvement.
From the analysis of the electrode position dur-
ing test stimulation, it was found that the positions
were distributed in 7 thalamic nuclei: Center Median
(CM), Intermedio-Lateral (InL), Ventrointermediate (VIM),
Ventrocaudal lateral (VCL), Ventrocaudal medial (VCM),
Ventro-Oral (VO) and also in Preleminiscal Radiations
(PreR). Table 1 shows the average values of the dierent
parameters extracted from the visual and the quantitative
evaluations. The number of evaluations in the CM region
(3) of the thalamus is small compared to the others and
thus the signicance of the results is very low. The values
of QA are lower than VA for all the structures, the dier-
ence between them being the largest for InL, VO and the
VIM.
Figure 2A shows the average minimum stimulation
amplitude required to see 75% reduction in tremor quan-
titatively while 2B shows the number of test stimulations
with and without side-eects (red and blue respectively).
The VCL and the PreR achieve similar reductions in tremor
at lower amplitudes. But these structures also have higher
occurrence of side eects. TheVCM require higher stimula-
tion amplitudes than VCL and PreR, but also has high oc-
currence of side-eects. The InL and theVO require similar
stimulation amplitudes as the VIM but have much lower
occurrence of side eects. The VIM requires the highest
stimulation amplitude to achieve 75% reduction, but also
has high occurrence of side-eects.
4 Discussion
Various methods have been used previously to quantita-
tively evaluate tremor [6], but only a handful have been re-
ported to be usedduringDBS surgery. Shamir et al. [7] used
goniometers for Parkinson’s patients undergoing DBS,
but only during MER to identify borders of sub-thalamic
nucleus and not to quantitatively evaluate tremor dur-
ing test stimulations. Other quantitative evaluation tech-
niques have been used to optimize the stimulation pa-
rameters of DBS but only after the implant position of the
electrode was already decided [8, 9]. To the best of our
knowledge, no other group has previously used quantita-
tive tremor evaluation to compare the ecacy of dierent
thalamic nuclei.
One of the observations of the application of our
method to the current set of patients was that the use
of quantitative evaluation during DBS surgery did not in-
crease the duration of the surgery or cause any discomfort
to the patient.Moreover, our results suggest that this quan-
titative method is more sensitive than the current visual
evaluation methods used during the surgery. The signi-
cant dierence (0.6mA) between average values of VA and
QA shows that stimulation parameters may be further op-
timized by using quantitative tremor evaluation.
The anatomical analysis of the data obtained using
quantitative tremor evaluation suggests that the conven-
tional target, VIM, may not be the most ecient target for
ET patients undergoing DBS surgery. All other structures
required stimulation amplitude equal to or lower than the
VIM to reduce tremor by 75%. However, after looking at
the number of positions with side eects, the VO and InL
seem to be more ecient in reducing tremor and limit-
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Table 1: Average visual and quantitative parameters for dierent thalamic nuclei
CM InL VO VIM VCL VCM PreR
No. of Stimulations 3 19 18 52 13 24 15
No. of side-eect occurrence 0 1 1 10 2 6 2
Average VC (%) 50 45 63 60 65 72 67
Average QC (%) 76 66 65 57 76 66 57
Average VA (mA) 1.1 2.2 1.9 1.8 1.4 1.6 1
Average QA (mA) 0.4 1.3 1.1 1.3 1 1.5 0.7
Figure 2: Comparison of ecacy of dierent thalamic nuclei. A)
Average stimulation amplitude required to achieve 75% reduction in
tremor. B) Stacked column plot of number of test stimulations with
and without side-eects.
ing side-eects of the therapy. This seems to conrm pub-
lished data [5] suggesting that parts of the ventro-oral nu-
cleus (VO) could be appropriate targets as well.
The results have also indicated some limitations of the
current method. One of the main factors that inuences
the proper functioning of the method is the recording of
baseline data. Aminimumbaseline recording of 5 seconds
is necessary to extract proper statistical features. However,
in case a baseline recording is not available for the current
position, the baseline data of the previous recording can
be used to perform the analysis. Furthermore, the current
analysis method is post-operative. The next step for this
method will to perform real-time data analysis so that the
results are available to the surgical team when they iden-
tify the nal implant site.
5 Conclusion
The current paper presents the results of quantitative
tremor evaluation during DBS surgery for ET patients.
The results indicate that our method is more sensitive
to changes in tremor than the current visual evaluation
methods. Furthermore, the results of the anatomical anal-
ysis suggest that the thalamic sub-structures InL and VO
are more ecient targets for DBS than the conventional
and targeted VIM.
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Chapter 7
Spatial Eects of Stimulation
The use of the electrode contact position only for anatomical analysis provides
a preliminary idea but does not represent the full eects of DBS. The eects
of stimulation are not conned to the location of the stimulating contact, but
spread out in all directions depending on parameters and the surrounding tissue.
Although technological limitations do not allow study of the true distribution of
stimulation eect in human beings, a very good estimate can be obtained using
computer simulations. On a microscopic level, this spatial eect of stimulation
can be estimated by understanding its inuence on the ion channels in the mem-
brane of the surrounding neurons and neuronal projections (axons/dendrites).
On the other hand, at a macroscopic level, stimulation eect can be estimated
by understanding the electrical property of the neuronal tissue surrounding the
electrode. Both these phenomenons can be modelled using mathematical func-
tion and can be simulated using software.
A commonly used technique to simulate such mathematical models is known as
the Finite Element Method (FEM) proposed by Olgierd Zienkiewicz in 1947.335
In principle, the region in which a model has to be simulated is broken down
into a mesh of tiny elements, each having its own variables for the mathematical
model. The complete solution is obtained by calculating the values for all the
variables in the mesh. In the eld of DBS, FEM was rst used by McIntyre226
to study the eects of DBS on neurons. In general, the spatial eects of stimu-
lation can be studied by simulations of dierent electrical quantities like electric
potential,45 electric eld,143,351 the second derivative of electric potential220 or
estimating the VTA by combining neuron models (mathematical representation
of a neuron) with FEM.45,308
Until now, FEM modelling has been frequently used to study the eects of
chronic stimulation through the DBS leads. We hypothesized that by simulating
the eects of intraoperative stimulation tests and analysing the data in relation
to the surrounding anatomy, more information about the dierent structures
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Figure 7.1: The MR image contrast is used to assign the conductivity values for the
dierent voxels in the image volume and used to generate the patient-specic brain
model. For details, refer to Astrom et al.11
could be obtained. In order to do so, a patient-specic stimulation method
that could be adapted to a model of the intraoperative electrode was required.
Based on a published review comparing the dierent FEM simulation methods
in DBS,12 the method proposed by Astrom14 was identied to t the criteria.
Extensive details of the patient-specic simulation method are available in the
doctoral thesis of Mattias Astrom.11 The method simulates the distribution of
Electric Field (EF) in the vicinity of the electrode during stimulation. To make
it patient specic, MR images of the patient are used to estimate the tissue
surrounding the electrode and assign electrical properties accordingly (Figure
7.1). The method was developed in the lab of Prof. Karin Wardell at the Insti-
tutionen for medicinsk teknik (IMT) at the Linkoping University (LiU), Sweden
to simulate the eects of stimulation through the DBS lead. In collaboration
with Prof. Wardell and with Prof. Dr. Jean-Jacques Lemaire at the University
Hospital in Clermont-Ferrand, this patient specic method was modied to sim-
ulate the eect of intraoperative stimulation tests and applied to 5 ET patients
who underwent VIM-DBS. These simulations were combined with the results
of intraoperative quantitative tremor evaluation and analysed in relation to the
outline of anatomical structures extracted from the surgical planning software.
Elaborate description about the method, the results of application and further
discussion can be found in the publication titled "Patient-specic electric eld
simulations and acceleration measurements for objective analysis of intraopera-
tive stimulation tests in the thalamus" attached in the current chapter (Section
7.1)
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7.1 Patient-specic electric eld simulations and ac-
celeration measurements for objective analysis of
intraoperative stimulation tests in the thalamus
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the Thalamus
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Jean-Jacques Lemaire3,4 and Karin Wårdell2
1 Institute for Medical and Analytical Technologies, School of Life Sciences, University of Applied Sciences and Arts
Northwestern Switzerland FHNW, Muttenz, Switzerland, 2 Department of Biomedical Engineering, Linköping University,
Linköping, Sweden, 3 Université Clermont Auvergne, Université d’Auvergne, EA 7282, Image Guided Clinical Neurosciences
and Connectomics (IGCNC), Clermont-Ferrand, France, 4 Service de Neurochirurgie, Hôpital Gabriel-Montpied, Centre
Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France
Despite an increasing use of deep brain stimulation (DBS) the fundamental mechanisms
of action remain largely unknown. Simulation of electric entities has previously been
proposed for chronic DBS combined with subjective symptom evaluations, but not
for intraoperative stimulation tests. The present paper introduces a method for an
objective exploitation of intraoperative stimulation test data to identify the optimal
implant position of the chronic DBS lead by relating the electric field (EF) simulations
to the patient-specific anatomy and the clinical effects quantified by accelerometry. To
illustrate the feasibility of this approach, it was applied to five patients with essential
tremor bilaterally implanted in the ventral intermediate nucleus (VIM). The VIM and its
neighborhood structures were preoperatively outlined in 3D on white matter attenuated
inversion recovery MR images. Quantitative intraoperative clinical assessments were
performed using accelerometry. EF simulations (n D 272) for intraoperative stimulation
test data performed along two trajectories per side were set-up using the finite element
method for 143 stimulation test positions. The resulting EF isosurface of 0.2 V/mm
was superimposed to the outlined anatomical structures. The percentage of volume
of each structure’s overlap was calculated and related to the corresponding clinical
improvement. The proposed concept has been successfully applied to the five patients.
For higher clinical improvements, not only the VIM but as well other neighboring
structures were covered by the EF isosurfaces. The percentage of the volumes of the
VIM, of the nucleus intermediate lateral of the thalamus and the prelemniscal radiations
within the prerubral field of Forel increased for clinical improvements higher than 50%
compared to improvements lower than 50%. The presented new concept allows a
detailed and objective analysis of a high amount of intraoperative data to identify
the optimal stimulation target. First results indicate agreement with published data
hypothesizing that the stimulation of other structures than the VIM might be responsible
for good clinical effects in essential tremor.
(Clinical trial reference number: Ref: 2011-A00774-37/AU905)
Keywords: deep brain stimulation (DBS), intraoperative stimulation tests, essential tremor, acceleration
measurements, finite element method (FEM) simulations, ventral intermediate nucleus (VIM), patient-specific
brain maps
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INTRODUCTION
Deep brain stimulation (DBS) is a common neurosurgical
procedure for relieving movement disorders such as those
observed in Parkinson’s disease (PD) (Benabid et al., 1993,
2009; Hemm and Wårdell, 2010), essential tremor (ET) (Benabid
et al., 1991) and dystonia (Coubes et al., 2000; Cif et al., 2010).
Despite an increasing use and an extension of the indications
(Hariz et al., 2013), the fundamental mechanisms underlying
stimulation-induced effects, either therapeutic or adverse, remain
largely unknown. The exact anatomical regions or white matter
fibers responsible for these effects are still subject of discussion
(Herrington et al., 2015). During a typical surgical planning,
the optimal implantation position for a specific target is first
approached based on anatomical images. Intraoperatively, the
micro contact of an exploration electrode is often used for micro-
electrode recordings (MER) (Coste et al., 2009) to evaluate the
neuronal activity at previously planned positions of deep brain
structures. In a further step, intraoperative stimulation tests
are performed through the macro contact of the exploration
electrode at different locations with help of the MER-system,
and changes in the patient’s symptoms are observed by clinical
examination. The DBS electrode is finally implanted at the
location with the highest therapeutic effect on the symptom
with minimal stimulation amplitude and side effects, or with
side effects occurring only for high stimulation amplitudes. This
procedure is completely based on the physicians experience and
will therefore vary depending on the clinical skills (Post et al.,
2005).
A way to objectify this evaluation is to use accelerometer
recordings of the movements. We have previously presented
a method to support the physician’s evaluation during surgery
by quantifying intraoperatively obtained therapeutic effects
on tremor (Shah et al., 2016b) and rigidity (Shah et al.,
2016a) with the help of wrist acceleration measurements. These
results suggest that mathematical parameters extracted from
the acceleration signal are more sensitive to detect changes in
tremor during intraoperative stimulation tests than the subjective
neurologist’s evaluation. An enhancement of this methodology
would be to relate the wrist accelerometer measurements for the
evaluation of intraoperative stimulation tests with the patient’s
own brain anatomy and patient-specific simulations of the EF
around the stimulation electrode.
The finite element method (FEM) is commonly used to
simulate the distribution of the EF around DBS electrodes often
taking into account the individual patient’s anatomical data
(Åström et al., 2009; Chaturvedi et al., 2010; Wårdell et al.,
2015). The established models have been applied to relate the
results of long term chronic stimulation to anatomical structures
surrounding the stimulating contact. However, the use of patient-
specific models to simulate data acquired during intraoperative
stimulation tests has not yet been proposed.
To support the patient-specific simulations and also the
surgical planning, different brain atlases have been suggested
over the years (Schaltenbrand and Bailey, 1959; Morel, 2007).
This is especially important for brain nuclei generally not visible
with current conventional magnetic resonance imaging (MRI).
With specific sequences it is possible to detail most common
substructures of the thalamus and of other deep brain regions
(Zerroug et al., 2016). Lemaire et al. (2010) introduced a high
resolution atlas of the thalamus which makes extraction of such
nuclei possible.
The aim of the present study was to introduce a new
methodology combining different patient-specific data to identify
the optimal implant position of the chronic DBS lead: thalamic
patient-specific brain maps, EF simulations for intraoperative
stimulation tests based on patient-specific simulation models and
the corresponding therapeutic effects quantitatively evaluated
by wrist accelerometer recordings. To illustrate the feasibility
of this methodology, it was applied to five patients with ET
who underwent stimulation tests during targeting of the ventral
intermediate nucleus of the thalamus (VIM). An exemplary way
of analysis is presented by comparing the extension of stimulation
for no/low and intermediate/high improvements.
MATERIALS AND METHODS
An overview of the methodology including imaging, generation
of patient-specific maps of the thalamic region, surgical
planning, surgical procedure, stimulation tests, accelerometer
measurements, patient-specific EF simulations and data analysis
is presented in Figure 1.
Surgical Protocol
Stereotactic exploration and lead implantation were performed at
the Department of Neurosurgery, Clermont-Ferrand University
Hospital, France, under local anesthesia in a two-day procedure.
The first day, the stereotactic frame was mounted on the
patient’s head (Leksell R G frame, Elekta Instrument AB, Sweden)
under local anesthesia. T1 MRI (0.63 mm 0.63 mm1.30 mm)
and white matter attenuated inversion recovery images (WAIR,
0.53 mm  0.53 mm  2.00 mm) (Magnotta et al., 2000;
Lemaire et al., 2007) were acquired (Sonata, 1.5T, Siemens,
Germany). Using a stereotactic planning software (iPlan 3,
Brainlab, Feldkirchen, Germany), the VIM and its anatomic
neighbors were carefully identified and manually outlined on
the coronal plane of the WAIR sequence (Lemaire et al., 2010;
Zerroug et al., 2016). The nuclei identification followed the
previously published nomenclature (Lemaire et al., 2010; Vassal
et al., 2012) based on their relative positions, intrinsic MRI tissue
contrasts on 1.5T WAIR images (see Figure 6 in Zerroug et al.,
2016) and an in-house microscopic 4.7T 3D T1 MRI atlas (see
Figure 1 in Vassal et al., 2012). Target coordinates and two
parallel trajectories were defined according to the stereotactic
reference system, without AC-PC referencing. Figure 2 shows
a stereotactic planning including the patient-specific brain map
and the planned trajectory.
The second day, after repositioning of the frame
and stereotactic computed tomography (CT) acquisition
(0.59 mm  0.59 mm  1.25 mm), the planned trajectories were
checked and adjusted if necessary with the stereotactic reference
system of the CT after rigid image fusion of WAIR and CT
data sets. The target region was then explored intraoperatively
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FIGURE 1 | Overview of the surgical workflow and the different data acquisition methods. WAIR, white matter attenuated inversion recovery.
(MicroGuide Pro; Alpha Omega Engineering, Nazareth, Israel)
(Slavin and Burchiel, 2002) under local anesthesia using two
exploration electrodes (Neuroprobe 366-000024, Alpha Omega
Engineering, Nazareth, Israel) that were steered by rigid guide
tubes (ACS-7905/200-5, DIXI Microtechniques, Besançon,
France): one for the planned track (named the central track) and
one placed 2 mm in parallel, usually posterior or posterolateral
to the central one. MER was acquired in millimeter steps using
the micro contact of the electrode which was retracted before
starting stimulation tests in order to avoid tissue damage.
Gradual stimulation tests were performed at the same locations
through a macro contact to assess clinical benefit and adverse
effects and to identify the optimal target. For each stimulation
test, the surgical team identified and noted the maximum change
in the patient’s tremor relative to the initial state of the patient
(baseline), and the corresponding stimulation amplitude as well
as the occurrence of side effects. MER and stimulation tests were
in general performed in a range starting some millimeters in
front of the target point and going slightly below depending on
the anatomical location. In addition to this routine assessment of
tremor, wrist accelerometer measurements and video recordings
were performed. Following the stimulation tests, a quadripolar
DBS-lead (Lead 3389, Medtronic Inc., USA) was implanted at
the optimal stimulation spot for chronic stimulation.
Acceleration Measurements
To perform intraoperative acceleration measurements, a 3-axis
accelerometer, placed inside an in-house developed plastic
case, was tied to the patient’s wrist on the opposite side of
the stimulated hemisphere. Via a USB cable, the device was
connected to a laptop based data recorder using homemade
software LemurDBS (Java 1.6, Oracle, USA) (Shah et al., 2013).
Synchronization between acceleration data and test stimulation
amplitudes was assured by a pulse sent from the laptop to
the stimulating equipment. The sensor was always attached at
the same position on the wrist of the patient, and at each
position a baseline recording was acquired before initiation of
each stimulation sequence.
In order to quantify the clinical improvement for each
stimulation amplitude, a previously developed analysis method
in Matlab (R2014b) was used (Shah et al., 2016b). As a first
step, movements other than tremor were removed offline by
using the smoothness priors method (Tarvainen et al., 2002)
and thereafter a second order Butterworth low pass-filter was
applied at 10 Hz in order to suppress noise. Statistical features
(standard deviation, signal energy and the spectral amplitude
of the dominant frequency, defined as the frequency of the
signal with maximum spectral power) were extracted by moving
a 2 second-window over the data. These features were then
normalized to the feature set representing the most intense
tremor at baseline, i.e., during an initial off-stimulation period
at the same position. For each stimulation amplitude the mean of
the obtained quantitative clinical improvement was retained as a
percentage value. An example is presented in Figure 3A where a
typical acceleration signal in one position is presented together
with the clinical improvement based on the calculated features.
In the presented example, it can be seen that an improvement of
98.1% was obtained at a stimulation amplitude of 1.0 mA.
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FIGURE 2 | Frontal view of left hemisphere of a 3D stereotactic
planning for targeting the VIM, after manual outlining of the thalamic
nuclei on 1.5 T WAIR images: VIM; VO; nucleus intermedio lateral (InL);
nucleus ventrocaudal lateral (VCL); nucleus dorsolateral (DL); pulvinar
(PU); nucleus anterolateral (AL); nucleus ventro-oral (VO); field of Forel
(FF); nucleus centromedian (CM); the nucleus ventrocaudal medial
(VCM) and the pre-lemniscal radiations (PLR) within the prerubral field
of Forel are not visible. Central and posterior left trajectories are visible
(brown lines) and marked as dashed lines if inside the nuclei.
Electric Field Simulations
In order to simulate the EF spatial distribution within the brain, a
3D FEM model of the exploration electrode with the surrounding
brain tissue was built (Comsol Multiphysics, Version 4.4 Comsol
AB, Sweden) for adapting an already established patient-specific
modeling technique for DBS leads (Åström et al., 2010; Wårdell
et al., 2015).
Brain Tissue Model
The axial preoperative T1 MRI was registered and resampled
to the stereotactic preoperative axial CT dataset. In a next
step, it was imported into the in-house developed software
(Matlab R2013) (Wårdell et al., 2012) modified for the creation
of the brain tissue models. A separate filtered axial T1
image batch with enhanced region of interest was used to
segment cerebrospinal fluid (CSF), gray matter and white
matter (Alonso et al., 2016). The segmented image voxels
were assigned with the corresponding electrical conductivities
(s) (Gabriel et al., 1996)1. CSF and blood were set to
2.0 Siemens/meter (S/m) and 0.7 S/m, respectively. Considering
the frequency (130 Hz) and pulse length (60 ms) of the
stimulation (Wårdell et al., 2013), to gray matter was assigned
0.123 S/m and to white matter 0.075 S/m. Interpolation was
done for conductivity values in-between the thresholds used.
In order to reduce the simulation time, a region of interest
(a cuboid of approximately 100 mm per side) covering the
thalamus and its surroundings was selected from the brain tissue
model.
Exploration Electrode and Guide Tube Model
A model of the stimulating contact of the exploration electrode
and the guide tube was developed. Figure 4A presents the
outer and inner dimensions of the exploration electrode and the
guide tube, Figure 4B the corresponding model. The end of the
guide tube was fixed 12 mm above the chosen target point, i.e.,
above the a priori optimal anatomic spot. A second exploration
electrode and guide tube model was positioned in parallel at
a distance of 2 mm. The distance between the guide tube and
the center of the stimulating contact decreased or increased
when the simulation site was ahead or beyond the target point,
respectively. The center of the stimulating contact was placed at
the different planned stimulation positions. The micro contact
was not considered as it was retracted during the stimulation
tests.
Simulations
The EF was calculated by using the equation of continuity for
steady current according to:
r   J D r  .srV/ D 0
where J is the current density, s a matrix containing the
electrical conductivity values for the region of interest (thalamus
and neighborhood) and V the electric potential. A monopolar
configuration was conducted using the guide tube as the reference
electrode setting it to ground, and the active electrode set to
the same current as used during the stimulation tests. The
non-active contact of the parallel lead was set to floating
potential (Schmidt et al., 2013). The exterior boundaries of
the tissue model were set to electrical insulation. The mesh
density (consisting of about 250,000 tetrahedral elements) was
defined by the built in physics-controlled mesh generator, where
the smallest elements (0.204 mm) were located nearby the
stimulating contacts in order to capture the strong EF gradients.
The Cartesian coordinates of the points describing the surface of
the simulated EF volume (Figure 3C) were exported for further
analysis. In this study an EF isolevel of 0.2 V/mm was used in
order to be able to perform relative comparisons between the
simulations and to comply with approximate axon diameters in
the thalamus (Kuncel et al., 2008; Åström et al., 2015; Alonso
et al., 2016).
1Andreuccetti, D., R. Fossi and C. Petrucci, Florence, Italy. (2005). “Dielectric
properties of the tissue.” from http://niremf.ifac.cnr.it/tissprop/.
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FIGURE 3 | Workflow for the generation of patient-specific 3D brain maps. (A) Typical data in one stimulation position showing changes in tremor in relation
to the increasing stimulation amplitude [mA] (red curve), filtered acceleration data [g] (gray curve), clinical improvement relative to baseline, quantified by acceleration
measurements in percentage values from 0 to 100% (mean value for each stimulation amplitude; black dotted line). (B) MR-WAIR sequence used for planning
including manually outlined structures. (C) Patient-specific EF simulation visualized at isolevel 0.2 V/mm at the stimulation position for an amplitude of 1 mA (green
circle) corresponding to 98.1% improvement. (D) Manually outlined structures: CM (red), VO (light blue), VIM (dark blue) and VCM (pink). (E) Brain map with
superimposed EF isosurface (green). (F) Close up view of (E) with the structure volumes inside the EF isosurface indicated in orange.
Thalamic Brain Maps and Electric Field
Visualization
The thalamic structures (Figures 2 and 3B) initially outlined
on the WAIR weighted sequence in the iPlan software were
exported in form of slices parallel to the stereotactic CT data
set via an interface based on VVLink and VTK (VTK 5.2.0,
Kitware Inc., Clifton Park, NY, USA). Target and trajectory
coordinates were also exported in CT image coordinates by
the same software interface. The CT data set was chosen
as it provides a higher resolution and no distortion of the
stereotactic reference system compared to MR sequences.
With the exported data a 3D thalamic brain map with
trajectories was generated in Matlab (R2014b) (Figure 3D).
For each stimulation test position and amplitude, the EF
isosurface generated through FEM simulations was imported,
superimposed to the 3D thalamic brain map and color-coded
depending on the induced, quantitatively evaluated improvement
(Figure 3E).
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FIGURE 4 | (A) Schematic representation of the guide tube and the exploration electrode including the micro contact for recording and the macro contact for
stimulation, (B) FEM model of the exploration electrode (recording tip is excluded as it is retracted during stimulation) and the guide tube. The probe slides within the
fixed grounded guide tube placed 12 mm from a target point corresponding to the a priori optimal anatomic spot. Explorations were performed moving the
stimulation point along the trajectory, D millimeters proximal or distal to the target position.
Volumetric Analysis
An in-house algorithm developed by FHNW in Matlab
(R2014b) was applied to detect and calculate the volume
of the anatomical structures inside each EF isosurface. To
reduce the computational time, a list of candidate structures
(e.g., VIM, VO, and CM) was identified from the entire
structure group by excluding the structures outside the
coordinate’s ranges of the EF volume. For each candidate
structure, the points of the EF isosurface inside the structures’
volume were detected by considering them as a concave or
convex hull according to their shape. The obtained volume
based on the selected point cloud was then calculated and
associated with the respective clinical improvement. The
algorithms then generated a list of the thalamic structures
lying partially or completely inside the 0.2 V/mm EF
isosurface, their volumes as well as the volume covered
by the EF surface and the associated improvement value
(Figure 3F).
Clinical Application
The above presented protocol was applied to five ET patients
(three male and two female) undergoing bilateral DBS electrode
implantation in the VIM region and successively to both
hemispheres. They gave their written informed consent to
participate in the study (Ref: 2011-A00774-37/AU905, Comité de
Protection des Personnes Sud-Est 6, Clermont-Ferrand, France).
No alterations were made to the routine surgical procedure.
In all patients a central and a posterior trajectory were chosen
per hemisphere for MER and stimulation tests (stimulation
parameters: amplitude D 0.2 to 3.0 mA in steps of 0.2 mA,
pulse width D 60 ms, frequency D 130 Hz). At each stimulation
position stimulation lasted 1 to 3 min depending on the response
of the patient and on side effect occurrence or not. Between
all stimulation tests, a non-stimulation period was maintained
to leave time to the symptoms to come back. The duration of
this period depended on patient symptoms (minimum 2 min).
Acceleration measurements were performed in parallel to the
Frontiers in Human Neuroscience | www.frontiersin.org 6 November 2016 | Volume 10 | Article 577
fnhum-10-00577 November 23, 2016 Time: 17:24 # 7
Hemm et al. Patient-Specific Simulations and Acceleration Measurements
FIGURE 5 | Visual example of the calculation of the percentage of
volume of VIM (gray area) inside the EF (dashed green line). The volume
V1 is the intersection between the volume of the EF (VEF ) and the volume of
VIM (VVIM ).
test stimulation in 31, 22, 30, 28, and 32 positions for Patient
1 to 5, respectively, mostly from 5 mm above the target point
down to 4 mm below depending on the individual anatomical
locations. The final electrode implantation site was based on
clinical subjective evaluations.
Electric field simulations were performed for all stimulation
test positions in both hemispheres of the five patients. At
each position, up to four tested stimulation amplitudes were
chosen for simulations using the following criteria based on the
quantitatively evaluated symptom improvements (Iacc): (1) The
highest amplitude not resulting in any improvement in tremor
compared to baseline; (2) the lowest amplitude at which a first
improvement in tremor was measured; (3) The lowest amplitude
resulting in at least 50% improvement in tremor; (4) The lowest
amplitude resulting in at least 75% improvement. When the
first improvement in tremor was more than 75%, criteria (2–
4) gave the same amplitude. When the first improvement was
identified already between 0.2 and 0.6 mA, no simulations were
performed for the criterion 1. The extracted patient-specific 3D
brain maps of the thalamus were superimposed with the four
trajectories of each patient and with the simulated patient-specific
EF isosurfaces. To make the data comparable between patients,
the volume inside the isosurface was normalized to the size of
the structure resulting in the percentage of the structure covered
by the EF (Figure 5). For example, if the volume of VIM was
10 mm3 and only 2 mm3 of it was encompassed by an EF
isosurface, the covered volume of VIM for that EF would have
been (2/10)100D 20%.
In order to identify structures responsible for the reduction
in tremor, the results of all patients together were classified
following the quantity of improvement detected by accelerometry
(Iacc). Data were divided into two groups considering
no/low improvements (Iacc  50%) and intermediate/high
improvements (Iacc > 50%), respectively. The resulting data are
presented in two different ways for comparison of these two
improvement groups. Firstly, for each thalamic structure, the
relative number of occurrences (the structure is at least partially
covered by the EF) was determined: the absolute number of
occurrences of each structure in the considered improvement
range was normalized to the total number of occurrences of all
structures in this range. Second, the percentage volume of each
structure covered by a specific EF isosurface was analyzed to see
for example if the covered volume of some structures increases
for higher improvements. These percentage volumes were
graphically represented and visually analyzed together with the
induced clinical improvement for all simulations. Furthermore,
mean values and the standard error of the mean (SEM) were
determined for each structure for the two improvement groups.
The results for each structure in the two improvement ranges
were statistically compared applying the Mann–Whitney U test.
Mean stimulation amplitudes for 50% or less improvement and
more than 50% improvement were determined.
RESULTS
Simulations
The proposed concept has been successfully applied to the five
patients, resulting in 272 simulations at 143 different stimulation
test positions. The detailed numbers of simulations for each
patient and different improvement ranges are presented in
Table 1.
Visualization
Figure 6 shows an example of visualization for Patient 4
with three simulated EF isosurfaces in the left hemisphere
along the central tract. Each isolevel is superimposed to the
extracted anatomical structures (seen in brown) and the patient-
specific MRI (Figure 6A). At the target position or the a
priori optimal anatomic spot for the left central trajectory an
improvement of 90% was reached with a stimulation amplitude
of 3 mA (Figure 6B). 3 mm below the target no improvement
in tremor could be observed. The corresponding EF in red
overlays the EF of 90% of improvement as can be seen at cross
section II through the stimulation electrode as presented in
Figure 6C.
Involvement of Anatomical Structures
The relative occurrences of the different thalamic structures
within the isosurfaces for improvements above and below
50% are presented in Figure 7. It shows that the percentage
TABLE 1 | Number of simulations per patient and clinical improvement
range as recorded by accelerometry (Iacc).
0 < Iacc 
25%
25 < Iacc 
50%
50 < Iacc 
75%
75% < Iacc
 100%
Total
Patient 1 3 13 17 12 45
Patient 2 3 11 20 10 44
Patient 3 1 23 15 22 61
Patient 4 2 9 23 18 52
Patient 5 2 15 23 30 70
Total 11 71 98 92 272
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FIGURE 6 | EF isosurfaces for Patient 4 simulated for three positions (proximal, zero, and distal) on the central electrode track of the left hemisphere,
color-coded following the induced clinical change (red – 0% and green – 100% improvement) and superimposed to selected anatomical structures
(brown). (A) Axial MRI superimposed to 3D structures and EF isosurfaces. (B) 3D frontal view of structures and electric fields; positions and amplitude of the
simulations are summarized below; lines indicate the positions of sections visualized in (C). (C) Three axial sections at different levels: proximal (negative numbers), at
(0) and distal (positive numbers) to the target.
of occurrences of the different structures was always inferior
or equal to 30%. The relative occurrence of InL, VO and
especially VIM decreases for higher improvements. This means
that their appearance does not as much increase as for CM,
VCM, VCL and especially for FF/PLR. For all four structures
the relative occurrence increases for higher improvements.
Mean stimulation amplitudes for improvements Iacc  50%
and Iacc > 50% were 0.9  1.1 mA and 1.5  1.2 mA,
respectively.
Relation of Structure Occurrences,
Clinical Improvement, and Volumes
Covered by the Isosurfaces
A comparison between the clinical improvement and the
volume of the structures included in the isosurface of the
corresponding simulation is presented in Figure 8. While
Figure 8A shows all available data of the five patients,
Figures 8B,C summarize the data in form of mean and SEM
for improvements 50% and >50%. All SEM values remain
below 3% except for the VO and the InL for the range
Iacc  50% and the FF/PLR for both improvement ranges.
A closer analysis of the volume of the different structures
covered by the EF isosurface shows that the percentage volumes
of the target structure VIM, of the InL and of the FF/PLR
increase with significant clinical improvements. The difference
for the VIM was statistically significant (p < 0001). Only
small volumes of CM and VCL are covered by the isosurface
in both improvement ranges. Nevertheless the difference for
the CM could be shown to be significant (p < 0.01).
The neighboring nuclei VIM and VCM appear together for
nearly all simulations. FF/PLR and VO occur mostly in
combination with VIM and VCM (same horizontal line)
(Figure 8A).
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FIGURE 7 | Occurrence of anatomical structures related to improvements of Iacc  50% (gray bars; n D 193) and of Iacc > 50% (black bars; n D 662)
in percent of the total number of structures occurring inside electrical field isosurfaces of 0.2 V/mm. For structure nomenclature, see Figure 2.
DISCUSSION
In the present study, a methodology is described that has the
potential to give new insights into the efficacy of different
anatomical structures in DBS. It consists in the combined analysis
of intraoperatively acquired accelerometry data, patient-specific
EF simulations for intraoperative stimulation tests and patient-
specific anatomy. The method was successfully applied to five
patients with ET and included more than 250 EF simulations.
An exemplary way of analysis and preliminary results have been
presented for the identification of the therapeutically effective
anatomical region.
Quantitative Symptom Evaluation
In order to overcome the limits of existing routinely used clinical
rating scales, i.e., the inter- and intra-observer variability (Post
et al., 2005; Palmer et al., 2010), the discrete evaluation levels
and the high dependence on the experience of the evaluating
neurologist (Griffiths et al., 2012), we have used accelerometry-
based, quantitative tremor evaluations during intraoperative
stimulation tests.
Tremor quantification outside the OR has been proposed since
a long time by various authors (Mansur et al., 2007), many of
whom have concluded that a quantitative evaluation method is
more sensitive than the visually performed clinical evaluation.
Birdno et al. (2008) used an acceleration sensor to study the
effects of temporal variations of the stimulation pulse during
the replacement of the implantable pulse-generator. Journee
et al. (2007) and Papapetropoulos et al. (2008) used quantitative
tremor evaluation after the DBS lead was implanted, in order
to compare the effects of stimulation through different contacts.
But those systems were not designed to be used in different
clinical centers or during stimulation tests performed through an
exploration electrode. In a previous study, we have demonstrated
the use of our system in 15 DBS surgeries in two different
clinical centers, the possibility to visualize and revisit recorded
data during surgery and the possible influences of quantitative
evaluations on the choice of the final implant position of the lead
for chronic stimulation (Shah et al., 2016b).
Determination of the Therapeutically
Implicated Structures
In the present clinical study, structures individually outlined by
the neurosurgeon were available and could be used as anatomical
reference. The use of the patient-specific MR-WAIR sequence
together with a 4.7 T in-house atlas as reference and stereotactic
books make an approximate identification of the structures
possible (Zerroug et al., 2016). Other groups have proposed
various approaches (Caire et al., 2013) among them projecting
the position of the active contact(s) directly onto anatomical
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FIGURE 8 | (A) Comparison of the occurrences of the different thalamic brain structures (x-axis; each color represents one structure) with the corresponding clinical
improvement evaluated by accelerometry (y-axis) for all simulations (n D 272). Structures appearing in a same simulation have identical clinical improvement and can
in consequence be found on the same horizontal level. As an example, the horizontal line at an improvement of approximately 18% indicates that VIM, VCM, VCL,
and FF/PLR were present inside a same EF isosurface. (B) Summary of the mean percentage volume included in the EF isosurfaces and the standard error of the
mean for the different structures in the improvement range >50% and (C) in the improvement range 50%. : Statistically significant difference between the results
of the two improvement groups for a specific structure with p < 0.001. : Statistically significant difference with p < 0.01.
images (Vayssiere et al., 2004), onto anatomical (Saint-Cyr et al.,
2002; Sarnthein et al., 2013) or probabilistic functional atlases
(Lalys et al., 2013), or linking them to MER results (Zonenshayn
et al., 2004) sometimes combined with imaging data (Weise et al.,
2013) and white matter tracking (Coenen et al., 2012). To analyze
the relationship between the anatomical location of stimulating
contacts and the clinical effectiveness of stimulation, we have
decided to take into account the extent of stimulation by using
EF simulations (Åström et al., 2012) as discussed in detail in the
next paragraph. Other published approaches consider either the
anatomical position of the center of the contact (Starr et al., 2002;
Voges et al., 2009; Garcia-Garcia et al., 2016) or of the whole
contact taking into account its dimensions (Saint-Cyr et al., 2002;
Zonenshayn et al., 2004; Herzog et al., 2007; Hemm et al., 2008).
Electric Field Simulations
Finite element method models are commonly used to simulate
and visualize the EF distribution around DBS electrodes and the
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EF is one of the electrical entities that may be used to represent
the stimulation field. In comparison with the electric potential or
the second derivative of the electric potential with respect to the
distance (activating function), EF has been shown to be the most
stable and unchanged entity for different stimulation parameters
(amplitude and pulse width) (Åström et al., 2015).
Today, FEM models have progressed from non-specific
(McIntyre et al., 2004; Hemm et al., 2005; Åström et al., 2006)
to patient-specific taking into account the individual’s data
(Åström et al., 2009; Chaturvedi et al., 2010; Wårdell et al.,
2015). There is no consensus of the degree of complexity of
the model to accurately simulate the neural response, however,
many groups (Chaturvedi et al., 2010; Schmidt et al., 2013;
Alonso et al., 2016; Howell and McIntyre, 2016) have shown
that the inclusion of the heterogeneity and anisotropy of
the brain tissue increases the model accuracy and prediction
capability. For instance, Chaturvedi et al. (2010) and Åström
et al. (2012) observed an overestimation of neural activation for
homogeneous models. The present study relies on a brain model
built upon the segmentation of the gray matter, white matter,
CSF and blood from the patients’ MRI and in consequence takes
into consideration the inhomogeneity of brain tissue. An even
more realistic model may be based on DTI which provides more
anisotropic information, however, its resolution is lower than
the one of MRI and may introduce other errors (Åström et al.,
2012). The simulations in this study were performed for constant
current while the dispersive components of the brain tissue have
been considered by adjusting the conductivity values for gray and
white matter to the particular stimulation frequency and pulse
width (Wårdell et al., 2013).
According to previous studies where neuron activation
distances were calculated using neuronal models (Åström et al.,
2015), an isolevel of 0.2 V/mm represents an equivalent activation
distance for neurons within 3–4 mm of diameter (Alonso et al.,
2016) and thus seems to comply with axon diameters in the
thalamus as previously calculated by Åström et al. (Figure 6,
2015) based on Kuncel et al. (2008). The selection of a fixed EF
isolevel allows then to compare the volume recruited for different
amplitude settings and different positions.
Transferability
The described methodology has been presented for an
institution-specific surgical protocol but can be transferred
to other clinical centers. The approach can be adapted to any
kind of anatomical information. Instead of using manually
outlined structures, it is possible to combine the generated
data with anatomical atlases – with the limitations inherent
to such an approach (Vayssiere et al., 2002; Wodarg et al.,
2012; Anthofer et al., 2014) – or with fiber tracking data in
order to analyze the implication of different fibers in the
mechanism of action of DBS (Coenen et al., 2012). The MR
image data (T1, T2) that are needed for the EF simulations
are generally acquired in every institution for the surgical
planning procedure. A modification of the developed model
to the institution-specific stimulation test protocol in awake
patients might be necessary: the characteristics of the stimulating
electrode as well as the position of the guide tube during
stimulation have to be adapted. The acceleration data recording
can relatively easily be added in the intraoperative phase without
any changes in the surgical protocol, without lengthening
surgery and most importantly, without any discomfort for
the patient. Nevertheless, the correlation of the simulation
results can be performed as well based on subjective visual
evaluations.
Clinical Application
The results of the present paper are described as relative
occurrences and percentage volumes of the different anatomical
structures covered by the EF isosurface. Even if the number of
patients presenting ET in our clinical study was low and thus the
confidence concerning the analysis of the mechanism of action of
VIM-DBS is limited, we can present preliminary results thanks to
the high number of stimulation test positions and EF simulations
per patient. First results of these EF simulations in Figure 7 show
that the percentage of occurrence of VCM, CM, and FF/PLR
increases for higher improvements while the percentage of VIM
occurrences decreases. This can be explained by the fact that in
60 out of 143 measurement sites the center of the stimulation
contact was already within the VIM. Furthermore, as shown,
there is a tendency that higher improvements are linked to higher
stimulation amplitudes leading in general to a larger distribution
of EF for a same tissue type. When looking at the percentage
of volume of the VIM covered by the isosurface between the
two improvement groups (Figures 8B,C), a statically significant
difference exists. Nevertheless, the size of the individual volumes
varies inside each group. This result can be interpreted in two
ways: either (I) a specific part of the VIM, for example the efferent
fibers, has to be stimulated or (II) other structures than the
VIM might at least partially be responsible for the therapeutic
effect. Following our preliminary results such structures could
be the InL or especially the fiber tracks FF/PLR. This hypothesis
would confirm previously published data: parts of the InL
have been earlier mentioned for tremor reduction (Hirai and
Jones, 1989) and several authors (Spiegelmann et al., 2006;
Vassal et al., 2012) have reported that chronic stimulation of
PLR works very well. Some authors (Caparros-Lefebvre et al.,
1999; Vassal et al., 2012) already suggested that parts of the
VO or of the zona incerta (Fytagoridis et al., 2012) could
be appropriate targets as well. Recently Groppa et al. (2014)
proposed the dentatothalamic tract as key therapeutic DBS target
structure.
Following Figure 7 our data suggest that parts of VCL and CM
might be stimulated in some cases. However, Figure 8 shows that
the structure volumes included in the isosurface are below 5% in
both improvement ranges. In order to avoid misinterpretation,
either patient-specific improvement maps should be used for
presentation or thresholds should be introduced to exclude
insignificant volumes.
An optimal stimulation position and statistically significant
clinical conclusions can only be provided after the analysis of
more intraoperative data, the identification of occurring structure
combinations and especially the side effect occurrences, which
have a major influence on the choice of the final implant position
of the chronic DBS lead.
Frontiers in Human Neuroscience | www.frontiersin.org 11 November 2016 | Volume 10 | Article 577
fnhum-10-00577 November 23, 2016 Time: 17:24 # 12
Hemm et al. Patient-Specific Simulations and Acceleration Measurements
Limitations and Future Work
The suggested methodology allows a detailed interpretation of
intraoperatively acquired data but one has to be aware of certain
limitations. First of all, the substantial caveats of non-stimulation
factors influencing tremor are undeniable and unfortunately
inherent in the operating room conditions. Nevertheless, we
have employed various signal analysis techniques to minimize
the effect of such non-stimulation factors on the evaluation
of tremor using accelerometer. Furthermore, the method was
defined in a way trying to limit transformation and fusion
errors as much as possible (Zrinzo, 2010). Nevertheless due
to the available data, WAIR and T1 MRI data sets containing
the anatomic information had to be fused to the stereotactic
preoperative CT data set providing the reference for the targeting
procedure. Concerning the position of the stimulating contact in
relation to the structures, we assumed that the microelectrode
was positioned exactly as planned. This seems to be a reasonable
approach as the microelectrode was the first entering the brain,
and it has been observed that brain shifts in the final electrode
position and trajectory can appear when the exploration electrode
is replaced by the DBS lead (unpublished data).
As the anatomical information is based on the structures
manually outlined on the preoperative image data set, the
approach does not consider the movement of the tissue due
to the electrodes’ insertion or brain shift between implantation
sides. On the other hand, the use of these preoperative image
data sets is common in analysis and simulation methods. The
limitations are acceptable as postoperative image data sets present
disturbing artifacts around the implanted DBS leads, in the
region of interest. To increase the power of the statistic test
performed in the present study, more data should be acquired
from further patients and included in the analysis. A further
limitation, specific to the anatomical information, concerns the
availability of only some anatomical structures and the FF/PLR
and that always part of the volume of the EF isosurface is outside
any manually defined anatomical structure. In consequence,
information from white matter fiber tracking would be helpful
to define the region anterior to the VIM and the InL and for
further investigating possible activation of fiber tracks (Coenen
et al., 2012).
The method could in a next step also be complemented with
the available MER data at the different positions including the
analysis of time patterns describing the network dynamics as
proposed by Andres et al. (2015).
The data analysis approach proposed in the present paper
considers the percentage of the structure volume covered by the
simulated EF isosurface and not which parts of the structure.
Further data interpretation could consider the 3D position as
well and should generate improvement maps taking into account
stimulation positions of amplitudes as well as the occurrence of
side effects.
CONCLUSION
A new concept for the analysis of data acquired during DBS
surgery has been proposed. A workflow and methodology
combining objective intraoperative tremor evaluation with
patient-specific EF simulations on manually outlined anatomical
structures has been defined and applied to five patients
with ET undergoing DBS-implantation. This new approach
is combined with an algorithm for detection of the volume
of the anatomical structures involved during intraoperative
microelectrode stimulation. It can be adapted to further surgical
protocols, intraoperative set-ups and to other anatomical data.
Its application will allow the analysis of intraoperative data
obtained in clinical routine and will support the identification
of anatomical structures, parts of them or white matter fibers
responsible for the therapeutic effect. The analysis of more data
and inclusion of occurrence of side effects are necessary to
draw any final conclusions of the most efficient brain targets.
The first results, however, indicate agreement with published
data hypothesizing that the stimulation of structures other
than the VIM might be responsible for good clinical effect
in ET.
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Chapter 8
Data Visualization during DBS
Surgery
The existing pool of scientic work described in the background (Section 2.7)
shows the potential that a software tool has to assist the surgical team during
the important task of lead placement. The variety of data collected during our
clinical study in CHU, Clermont-Ferrand as listed below, presented an excellent
opportunity to develop such a tool to assist during the decision making process.
Radiographical Images Preoperative stereotactic CT, stereotactic T1 MR and
stereotactic WAIR MR images are acquired to facilitate surgical planning.
Expert-Labelled Anatomical Structures Using the planning software, for each
patient, all the relevant anatomical structures are outlined and labelled.
Surgical Planning Data The desired target is identied through the surgical
planning software and trajectories are planned and saved.
Electrophysiology During the surgery, MER is performed at the planned posi-
tions to obtain electrophysiological data of the region of interest.
Therapeutic and Adverse Eects of Stimulation Stimulation tests are ad-
ministered at the desired locations and the patient's response (therapeutic
and adverse eects) are noted along with the stimulation parameters using
pen and paper.
Quantitative Symptom Evaluation Analysis of acceleration data synchronized
with the stimulation tests provide the quantitative improvement in symp-
toms for each stimulation current amplitude.
Spatial Eects of Stimulation The patient-specic FEM technique to sim-
ulate the electric eld distribution based on the stimulation current am-
plitude provides information about the spatial eect of stimulation in the
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brain tissue.
The consolidation of such variety of data into one visualization requires over-
coming some hurdles. The image data sets, the labelled anatomical structures
and the planned trajectories are stored on the planning software, the MER and
test stimulation parameters are stored on the electrophysiology system, the ac-
celerometer data are stored on our system and the simulations are performed at
LiU. All this information has to be transferred to one system and then processed
and visualized in a manner that retains the proper spatial position of each data
set. The second hurdle is the amount of data that can be generated. During
intraoperative stimulation tests, stimulation current amplitude is increased from
0 to 3 mA in steps of 0.2 mA at an average of 7 test stimulation positions each
on two parallel trajectories. If all of the stimulation current amplitudes were
simulated, it would result in an average of 210 (15 x 7 x 2) simulations per
patient implantation. Although visualizing all this data along with the anatomi-
cal structures and patient images would be possible, the resultant visualizations
would contain redundant information and would also be dicult to analyse.
The adverse eects of stimulation are also considered when choosing the opti-
mal place of the DBS lead. Therefore, adverse eects observed during intra-
operative stimulation tests are also noted along with the corresponding current
amplitude. In contrast to therapeutic eects which are noted for all stimula-
tion test positions, adverse eects are only noted for the positions where they
are observed. Additionally, in CHU, Clermont-Ferrand, the stimulation test at
a given position is stopped at the rst adverse eect occurrence. The visual-
ization of this adverse eect dataset of one current amplitude per stimulation
test position would depict the "no-go" zones for chronic stimulation. Out of
the 5 ET patients that were used for the EF simulation study, adverse eects
were observed during stimulation tests in 4 patients. EF simulations for the ad-
verse eect inducing current amplitudes were analysed and visualized together
with the patient images and outlines of the anatomical structures to create an
"Adverse Eect Map". The details of the method, its application and results
are described further in the recently accepted paper titled "Analysis of adverse
eects of stimulation during DBS surgery by patient-specic FEM simulations"
attached in the current chapter (Section 8.1).
The results of the adverse eect map study concur with the ndings of other
studies in terms of the anatomical structure that is responsible for a specic
adverse eects. This demonstration of the utility of the maps gave the impetus
to summarize and visualize all the data that are necessary for optimally placing
the DBS lead. To reduce the redundancy of the data and to simplify the
analysis, we propose a two-step technique. The rst logical step is to simulate
only selected stimulation current amplitudes per test position, i.e. those that
signicantly suppress the symptoms, which in turn, would reduce the number of
simulations per implantation. Despite the reduction of simulations, there would
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be many voxels in the stimulation test region which would be encompassed
by more than one electric eld simulation and in turn be associated to more
than one value of improvement. Therefore, the next step to simplify analysis
is to assign one improvement value to a voxel to divide the stimulation test
region into smaller parts, each representing dierent levels of improvement in
the symptom. The collective visualization of these improvement regions with
the patient images and labelled anatomy is termed as "Improvement Maps."
The two important factors that would decide the shape and size of dierent
regions in the improvement maps would be the choice of stimulation current
amplitude that are simulated and the function used to assign one improvement
value to each voxel. As our rst approach, we simulated the lowest stimulation
current amplitudes that resulted in the maximum improvement and also assigned
the maximum improvement value to one voxel. This choice was based on the
understanding that the aim of the DBS surgery is to place the lead at a position
with maximum improvement in symptoms. This specic type of improvement
maps were termed as "Maximum Improvement Maps" and were retrospectively
created for 5 ET patients who underwent VIM-DBS at CHU, Clermont-Ferrand
with the aim to gauge their utility. The resulting visualizations were analysed
post-operatively by the surgical team at CHU, Clermont-Ferrand to choose the
position for DBS lead placement. The following draft paper titled "Improvement
Maps: a technique to visualize results of intraoperative stimulation tests for
deep brain stimulation surgery" contains the detailed method of creating the
maximum improvement maps, the results of application to 5 ET patients and the
relevant discussion. The subsequent supplementary le contains the maximum
improvement map gures for all implantations.
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Abstract— Deep brain stimulation (DBS) represents today a 
well-established treatment for movement disorders. 
Nevertheless the exact mechanism of action of DBS remains 
incompletely known. During surgery, numerous stimulation 
tests are frequently performed in order to evaluate therapeutic 
and adverse effects before choosing the optimal implantation site 
for the DBS lead. Anatomical structures responsible for the 
induced adverse effects have been investigated previously, but 
only based on stimulation data obtained with the implanted DBS 
lead. The present study introduces a methodology to identify 
these anatomical structures during intraoperative stimulation 
tests based on patient-specific electric field simulations and 
visualization on the patient specific anatomy. The application to 
4 patients undergoing DBS surgery and presenting dysarthria, 
paresthesia or pyramidal effects shows the different anatomical 
structures, which might be responsible for the adverse effects. 
Several of the identified structures have been previously 
described in the literature. To draw any statistically significant 
conclusions, the methodology has to be applied to further 
patients. Together with the visualization of the therapeutic 
effects, this new approach could assist the neurosurgeons in the 
future in choosing the optimal implant position.          
I. INTRODUCTION 
DBS represents today a well-established therapy for the 
symptomatic treatment of movement disorders such as 
Parkinson’s disease (PD) and essential tremor (ET) but as well 
for other diseases. Electrodes are implanted in the brain 
through which the surrounding structures are continuously 
stimulated. Before surgery, the brain target is chosen and the 
trajectory to reach it is planned on magnetic resonance images 
(MRI). During surgery, many centers perform microelectrode 
recording (MER) and stimulation tests on predefined positions 
on one or more parallel trajectories. Evaluations of therapeutic 
effects and adverse events are performed at these sites based 
on which the optimal stimulation position is chosen [1]. 
Despite the success of the therapy, the mechanism(s) of action 
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of DBS [2] and the exact structures or structure parts 
responsible for the therapeutic effect and certain adverse 
effects remain incompletely known. The aim of the present 
paper is to present a methodology to analyze the anatomical 
structures involved in inducing side effects during 
intraoperative stimulation tests based on patient-specific 
electric field simulations and visualization on the patient 
specific anatomy. The new approach is applied to 
intraoperatively obtained data in one clinical center in 
Clermont-Ferrand, France. 
II. METHOD 
A. Surgical procedure 
At Clermont-Ferrand University hospital, the surgical 
procedure is defined as follows [3]: an extensive preoperative 
surgical planning is performed. Stereotactic CT, T1 MRI and 
white-matter attenuation inversion recovery sequences 
(WAIR) are acquired (Sonata 1.5T, Siemens, Germany). The 
different thalamic nuclei and the basal ganglia are then 
outlined by the neurosurgeon using a commercial planning 
software (iPlan stereotaxy 3.0, Brainlab, Munich, Germany) 
based on the spontaneous contrast of the WAIR sequence and 
with an in-house developed 4.7T brain atlas (Fig. 1). Based on 
these outlined structures, an anatomical target e.g. the ventral 
intermediate nucleus (VIM) for ET patients and an entry point 
are carefully chosen. Two parallel trajectories and positions 
for neuronal recording and stimulation tests are carefully 
identified within the volume of interest for the intraoperative 
testing. During surgery, MER is first performed followed by 
stimulation tests at the predefined positions. During 
stimulation tests the stimulation amplitude is increased from 0 
to 3 mA in 0.2 mA steps and the symptom improvement is 
estimated. In addition, amplitudes and the kind of adverse 
effect are noted. The final implantation position of the DBS 
electrode is chosen where 1) the stimulation amplitude 
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inducing significant therapeutic effects is very low; 2) 
therapeutically effective stimulation amplitudes at the 
neighboring positions are relatively low; 3) no adverse events 
are present or only at high stimulation amplitudes; 4) 
anatomical position is suitable.       
B. Electric field simulations 
To evaluate the spatial distribution of the stimulation, FEM 
simulations were performed as previously presented for 
implanted DBS leads [4]. In the present study, this simulation 
approach was adapted to the intraoperatively used electrode 
and electrical setup. An electrode model of the microelectrode 
(Neuroprobe, Alpha Omega Engineering, Nazareth, Israel) 
was generated. Like in clinical practice, two electrode models 
were positioned in parallel at a distance of 2 mm. The leading 
guide tubes were fixed 12 mm above the target. Patient-
specific brain models were generated in the target area based 
on the patients’ T1 MRI which was enhanced in the basal 
ganglia and thalamic area. Image voxels were classified into 
cerebrospinal fluid (CSF), gray matter and white matter and 
conductivity values were assigned to each voxel [5]: CSF - 2.0 
Siemens/meter (S/m), blood - 0.7 S/m, gray matter 0.123 S/m 
and white matter 0.075 S/m. Between the selected thresholds, 
conductivity values were interpolated [4].  
The electric field (EF) was calculated by using the equation 
of continuity for steady currents according to:  
  ∇·(σ∇V) = 0   (1) 
where σ is a matrix composed of the electrical conductivity 
values and V the electric potential. For each simulation, the 
electrodes were positioned at the clinically used electrode 
position. The active electrode contact was set to the clinically 
applied stimulation current while the non-active contact of the 
parallel lead was set to floating potential. The guide tube was 
set to ground and the boundaries of the tissue model to 
electrical insulation. The mesh density was set to about 
250,000 tetrahedral elements using the in-built mesh generator 
(Comsol Multiphysics AB, Sweden), the smallest elements 
located close to the stimulating contacts to capture the strong 
EF gradients. For the points defining the surface of the 
simulated volume, the Cartesian coordinates were exported for 
further analysis. To perform relative comparisons between the 
simulations, the EF isolevel was fixed at 0.2 V/mm as this 
magnitude is required to stimulate neurons with axons of 
around 3-4 µm in diameter with a pulse width between 60 to 
90 µs [6, 7].    
C. Anatomical data extraction 
In order to be able to visualize the simulated electric field 
distributions on the patient-specific anatomy, a specifically 
designed interface based on VVLink and VTK (VTK 5.2.0, 
Kitware Inc. New York, USA) was used to extract the 
manually outlined anatomical structures from the stereotactic 
planning software [8]. To reduce error sources, to increase 
resolution and to remain in the same image coordinate 
reference system as the CT images, the outlined anatomical 
structures were exported in the CT reference space parallel to 
the CT images. Each anatomical structure was converted from 
slices to tabular list and saved as csv files (Matlab scripts). 
D. Clinical Application 
Four patients with ET, treated by bilateral DBS and 
presenting adverse effects during intraoperative stimulation 
tests were included in the current work (part of clinical study 
undertaken at the University Hospital; Ref: 2011-A00774-
37/AU905, Comité de Protection des Personnes Sud-Est 6, 
Clermont-Ferrand, France). Trajectories towards the VIM 
vary from patient to patient due to the planning and individual 
anatomical differences but follow the path from the superior-
anterior-lateral thalamus (ventro-oral nucleus, VO) towards 
the inferior-posterior-medial direction passing the VIM with 
the target at its inferior border. For each implantation, the 
stimulation test positions inducing adverse effects were 
identified. EF simulations were performed with the current 
amplitudes inducing the adverse effect. Three different types 
of adverse effects were observed: dysarthria (speech 
disturbances), paresthesia (abnormal sensations) and 
pyramidal effects (motor contractions mostly of the 
contralateral face and upper limb). Details of the 
implantations with adverse effects are presented in Table 1. 
E. Data Processing and Analysis 
The data generated through clinical application were 
processed for one implantation at a time. Using Matlab, the 
EF simulations for adverse effects were reconstructed as 
volumes. Union operations were applied when several 
domains were overlapping. For the visualization of the 
threshold on the patient-specific images the following data 
were imported in Paraview (Kitware) using Python 
(Python.org) scripts: 1) T1 MR and the WAIR MR image data 
sets, cropped to the region of interest; 2) csv files containing 
the coordinates of the thalamic nuclei and visualized as 
surface extracts of Delaunay triangulation of these co-
ordinates; 3) adverse effect thresholds, visualized to depict 
them as boundary beyond which side effects were observed. 
The data were first visualized in 3D and then in orthographic 
slice view using a custom macro script. 
The generated adverse effect maps were visually analyzed 
in axial, coronal and sagittal sections across all the visualized 
data for one implantation simultaneously in the orthographic 
slice view. For each side effect, the structures just at the limits 
 
Figure 1.  Example of outlined structures in the target area presented 
in 3D. AL:  nucleus anterolateral; InL: nucleus intermedio lateral; 
VCL: nucleus ventrocaudal lateral; DL: nucleus dorsolateral; PU: 
pulvinar; VO: nucleus ventro-oral; FF: field of Forel; CM: nucleus 
centromedian; VCM: nucleus ventrocaudal medial; PLR: pre-
lemniscal radiations. VIM: ventral intermediate nucleus 
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and beyond the adverse effect outline were noted together 
with the kind of side effect and listed in a table. 
TABLE I.  DETAILS OF THE SURGERIES FOR THE PATIENTS 
PARTICIPATING IN THE CLINICAL STUDY. 
 
Brain Hemisphere Side Effects (N° of appearances) 
Pa
tie
nt
 N
° 
1 
Left Paresthesia (4), Pyramidal (1) 
Right Paresthesia (3) 
2 Right Paresthesia (2) 
3 Right Paresthesia (6), Pyramidal (2) 
4 
Left Dysarthria (1) 
Right Dysarthria (1) 
III. RESULTS 
The routine surgical procedure was not altered by 
application of this method in any way as the data were 
analyzed post-operatively. Adverse effect maps were analyzed 
for all six implantations. Table II lists the anatomical structures 
directly outside the adverse effect threshold outlines for the 
different types of adverse effects. Adverse effects induced due 
to stimulation of the pyramidal tract were observed during two 
implantations. The corresponding maps showed that the 
adverse effect outlines run through the internal capsula (Fig. 2, 
first row; Table II). Paresthesia was observed in three 
implantations. The adverse effect outlines in these maps were 
posterior to the VIM and penetrated the VCM, VCL and 
LaCM nuclei. In most cases, the outline was also inferior to 
the VIM, entering the posterior subthalamic area (Fig. 2, 
second row; Table II). For the right hemisphere of patient 4, 
on the posterior trajectory at the target position dysarthria was 
observed. From the axial and sagittal images, it could be 
observed that this outline penetrated the VCL, VCM and the 
LaCM nuclei of the thalamus (Fig. 2, third row; Table II). 
Stimulation tests in the left hemisphere of patient 4 also 
induced dysarthria at one position, and the adverse effect 
threshold outline was observed in a similar thalamic region. 
IV. DISCUSSION 
This paper describes a new digital approach to assist 
clinicians in identifying the adverse effect region based on 
data acquired during intraoperative stimulation tests. In 
addition to learning more about the regions responsible for the 
different adverse effects, the combination of this information 
with the therapeutically effective regions would support the 
neurosurgeon in choosing the optimal implantation position.  
To the best of our knowledge, commercial software solutions 
for DBS do not offer visualization capabilities for 
intraoperative stimulation tests today. D'Haese et al. [9] 
developed a system visualizing therapeutic and adverse 
effects of stimulation in form of spherical balls without 
simulations. Miocinovic [10] proposes a software tool, 
Cicerone, estimating and visualizing the spatial distribution 
of stimulation for adverse effects. It visualizes patient images 
with brain atlas, MER, DBS leads and the volume of tissue 
activated (VTA) in three dimensions and can be used 
intraoperatively. However, the estimation of VTA is not 
patient specific and is based only on the model of the DBS 
ead. In contrast to the existing literature, the approach 
described in the present paper was specifically designed for 
intraoperative use. It benefits from patient-specific electric 
field simulations to estimate the spatial effects of stimulation. 
Other groups tried as well to identify the structures linked to 
the occurrence of side effects. Baumgarten [11] introduced a 
method based on Artificial Neural networks to predict 
pyramidal tract side effects for postoperative programming of 
the DBS lead and showed that it was more effective than the 
calculation of the VTA based on simulations considering 
homogenous tissue. No comparison with patient-specific 
electric field simulations is available so far despite the fact 
that EF has been shown to be the most stable and unchanged 
entity for different stimulation parameters (amplitude and 
pulse width)[6]. We [12] have previously successfully applied 
the same patient-specific electric field simulations to visualize 
the extent of stimulation but to DBS leads and on atlases but 
not with patient-specific anatomical data. No study has so far 
used simulations for intraoperative exploration electrodes.      
The structures identified behind the outline of adverse effect 
thresholds presented in the present paper in different maps 
concur with the findings of other researchers. Adverse effects 
associated with the stimulation of the pyramidal tract were 
only observed when the threshold outline was very close to 
the internal capsula supero-lateral to the thalamus. Dowsey-
Limousin reported similar effects during post-operative 
programming of the implanted pulse generator [13]. 
Dysarthria could be associated with the area posterior to the 
VIM where the VCL, VCM  and the LaCM nuclei are located. 
Similar results were also observed by Reker’s group [14] 
using post-operative stimulation tests. Paresthesia was 
observed for patients 1, 2 and 3. Few studies have associated 
paresthesia with the stimulation of medial lemniscal fibers 
that provide input to the VCM and VCL nuclei [15, 16] and 
to the zona incerta (ZI, [17]). The adverse effect outline in the 
adverse effect maps concur with results suggesting 
involvement of medial lemniscal fibers. To draw any 
statistically significant conclusions, these results have to be 
confirmed by the application of the method to further patients. 
TABLE II.  THALAMIC NUCLEI PENETRATED BY THE DIFFERENT 
ADVERSE EFFECT THRESHOLD OUTLINES 
 Side-Effect 
Pyramidal 
effect 
Parasthesia Dysarthr. 
Pat/Hemisph. 1/L 3/R 1/L 1/R 2/R 3/R 4/L 4/R 
A
na
to
m
ic
al
 s
tr
uc
tu
re
s INL X        
VO X     X  X 
VIM        X 
PLR     X  X X 
VCL    X  X X X 
VCM   X  X X  X 
LaCM X    X  X X 
IC* X X       
* Internal Capsule (IC) is not outlined during the planning, but is distinguishable based on 
spontaneous MR contrast. 
Lt: left; Rt: right; For structure names see Fig. 1. 
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V. CONCLUSION 
The current work presents a new approach how to identify 
anatomical regions that might be responsible for inducing 
adverse effects. Together with the visualization of the 
therapeutic effects, it could assist the neurosurgeons in the 
future in choosing the optimal implant position. 
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Figure 2.  Example of Orthogonal sections across the electric field  simulation for the different stimulation induced side effects. First row: Pyramidal 
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Second row: Paresthesia effects, right hemisphere, patient 1 - VCL, VCM and LaCM nuclei may be involved. Third row: Dysarthria effect, right 
hemisphere, patient 4 - VCL, VCM, LaCM and the PLR might be involved. 
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Abstract:  
Deep brain stimulation (DBS) is an established therapy for movement disorders such as Parksinon’s 
disease, but mechanisms of action remain incompletely known and the optimal target position is still 
subject of discussion. Positioning the DBS lead in the patient’s brain is crucial for effective treatment. 
Extensive evaluations of improvement and adverse effects of stimulation at different positions for various 
stimulation amplitudes are performed intraoperatively. However, to choose the optimal position of the 
lead, the information has to be “mentally” visualized and analyzed. This paper introduces a new 
technique called Improvement Maps, which summarizes and visualizes the high amount of relevant data 
with the aim to assist in identifying the optimal DBS lead position. It combines three methods: a) direct 
visual surgical planning with outlines of the relevant anatomical structures, b) quantitative symptom 
evaluation during intraoperative stimulation tests and c) patient-specific electric field simulations to 
estimate the spatial distribution of stimulation. Through this combination, each voxel in the stimulation 
region is assigned one value of symptom improvement, resulting in the division of stimulation region 
into areas with different improvement levels. This technique was applied to five Essential Tremor (ET) 
patients who participated in a clinical study in the University Hospital in Clermont-Ferrand, France. Apart 
from identifying the optimal implant position, the resultant nine improvement maps show that the 
highest improvement region is frequently in the posterior sub-thalamic area. The results demonstrate 
the two fold utility of the improvement maps: identify the optimal implant position and improve DBS 
target selection.  
 
Keywords: deep brain stimulation, electric field simulations, accelerometry, data visualization, essential 
tremor  
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1 Introduction  
Deep brain stimulation (DBS) is a neurosurgical treatment for movement disorders like Essential Tremor 
(ET). Patients undergo a complex surgical procedure to implant leads in the brain, which are continuously 
stimulated through an implanted pulse generator (IPG) in the thoracic or the pelvic cavity. The outcome 
significantly depends on the location of the DBS lead in the brain. Over the years of DBS usage, clinicians 
have established few specific target regions in the brain based on the disease being treated, e.g. the 
ventro-intermedius nucleus (VIM) of the thalamus for ET. However, as these targets have a size in the 
range of millimeters and as the exact mechanisms behind the functioning of DBS are unknown 
(Herrington et al. 2016), clinicians implant the DBS lead after testing various positions on a locally 
anesthetized patient during surgery (Abosch et al. 2013; Hemm and Wårdell 2010).  
Before the actual surgery, clinicians perform planning using specially designed software to identify the 
target structure on the patient images and the best path to reach it from an entry point in the skull. 
During the surgery, one or more parallel test electrodes are inserted along the planned path and 
neuronal recording and stimulation tests are performed at pre-determined positions. Therapeutic and 
adverse effects are evaluated at these stimulation test positions. The details of the surgical procedure 
may vary between centers, but certain limitations are observed in all centers: The therapeutic effects of 
stimulation tests for example, are evaluated visually or through passive movements using subjective 
clinical scales (Post et al. 2005; Palmer et al. 2010; Griffiths et al. 2012). Further, after completing 
stimulation tests for one hemisphere, the surgical team has to "mentally" visualize the results in relation 
to the anatomy to identify the optimal implant position.  
To limit the subjectivity associated with the clinical ratings used for therapeutic evaluation, researchers 
have proposed methods to use quantitative tools to estimate the changes in symptoms. We have 
previously published a method (Shah et al. 2016b) using accelerometers to quantitatively evaluate 
improvement in tremor during intraoperative stimulation tests. By synchronizing the accelerometer 
recordings with the electrical stimulation, the improvement in tremor induced by the different 
stimulation current amplitudes could be quantitatively evaluated. The application of this method to 
clinical routine showed that such quantitative techniques might be able to improve DBS targeting. The 
data collected from DBS for ET patients were classified based on the position of the electrode with 
respect to the nuclei. The results suggested that the ventro-oral nuclei of the thalamus can be as efficient 
in reducing tremor as the VIM (Shah et al. 2015).  
In the previous study, the location of the electrode contact’s center was considered with respect to the 
anatomy. However, the effect of stimulation spreads farther in the region surrounding the electrode 
depending on the brain tissue. Various researchers have used computational models based on finite-
element modelling (FEM) to simulate the distribution of electrical entities in the brain tissue for DBS 
(McIntyre et al. 2004; Hemm et al. 2005; Aström et al. 2006). Recent advancements in such techniques 
have made them patient-specific (Aström et al. 2009; Chaturvedi et al. 2010; Wårdell et al. 2015) where 
the patient's MR images are used to determine the tissue surrounding the electrode (white matter, gray 
matter or cerebro-spinal fluid) and assign electrical properties accordingly. We have developed a 
technique to simulate the electric field (EF) distribution during intraoperative stimulation tests using 
patient-specific computational models (Hemm et al. 2016). We applied this technique to 5 ET patients 
to simulate the EF distribution for multiple current amplitudes per stimulation test position. The aim of 
this previous study was to collectively analyze the data to study the role of different anatomical 
structures in reducing tremor. The resultant 272 simulations were classified based on the improvement 
in tremor (low or high) as measured by the accelerometer for the corresponding stimulation current 
amplitude. The data of the two groups was analyzed to identify 1) the difference in appearance of the 
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different anatomical structures covered by the EF and 2) the relative volume covered of a particular 
structure.   
In the current study, we propose a methodology allowing the individual analysis of the high amount of 
data per patient. The aim is to combine electric field simulations with tremor improvement quantified 
by accelerometry and then visually present in form of so-called improvement maps superimposed to 
the patient specific anatomy to assist in surgical decision making i.e. choosing the optimal implant 
position for the chronic DBS lead. This improvement map approach has been applied post-operatively 
to 9 implantations from Clermont-Ferrand university hospital.   
2 Method  
2.1 Surgical procedure 
The routine surgical procedure at the University Hospital in Clermont-Ferrand begins with a meticulous 
pre-surgical planning. A brief description of the procedure is given here while a complete description 
can be found elsewhere (Vassal et al. 2012). Numerous radiographic images including a stereotactic CT 
(0.59 mm x 0.59 mm x 1.25mm), stereotactic T1 MRI (0.63 mm x 0.63mm x 1.30mm) and white-matter 
attenuation inversion recovery (WAIR, 0.54 mm x 0,53 mm x 2.0 mm) sequence are acquired (Sonata 
1.5T, Siemens, Germany) to be used for the planning. Based on the spontaneous contrast observed on 
the WAIR sequence and an in-house developed high field (4.7 Tesla) brain atlas, the neurosurgeon 
carefully outlines various thalamic nuclei and basal ganglia structures using a commercial planning 
software iPlan stereotaxy 3.0 (Brainlab). After delineating the desired target structure viz. the VIM for ET 
patients, two parallel trajectories are planned from an entry point in the skull. The trajectories usually 
follow the path from the superior-anterior-lateral thalamus (ventro-oral nucleus, VO) towards the 
inferior-posterior-medial direction passing the VIM with a target at its inferior border. Various test 
stimulation positions (between 5 to 10) are planned along each trajectory spanning the whole region of 
interest.  
During surgery, the stereotactic co-ordinates of the planned trajectories obtained from the planning 
software are set up on the Leksell Stereotactic System (Elekta, Stockholm, Sweden) using the 
repositioning kit. After drilling the burr hole at the desired entry point, two intraoperative exploratory 
electrodes are inserted along the previously identified trajectories. Micro-electrode recording (MER) is 
performed at all the planned test-stimulation positions along both the trajectories simultaneously to 
confirm the location of the trajectories in relation to the surrounding anatomical structures (Coste et al. 
2009). Stimulation tests are then administered at these positions, with stimulation current varied in most 
cases from 0 to 3 mA in steps of 0.2 mA. The highest visually observed improvement in tremor is noted 
along with the corresponding stimulation current amplitude for every test position. The amplitudes 
resulting in adverse effects, if any, are also noted.  
After completion of stimulation tests for one brain hemisphere, the surgical team compares the results 
(current amplitudes improving tremor and/or inducing adverse effect) and mentally visualizes the 
information in relation to the patient’s anatomy. The DBS lead (Medtronic 3389, Medtronic, Minneapolis, 
USA) is implanted at a position fulfilling the following conditions: 
a) Low therapeutic stimulation current amplitude  
b) High adverse effect inducing stimulation current amplitude  
c) Neighboring test positions having relatively low therapeutic stimulation current amplitudes 
d) Anatomical position  
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2.2 Accelerometric tremor evaluation 
The changes in tremor during surgery were evaluated applying a previously published method using an 
accelerometer (Shah et al. 2016b). In short, a 3-axis acceleration sensor evaluation board (STEVAL-
MKI022V1, ST Micro, Geneva, Switzerland) was attached to the patient’s wrist with a Velcro strap and 
data were recorded with a sampling rate of 400 Hz and a range of 8 g using a computer application 
(LemurDBS) developed in Java (Oracle Corporation, California, USA). All data were stored for offline 
analysis. Data recording was synchronized with the MicroGuide Pro (Alpha Omega Eng., Nazareth, Israel) 
electrophysiology system that was used for MER and stimulation tests. For every stimulation test, 
changes in tremor were determined compared to the data recorded immediately before the start of the 
test. By using such a protocol, changes in tremor due to brain tissue damage caused by introducing the 
electrode would not influence the quantitative assessment.         
Accelerometer data were analysed post-operatively using Matlab. The magnitude of acceleration was 
calculated and filtered to extract the tremor signal. This data was then divided into two: data recorded 
before the start of the stimulation was called “baseline” and data recorded during stimulation was called 
“stimulation data”. Outcome measures (standard deviation, signal energy, and amplitude of dominant 
frequency) which have been shown to correlate with clinical changes (Shah et al. 2016b) were extracted 
from both the data sets in a windowed manner (time length of 2 seconds). The outcome measures for 
the stimulation data were normalized to the corresponding outcome measures of the baseline. The 
quantitative improvement in tremor was expressed by the mean of the three normalized outcome 
measures for each window and the average improvement per stimulation current amplitude was 
determined.   
2.3 Spatial distribution of stimulation 
The effects of electrical stimulation in the brain are not confined to the location of the electrode, but 
spread farther into the brain in all directions depending on the stimulation parameters and the brain 
tissue surrounding the contact. To understand these spatial effects of the stimulation, the distribution of 
the EF around the electrodes within the brain was simulated using an established patient-specific FEM-
modeling technique for DBS leads (Aström et al. 2009; Aström et al. 2010; Wårdell et al. 2015) which has 
been adapted to the conditions and set-up of intraoperative stimulation tests. Details about the 
simulation method can be found in the previous publication (Hemm et al. 2016).   
2.3.1 Microelectrode model  
A model of the microelectrode (Neuroprobe, Alpha Omega Engineering) used in Clermont-Ferrand 
University Hospital was generated with its specific dimensions. As electrophysiological evaluations were 
performed through two parallel electrodes, a second model of the MER-electrode was positioned at a 
distance of 2 mm. The end of the grounded guide tubes were fixed at 12 mm above the target point, i.e. 
the a priori optimal anatomic spot. In consequence, the distance (d) between the guide tube and the 
middle of the stimulating contact decreased or increased respectively when the simulation site was 
before or after the target (12 mm ± d) along the trajectory.  
2.3.2 Patient specific brain model  
The patient specific simulation of EF distribution necessitates a patient-specific brain model. For this 
purpose, the T1 MRI was used after registration and resampling to the stereotactic preoperative CT 
having higher resolution. This data was imported into the in-house developed software (Matlab) for 
creating brain tissue models. The T1 images were filtered and enhanced in the region of interest to 
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segment it into cerebrospinal fluid (CSF), gray matter and white matter (Alonso 2016). The segmented 
image voxels were assigned electrical conductivity values (sigma) based on published literature (Gabriel 
et al. 1996): CSF - 2.0 Siemens/meter (S/m), blood - 0.7 S/m, gray matter 0.123 S/m and white matter 
0.075 S/m. Conductivity values for voxels between the thresholds were interpolated. Simulation time was 
considerably reduced by selecting a cuboid region of interest of approximately 100 mm in each 
dimension encompassing the thalamus.  
2.3.3 Patient specific stimulation data  
For each patient, the planned trajectory to reach the target structure and the stimulation test positions 
along the trajectory were different. These data were extracted from the planning software (iPlan 
stereotaxy) and converted to the co-ordinate system of the brain model using Matlab. The target co-
ordinates and the trajectory angles were used to calculate and position the stimulating contact and the 
parallel electrode in the brain model for the different stimulation test positions. In addition, to simulate 
the EF, the stimulation current amplitude has to be provided as input. Although it would be possible to 
simulate all the stimulation current amplitudes (15) per position, the resultant data set would have 
redundant information and would be tedious to analyze. Therefore, for each stimulation test position, 
we decided to simulate the EF distribution for the stimulation current amplitudes with 1) the first 
appearance of highest change in tremor (between 0.2 mA to 3 mA) and 2) the first adverse effects were 
observed (between 1 mA to 5 mA). 
2.3.4 Electric field simulations  
The spatial distribution of EF was simulated by using the equation of continuity for steady state current: 
∇ .  𝐽 ̅ =  ∇ . (𝜎∇𝑉) = 0 
where J is the current density, σ is a matrix containing the electrical conductivity values for the region of 
interest (thalamus and its neighborhood) and V the electric potential. After placing the electrodes at a 
desired stimulation test position, the active contact was set to the stimulation current amplitude 
described in 2.3.3 and the guide tube was set to ground, resulting in a monopolar configuration. The 
inactive contact of the parallel lead was set to floating potential and the exterior boundaries of the tissue 
model were set to electrical insulation. The in-built mesh generator (Comsol Multiphysics) defined the 
mesh density (approximately 250,000 tetrahedral elements) where the smallest elements (0.03 mm) were 
located close to the stimulating contacts in order to capture the strong EF gradients. Previous research 
has shown that the EF isolevel of 0.2 V/mm represents the neuronal activation for the thalamic region. 
Therefore the Cartesian co-ordinates of the surface of EF volume for 0.2 V/mm were exported for further 
analysis.  
2.3.5 Surgical planning data 
In addition to the planned trajectory and target information, the manually outlined anatomical structures 
were extracted from the iPlan software via a specifically designed interface based on VVLink and VTK 
(VTK 5.2.0, Kitware Inc. New York, USA). In order to reduce error sources, only the CT data set was used 
as reference for the outlined anatomical structures and the target coordinates. In consequence, the 
structures initially outlined on the WAIR weighted sequence were transferred to the stereotactic CT data 
set providing a higher resolution and minimal distortion of the stereotactic reference system. The 
structures were exported in form of slices parallel to the CT data set in order to remain in the same 
image coordinate reference system. Using Matlab scripts the co-ordinates of each of the anatomical 
structure were converted from slices to tabular list and saved as csv files.  
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2.4 Clinical application 
A clinical study was undertaken at the University Hospital in Clermont-Ferrand, France (Ref: 2011-
A00774-37/AU905, Comité de Protection des Personnes Sud-Est 6, Clermont-Ferrand, France) and 5 
patients who were treated for ET using DBS were included for the current work (Table 1). The number of 
stimulation tests varied from patient to patient based on the size of the region of interest and the 
occurrence of side effects during the stimulation tests. Three types of adverse effects were observed for 
different patients viz. pyramidal effects, paresthesia and dysarthria. Accelerometer data were recorded 
during the surgery following the above presented protocol to evaluate the changes in tremor induced 
Table 1: Details of the surgeries for the patients that participated in the clinical study. 
Pat. 
No 
Brain 
Side 
AC-PC 
length 
(mm) 
Target Coordinates with 
respect to AC (mm) 
Trajectory No. of 
test  
positions 
No. of 
electric field 
simulations 
Side 
Effects 
Lat Post Inf 
1 Rt 30.37 18.24 13.22 3.04 Central 7 7   
Posterior 8 8 
2 Lt 24.17 15.24 19.86 3.69 Central 5 8 Paresthesia 
Pyramidal 
Posterior 5 7 
2 Rt 24.17 15.2 16.33 2.06 Central 7 8 Paresthesia 
Posterior 7 8 
3 Lt 26.23 16.04 16.11 2.52 Central 8 8   
Posterior 8 8 
3 Rt 26.23 13.47 15.52 2.4 Central 8 8 Paresthesia 
Posterior 8 10 
4 Lt 26.99 12.77 17.4 2.42 Central 9 9   
Posterior 9 9 
4 Rt 26.99 15.72 18.59 1.1 Central 5 9 Paresthesia 
Pyramidal 
Posterior 5 9 
5 Lt 27.98 15.75 19.04 4.23 Central 8 8 Dysarthria 
Posterior 8 9 
5 Rt 27.98 16.23 16.71 3.23 Central 8 8 Dysarthria 
Posterior 8 9 
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by varying stimulation current amplitudes. The procedure described above was applied to generate 
improvement maps for 9 brain hemispheres. For Patient 1, data acquired during the implantation of the 
left hemisphere were excluded from the analysis due to lack of synchronization with the 
electrophysiological data (recording software error).  
2.5 Improvement Maps 
2.5.1 Concept 
The setup for EF simulations for intraoperative stimulation tests resulted in a large number of simulations 
per hemisphere. For one hemisphere, on average, there were 2 trajectories with 7 different positions 
(Table 1) simulated with their respective current. Figure 1A is a diagrammatic representation of EF 
simulations for intraoperative stimulation tests at different positions along the two trajectories. Each EF 
corresponds to one stimulation amplitude, each of them inducing a specific clinical improvement. The 
EFs overlap and many voxels can be encompassed in more than one EF simulation. Figure 1B illustrates 
with four examples how different improvements can be associated to a voxel in the stimulation test 
region. To summarize the data and to facilitate analysis, only one improvement value was directly linked 
to one voxel to create an “Improvement Map”. 
2.5.2 Creation 
From the EF simulations, the Improvement Map is generated using Matlab scripts as presented in Figure 
2. All the EF simulation files from COMSOL (refer section 2.3.4) are imported in Matlab and the extent of 
the stimulation test region in a given hemisphere is calculated Figure 2, Step 1). A 3D mesh-grid with a 
resolution 4 times the resolution of the CT images is created (Figure 2, Step 2). Using the Delaunay 
Triangulation (Boris Delaunay 1934) and location-query function, the position of each EF in this mesh-
grid is identified and a mask is created. The mask is multiplied with the improvement associated with 
the EF i.e. the mesh voxels of the EF hold the improvement value and are zero otherwise. All such 
 
Figure 1: Diagrammatic representation of electric field simulations for the intraoperative stimulation tests in 
one hemisphere. Left: Sagittal view of the two electrodes with two stimulation test positions each. Each circle 
represents the electric field around one stimulation position generated by a specific current amplitude (mA) 
and inducing a specific clinical improvement (%). Four different voxels V1 to V4 have been picked between the 
two electrodes. Right: Graphical representation of the improvements induced by the different electric fields at 
the four voxels V1 to V4. 
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improvement masks have the same dimensions and are therefore appended together to create a 4D 
matrix (Figure 2, Step 3). By using a many to one function (e.g. minimum, mean, maximum etc.) on the 
4th dimension, a 3D matrix is obtained having the same dimensions as the mesh-grid, and each voxel 
holding only one improvement out of all the EF simulations that encompassed it (Figure 2, Step 4). After 
identifying the different levels of improvement in this 3D matrix and using the location-query function, 
the X, Y and Z co-ordinates of each improvement level are obtained and exported. For the EF of adverse 
effect thresholds, their co-ordinates in the mesh-grid are identified and exported as csv files without any 
additional processing.  
2.5.3 Visualization 
For visual analysis of the improvement map, data were imported in Paraview (Kitware) using Python 
(Python) scripts in the following order: 1) The T1 MR and the WAIR MR image data sets were imported 
and cropped to the region of interest. 2) The csv files containing the co-ordinates of the thalamic nuclei 
(see section 2.3.5) were imported one by one, and visualized as surface extracts of Delaunay triangulation 
of these co-ordinates. 3) The csv files containing the improvement map were imported and visualized as 
Delaunay triangulations. 4) The simulations for adverse effect thresholds were imported and visualized 
as surface extracts of Delaunay triangulations to depict them as boundary beyond which adverse effects 
were observed. The data were first visualized in the 3D view and then loaded into the orthographic slice 
view using a custom macro script.  
 
Figure 2: A diagrammatic representation of the steps to generate the Improvement Maps. The individual EF 
simulations are imported and the size of the stimulation test region is calculated (Step 1). A mesh grid of this 
size with 4 times the resolution of the MR data is created (Step 2). The location of each EF simulation in this 
mesh grid is determined (Step 3). Each voxel in the improvement map is then assigned the improvement value 
based on the chosen mathematical function (Step 4).  
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2.5.4 Maximum Improvement Maps 
The improvement maps represent a summary of many EF simulations based on the mathematical 
function used to associate one improvement value to a voxel. In order to choose this function, we 
visualized EF simulations of the patients using Paraview. For some instances, the EF simulations of small 
stimulation amplitudes resulting in high improvement were encompassed by simulations of larger 
stimulation amplitudes of neighboring positions but with lower improvement (Figure 3A). Considering 
that the aim of the intraoperative tests is to identify regions, which are more effective with lowest 
stimulation current amplitude, we decided to assign the maximum improvement value to each voxel to 
create a "maximum improvement map". Figure 4A shows the maximum improvement map of the 
diagrammatic representation in Figure 1A with the maximum improvements for the selected voxels in 
 
Figure 3: A) Sagittal view of 8 electric field simulations for left hemisphere of patient 5. The color of the border 
represents the improvement in tremor. It underlines the need to summarize the information using improvement 
maps. B) The maximum improvement map of the EFs seen in A. The shade of green corresponds to the 
improvement associated with the region based on the scale in the legend. The black outline represents different 
thalamic nuclei and the grey ovals represent the trajectory of the electrode. 
 
 
Figure 4: Diagrammatic representation of maximum improvement map of the representation in figure 1. Left: 
Sagittal view of the maximum improvement map. The shade of green represents the level of improvement 
measured using the accelerometer (darker shade corresponds to higher improvement). Four different voxels 
V1 to V4 have been picked between the two electrodes. Right: Graphical representation of maximum 
improvement associated with the four voxels V1 to V4. 
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Figure 4B. The maximum improvement map for the EFs shown in Figure 3A is shown in Figure 3B where 
the smallest region with the highest improvement is clearly identifiable.  
2.6 Data Analysis 
The improvement maps were analyzed individually by simultaneously moving the axial, coronal and 
sagittal sections across all the visualized data in the orthographic slice view. For each map, the location 
of the region showing the highest improvement was identified and carefully studied with respect to the 
outlined anatomical structures and the adverse effect threshold outline. The optimal depth along the 
trajectory to implant the permanent lead was determined using the criteria defined earlier (Section 2.1) 
and it was listed for all implantations. In addition, in each map, the interaction of various anatomical 
structures with the induced clinical effects were meticulously examined. In the highest improvement 
regions, structures partially or completely covered were identified while for adverse effects, structures 
externally touching the adverse effect threshold outlines and external to any improvement region were 
noted. Finally, recurring structures were studied for their interaction with the highest improvement 
region and the adverse effect threshold outline across all the implantations.    
3 Results  
Through the clinical study in University Hospital in Clermont-Ferrand, accelerometer data was recorded 
for a total of 129 test stimulation positions from the 5 DBS surgeries. Using the FEM based technique, 
148 simulations (129 therapeutic + 19 adverse effects) were performed based on these stimulation tests 
and summarized in 9 improvement maps. These maps vary from patient to patient depending on the 
planned trajectory and the test stimulation positions along it. The analysis of one improvement map is 
provided in the following paragraph. The remaining 8 improvement maps and their analysis is provided 
in a supplementary file. The analysis of the variations in different maps is described in the final paragraph 
of this section.  
Figure 5 shows a typical improvement map of the right hemisphere of patient 5. The inferolateral part 
of the thalamus was explored during the stimulation tests (Fig 5A to 5C) with the planned target at the 
inferior border of the VIM (Fig 5D to 5F). The highest improvement region (95%) can be seen further 
along the trajectory from +1 mm to +3 mm in front of the target (Fig 5E, 5F and 5J to 5L) shaped like a 
drop with its peak in the posterior direction. The region starts just below the VIM, touches the medial 
edge of the ventrocaudal lateral nucleus (VCL), lateral edge of the Center median nucleus (LaCM) and 
penetrates the supero-lateral part of the PLR. On the other hand, the spherical adverse effect (dysarthria) 
outline (red) interacts with VO, VCL, VCM, LaCM and PLR (Fig 5D to 5K) outside of the different 
improvement regions. It does not interact with the highest improvement region but is the closest near 
the inferior, anterior medial edge (Fig 5K and 5L). Based on this improvement map, the position +2 (Fig 
5K) on the central trajectory would be optimal to implant the lead for chronic stimulation.  
The procedure described above was applied to all the 9 implantations and the results were summarized. 
Table 2 lists the optimal position along the trajectory for all improvement maps. The interactions 
between the anatomical structures and the highest improvement region and the adverse effect threshold 
outline respectively are listed in Table 3.  
In the 9 improvement maps, seven anatomical structures were identified that interacted with the highest 
improvement region: INL, VO, VIM, PLR, VCL, VCM and LaCM. The VIM, the planned target for all the 
patients, occurs the most frequently. It appears in 8 out of the 9 maps, with a complete coverage in 4 
cases. In 6 of the 9 improvement maps, the highest improvement region encompassed 
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Figure 5: Images of the improvement map for the right hemisphere of patient 5. Parts A to C show the overview of 
the explored region in relation to the patient's brain in form of orthogonal slices at the target position. Parts D to 
F show a close-up (magnification of 5) of the improvement maps at the same position. Parts G to M are axial slices 
at the different stimulation test positions from -3 to + 4 mm. The bottom right part of the figure shows the legend 
containing the improvement scale in shades of green, representation of the trajectory in gray, anatomical structures 
in black, side-effect outline in red and projection of AC/PC point in blue. The names of the relevant thalamic nuclei 
are abbreviated based on the nomenclature in (Lemaire et al. 2010) as follows: VIM: Ventrointermediate VCL: 
ventrocaudal lateral, VCM: ventrocaudal medial, LaCM : laminar caudal medial, VO: ventro oral, PLR: prelemniscal 
radiations. 
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the area inferior and posterior to the VIM (posterior sub-thalamic area, PSA) and included at least 
partially the PLR. This area was not explored in the other three maps as adverse effects were observed 
in this position at low stimulation current amplitudes. In addition the anterolateral part of the LaCM was 
partially enclosed in 6 maps, lateral parts of the ventrocaudal medial nucleus (VCM) in 5 maps, the VO 
was encompassed in 4 maps (2 partially, 2 fully), the inferomedial part of the VCL in 4 maps, and the 
inferior part of intermediolateral nucleus (InL) was partially included in 3 maps. 
Three different types of adverse effects were observed during 6 out of the 9 implantations as described 
in Table 3: dysarthria, paresthesia and pyramidal effects. Dysarthria was observed in both implantations 
of patient 5 and the outline in the two maps (Figure 5 and Figure S8) is posterior and slightly lateral 
compared to the different therapeutic regions. Adverse effects induced due to stimulation of pyramidal 
tract were also observed during 2 implantations (Patient 2 Left and Patient 4 Right). The improvement 
maps of these implantations showed that the adverse effect outlines were superior and lateral to the 
thalamus (Figures S2 and S7). Paresthesia was also observed in 4 implantations (Patient 2 Left and Right, 
Patient 3 Right and Patient 4 Right). The adverse effect outline for these improvement maps (Figures S2, 
S3, S5 and S7) was posterior to the VIM and penetrated the VCM, VCL and LaCM nuclei.  
The interaction of recurring structures and adverse effects across multiple implantations can be seen in 
Table 3. In case of paresthesia and dysarthria, VO and PLR are touching the adverse effect threshold 
outline for some implantations while, in others they are completely enclosed by the highest 
improvement region without inducing any adverse effects. , .  
4 Discussion  
This paper describes a new digital approach to assist the clinicians in identifying the optimal region to 
implant the chronic DBS lead after intraoperative stimulation tests: a task currently performed by 
evaluating handwritten notes taken during surgery. The approach combines the outline of the relevant 
Table 2: The choice of depth along the trajectory where the permanent DBS lead should be 
implanted based on improvement maps and their coordinates with respect to the AC. 
Patient 
Number 
Hemisphere 
Optimum implantation depth of permanent lead 
based on improvement maps 
1 Right +3mm 
2 Left -1mm 
2 Right +1mm 
3 Left -+1mm 
3 Right +2mm 
4 Left +4mm 
4 Right +1mm 
5 Left +2mm 
5 Right +2mm 
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anatomical structures with a novel technique to quantitatively evaluate the therapeutic effects and a 
patient-specific method to estimate the spatial effects of stimulation. This combination creates 
improvement maps, i.e. 3D visualization of the intraoperative stimulation test results with therapeutic 
areas, adverse effect areas and anatomical structures in the stimulation test region. The 9 improvement 
maps generated after applying this approach to 5 ET patients who underwent DBS surgery demonstrate 
the potential to support and facilitate the surgical team in determining the optimal implant position of 
the DBS lead and to better understand the mechanism(s) of action of DBS.   
Table 3: Table summarizing the results of the different improvement maps. The interaction 
of 7 structures with the highest improvement region and the adverse effect threshold 
outline for each implantation is listed. The improvement maps used to generate this table 
can be found in the supplementary material.  indicates full coverage,  indicates partial 
coverage and  indicates no coverage. Pyr is Pyramidal effect, Par is paresthesia and Dys is 
Dysarthria.  
Patient/ 
Hemisphere 
Max Improvement/ 
Adverse Effect* 
Structures 
INL VO VIM PLR VCL VCM LaCM 
1/R 
90%        
Adverse Effect  
       
2/L 
85%        
Adverse Effect  Pyr Pyr 
   
Par Pyr 
2/R 
85%        
Adverse Effect 
    
Par 
  
3/L 
90%        
Adverse Effect 
       
3/R 
85%        
Adverse Effect 
   
Par 
 
Par Par 
4/L 
100%        
Adverse Effect 
       
4/R 
95%        
Adverse Effect 
 
Par 
  
Par Par 
 
5/L 
95%        
Adverse Effect 
   
Dys Dys 
 
Dys 
5/R 
95%        
Adverse Effect 
 
Dys 
 
Dys Dys Dys Dys 
* For the interaction with adverse effect threshold outline, only the anatomical structures which were 
penetrated by different adverse-effect threshold outlines outside of the therapeutic improvement regions are 
considered.  
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4.1 Related work 
To the best of our knowledge, commercial software solutions for DBS do not offer visualization 
capabilities for intraoperative stimulation tests today. Some research based software systems which are 
capable of visualizing DBS data have been proposed. D'Albis et al. (2015) developed PyDBS to automate 
tasks like image registration, image segmentation and visualization. They designed it to assist clinicians 
during pre-operative planning and post-operative electrode validation, but not during intraoperative 
electrode placement. Guo et al. (2006) used non-linear image registration to visualize digitized brain 
atlas, segmented deep brain nuclei and final surgical targets as well as electrophysiological information 
from their own database on the patient images. Although their software could be used during the 
surgery, it did not have provisions to visualize therapeutic or adverse effects of stimulation at a given 
position. The group of D'Haese (2012) developed a system consisting of a central repository (Cranial 
Vault), modules to interact with the repository (CRanial VAult Explorer, CRAVE) and algorithms to 
automate certain tasks in the DBS treatment (pre-operative, intraoperative and postoperative phases). 
Their system is able to visualize therapeutic and adverse effects of stimulation, which the clinical team 
would manually enter during the surgery. However, the use of their intraoperative module during 
surgeries showed that the manual task of providing information to their system was stressful for the 
surgical team. In addition, none of the software described above estimates the spatial effect of 
stimulation. Miocinovic et al. (2009) proposed a software called Cicerone which visualizes patient images 
with brain atlas, MER, DBS leads and the volume of tissue activated (VTA) in 3 dimensions and can be 
used intraoperatively. However, the estimation of VTA is not patient specific and is based only on the 
DBS lead. In contrast to the existing literature, the approach described in this study was specifically 
designed for intraoperative use. It benefits from patient-specific EF simulations to estimate the spatial 
effects of stimulation as well as quantitative evaluations of induced therapeutic effects by using 
accelerometry.   
4.2 Improvement Map Types 
In the present study, we describe a specific case of improvement maps where each voxel in the 
stimulation test region is assigned the maximum value of improvement as measured by the quantitative 
technique. In general, however, the structure of the improvement maps, i.e. the different therapeutic 
regions and their location, is significantly affected by the choice of the improvement value assigned to 
a voxel. Theoretically, this choice can be made using computationally simple functions like mean, 
maximum, etc. or complex functions based on fuzzy logic, weighting function based on distance from 
trajectory, etc. However, the practical implications of this choice have to be considered. For this study, 
we aimed at identifying the optimal position to implant the permanent electrode. In consequence, it is 
necessary to identify the highest improvement region with the least amount of current (less battery 
consumption), justifying our choice of assigning the maximum improvement to each voxel. In addition 
to the choice of improvement value assigned to a voxel, the input stimulation current amplitude used 
for the EF simulations also affects the improvement maps. Both these choices depend heavily on the aim 
set forth before the start of data analysis. 
4.3 Improving DBS targeting   
The application of the improvement map approach to five patients showed how it could assist in 
choosing the depth for the permanent implantation of the DBS lead (Table 2). In addition, they also show 
the possibility of improving DBS targeting in general. The interactions of the seven structures presented 
in Table 3 with the therapeutic and adverse effect regions of the improvement map concur with the 
findings of other published research. The highest improvement regions in the different improvement 
maps are either in the inferior part of the VIM or in the PSA. The VIM is the gold standard target for 
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treatment of ET patients and results in optimal therapy for most patients (Blomstedt et al. 2007). 
Stimulation in the PSA has been shown to be effective for treating proximal tremor (Kitagawa et al. 2000; 
Murata et al. 2003) and ET (Plaha et al. 2004; Blomstedt et al. 2010) and some researchers argue that it 
is a better target compared to the VIM (Sandvik et al. 2012; Hamel et al. 2007). With regards to the 
adverse effects, those associated with the stimulation of the pyramidal tract were observed for two 
implantations where the threshold outline in the improvement maps was very close to the internal 
capsula, supero-lateral to the thalamus. Dowsey-Limousin (2002) reported similar effects during post-
operative programming of the implanted pulse generator. The dysarthria threshold outline for both 
implantations of patient 5 suggests that the stimulation of VCL, VCM and LaCM may be responsible for 
it. Similar results were observed by Reker group (2016) using post-operative stimulation tests. In contrast 
to the two adverse effects discussed above, paresthesia which is commonly observed in VIM DBS 
procedures, has been associated with different structures by different studies (Tamma et al. 2002: 
Subthalamic Nucleus, Krack et al. 2002; Murata et al. 2003; Keane et al. 2012: Medial lemniscus, 
Fytagoridis et al. 2013: Posterior sub-thalamic area, Dembek et al. 2017: Zona Incerta). As described 
above (Figure 5) and previously (Shah et al. 2018), the adverse effect outline can be often found in the 
PSA region suggesting that stimulation there might cause paresthesia, even if they do not indicate which 
anatomical structure or fibre tract may be responsible for them. When looking at table 3, VCL, VCM and 
LaCM could be candidates as well. Although VO and PLR are also listed in Table 3 for paresthesia as well 
as dysarthria effects, they are probably not responsible for these effects as in other implantations they 
are completely covered by the therapeutic regions without any adverse effect appearance. The 
similarities discussed here suggest that with a significantly large data set, the improvement maps could 
be used to improve DBS targeting and possibly support in studying the mechanisms of actions of DBS. 
4.4 Transferability  
In its current form described in this study, the procedure of creating the improvement maps is very 
specific to the type of data available from the University Hospital in Clermont-Ferrand. In general, 
however, the technique is very adaptable to the type of data available. In absence of pre-operative 
anatomical outline, the patient images can be co-registered to digitized atlases using open-source 
software like 3D Slicer (Fedorov et al. 2012) and segmented to outline the relevant anatomical structures. 
Regarding the spatial estimation of stimulation, the EF simulation procedure can be adapted to the type 
of MR data acquired and the type of exploration electrode used in a given surgical center. Concerning 
the use of accelerometers to evaluate tremor, our previous study has shown its advantages over the 
existing visual method and the relative ease with which it can be added to the surgical procedure without 
major alterations or loss of patient comfort. For DBS procedures of non-tremulous patients, e.g. 
Parkinson’s disease patients with rigidity, some quantitative tools to evaluate rigidity exist, including 
ours (Shah et al. 2016a). These methods, however are in experimental stage. These situations were 
considered during the design phase of the improvement map method. Therefore, for making the 
improvement maps, the improvement in symptoms estimated using routine clinical scales and subjective 
methods can also be used. To do so, the surgical team has to predetermine the levels of improvement 
they want to visualize and to note the stimulation parameters that result in these improvements.  
4.5 Limitations  
Closer examination of the improvement maps reveal that the anatomical structures appear to have sharp 
edges and corners. Such edges and corners are not found in the original outline in the planning software, 
but are a resultant of the procedure used to export and reconstruct them. One possible workaround for 
this limitation would be to export the anatomical structures in a 3D file format, but our version of the 
planning software did not have any such provision. In addition, the reconstruction of this outline of 
anatomical structures is also limited by the voxel dimension, which can only be improved by using 
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imaging systems with better resolution. Apart from this, any caveats associated with the quantitative 
tremor evaluation and EF simulation techniques also affect the improvement maps. Our previous 
research has shown that the quantitative tremor evaluation depends on proper acquisition of baseline 
data before every stimulation test (Shah et al. 2016b). In absence of sufficient baseline recording, the 
baseline data of a previous stimulation test position can be used. With regards to the EF simulations, to 
be able to use the images with the highest resolution, image fusion was used in a manner that limited 
the errors associated with transformation and fusion (Zrinzo 2012). Further, we do not consider the 
effects of brain shift on the position of the electrode based on the observation that the largest shift 
occurs when the exploration electrode is replaced by the chronic DBS lead. For exhaustive description 
of the limitations of each method, the readers are advised to refer to the respective literature of each 
method (Hemm et al. 2016; Lemaire et al. 2010; Shah et al. 2016b).   
4.6 Future Work  
The improvement maps presented here were generated and analyzed post-operatively. Steps to 
generate the improvement maps in real-time have been identified. The time between pre-surgical tasks 
(image acquisition and surgical planning) and the actual surgery needs to be utilized for all preparatory 
steps (extract outline of anatomy, generate the patient-specific brain model, etc.) Additional provisions 
have to be made to establish communication between the accelerometer recording software and the 
simulation software to simulate EF in real-time. The algorithms that generates the improvement maps 
from the EF simulation files take a maximum of 5 minutes and can be executed once stimulation tests 
are completed during the surgery. Once these steps are realized, a larger clinical study will be conducted 
to confirm the advantages of improvement maps highlighted in the current paper and to make them 
available during surgical decision making after the intraoperative stimulation tests.  
A likely long-term application of improvement maps would be to facilitate the use of directional DBS 
leads to steer the effects of stimulation in a certain direction. Schüpbach et al. (2017) recently studied 
the challenges that directional stimulation would bring to DBS and indicated that patient-specific 
visualization techniques (like improvement maps) will be required to limit alterations to targeting and 
intraoperative standards. Besides the intraoperative application, improvement maps provide another 
tool to better the understanding of the mechanisms of action of DBS. By applying this technique to a 
large patient cohort, an "improvement atlas" can be built to study the areas responsible for high 
improvement as well as adverse effects. By comparing such information to known anatomy and 
physiology of the disease, we can learn more about the mechanisms by which DBS alleviates symptoms.  
5 Conclusion  
This paper describes a new technique called improvement maps to summarize and visually analyze data 
from intraoperative stimulation tests for deep brain stimulation surgery. Data collected from 9 
implantations were analyzed with the aim to identify the optimal site to implant the chronic DBS lead. 
Clinicians found the visualizations intuitive and easy to interpret and to identify the region resulting in 
highest improvement in tremor. For 7 of the 9 improvement maps, the highest improvement region was 
found to be inferior and posterior to the VIM in the posterior sub-thalamic area in agreement with the 
scientific consensus. This method has the potential to simplify the surgical team's task in identifying the 
ideal implant location of the chronic DBS lead and to facilitate and expedite the use of directional leads 
in DBS.  
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Improvement maps for eight implantations described in the manuscript. 
This document contains the figures showing the 9 improvement maps generated by applying 
the technique described in the manuscript to 5 ET patients who underwent DBS surgery. Each 
figure is divided in to multiple parts: a) the first three parts (A to C) show an overview of the 
stimulation test region in axial, coronal and sagittal sections at the target position; b) the next 
three parts (D to F) show a close up of parts A to C at the target and c) the remaining parts 
starting from D are axial slices at the different depths along the planned trajectory at which 
stimulation tests were conducted. The improvement in tremor is represented by a color scale 
from white (least improvement) to dark green (highest improvement). The planned trajectory is 
represented as a gray cylinder. The anatomical structures outlined during the planning are rep-
resented with black outline for the overview and are labelled for the other close-up images. If 
adverse effects were observed during the stimulation tests, the first amplitude inducing these 
adverse effects were simulated and are indicated as red outline. The scale of the figure is indi-
cated on the top right corner for the parts A to F and, for the axial figures, in the top right of 
part G. The projections of the AC and PC points on the respective planes are shown as blue cir-
cles.  
Patient 1 Right: 
 
 
Figure S1: The target for this patient was chosen between the VO and the VIM as seen on the axial (D) and sagittal (F) slices. The 
deepest stimulation test position was 3 mm further along the trajectory (M). The highest improvement region for this patient en-
compasses the VO and the VIM and extends further to the inferior and anterior direction as seen on coronal (E) and sagittal (F) slices 
as well as axial slices from -2 mm to +3 mm (I to M). Adverse effects were not observed.  
 
  
Patient 2 Left: 
 
 
Figure S2: The planned target for the trajectories was in the middle of the VIM at the inferior border (E and F) and it was the deepest 
stimulation test position. The highest improvement region spans from the INL (F) to the VIM. Paresthesia and pyramidal side effects 
were observed at different stimulation test positions. The outline for pyramidal effects, labeled with Pyr in red, is at the supero-
lateral edge of stimulation test region suggesting stimulation of the inernal capsule. The outline for the paresthesia, labeled with Par 
in red, is posterior to the VIM in the VCL and VCM nuclei suggesting stimulation of the medial leminscal fibres.  
  
Patient 2 Right:  
 
 
Figure S3: The VIM was the target for this patient (D to F) and the stimulation tests were performed up to 2 mm (K) further along the 
trajectory. The highest improvement region is found encompassing the VIM and extending posterior to it in the ventro-caudal (VCL) 
nuclei as visible on all slices. Paresthesia was observed during stimulation on central and posterior trajectories and the adverse effect 
outline extends in posterior to the VIM in the VCL and VCM nuclei.  
 
 
  
Patient 3 Left: 
Figure S4: The antero-inferior border of the VIM was defined as the target for this patient (E, F) while stimulation tests were per-
formed upto a depth of 2mm further on the trajectory (M). : The highest improvement region is large for this patient as visible on 
the coronal (B) and sagittal (C) slices. It encompasses the VIM and penetrates the InL, VCM, VCL, and the VO. The region extends 
further inferior to the VIM. Adverse effects were not observed during the stimulation tests. 
Patient 3 Right:  
 
 
Figure S5: The planned target was at the inferior border of the VO for this patient (E and F) with stimulation tests performed until 
2mm further along the trajectory (M). The highest improvement region encompasses the complete VO and the VIM and extends 
further in the inferior and posterior direction. Paresthesia side effects were observed on the posterior trajectory at the most inferior 
stimulation test positions. The adverse effect outline penetrates the VCM and LaCM nuclei posterior to the VIM.  
  
Patient 4 Left: 
 
 
Figure S6: The planned target was located in the middle of the VIM (D, E and F) and stimulation tests were performed upto a depth 
of 4mm further on the trajectory (N). The highest improvement region is found to be most inferior in the stimulation test region, 
inferior and posterior to the VIM. It encompasses the PLR (M, N). Adverse effects were not observed during stimulation tests. 
 
  
Patient 4 Right:  
 
Figure S7: The medio-inferior part of the VIM was targeted (D to F) and stimulation tests were performed for 1 mm further than the 
target (J). The highest improvement region is inferior and posterior to the VIM penetrating the PLR, VCL and VCM (D, F, I, J). Pyrami-
dal and paresthesia side effects were observed during stimulation on both the trajectories. The outline for pyramidal effect, labeled 
as Pyr in red, edges the improvement regions at the antero-superior border of the VO (E and F) indicating stimulation of the internal 
capsule. The paresthesia outline, labeled as Par in red, is at the posterior edge of the stimulation test region penetrating the VCL and 
VCM nuclei (D and F to J).  
 
  
Patient 5 Left: 
Figure S8: The antero-lateral part of VIM was planned as the target (D to F) with stimulation tests performed upto 4 mm further on 
the trajectory (M). The highest improvement region encompasses the VIM and extends posterior and inferior to it (D to F and I to L). 
Dysarthria side effects were observed during stimulation on the lowest position on the posterior trajectory. The adverse-effect out-
line extends into the posterior sub-thalamic area (D to F and I to M).  
Chapter 9
Synthesis, Discussion and
Perspective
This thesis describes the eorts undertaken to introduce new techniques to the
traditional surgical procedure of implanting DBS leads in patient's brains for
chronic stimulation to treat movement disorders. The following sections review
the main results in relation to the goals that were set for this work followed by
discussion of these results in context of the existing literature. The intended
follow-up tasks are also described.
9.1 Summary of Key Findings
The results described in the seven publications in Chapters 4 to 8 relate to
one or more aims out of the four that were set for this doctoral work. The
rst goal was to improve the intraoperative symptom evaluation method
through quantitative tools. The publication describing the case study of us-
ing accelerometer based tremor evaluation (Section 4.1) shows the method's
feasibility and its ability to identify the eective (tremor suppressing) as well
as ineective (insignicant change in tremor) stimulation current amplitudes.
The larger clinical study described in Section 4.2 shows that the method can be
applied to multiple clinical centers. The outcome measures extracted from raw
acceleration data correlate with changes in tremor and are sensitive to minor
changes in tremor. The use of accelerometer based rigidity evaluation method
in Section 5.1 in 9 surgeries showed that changes in rigidity can be assessed
through the variations in speed of passive movements. Outcome measures de-
rived from acceleration data correlate with changes in rigidity and can be used
to identify the stimulation current amplitude that result in suppression of rigid-
ity. In combination, the above results clearly indicate that eorts made to reach
this rst goal of the study, have been successful.
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The second goal of this doctoral work was to identify the optimal target
structure for implanting the DBS leads. The rst results that support this
goal were obtained by comparing the eciency of STN, FF and ZI in suppressing
rigidity using the acceleration data of passive movements. Data shows that
stimulation in the STN has higher chances of inducing adverse eects and the
optimal target may be between STN, FF and ZI. Concerning tremor, for ET
patients, the comparison of structures surrounding the VIM using accelerometer
based tremor evaluation in section 6.1 similarly showed that the stimulation in
the VIM may not be ideal due to adverse eect occurrence. A deeper analysis
of the VIM region by estimating the spatial eects of stimulation as described
in section 7.1 indeed supports the nding and also suggests that the PSA may
a be better target of DBS for ET patients.
An important result of the clinical study involving evaluation of tremor using
accelerometry is that, out of 26 implantations, the choice of placing the lead
after intraoperative tests would have been dierent for 15 implantation if the
accelerometry results could be considered. Furthermore, this dierence in lead
placement is even larger for rigidity evaluation where 12 out of 14 choices of lead
placement would be altered. These results show the potential that quantitative
symptom evaluation techniques have in altering the choice of lead placement
after intraoperative stimulation tests. Apart from these, the improvement maps
techniques proposed in section 8.2 simplies the task of comparing the outcome
of dierent stimulation tests in relation to patient's anatomy and through bet-
ter management and visualization of intraoperatively collected data as well as
estimating the spatial eects of stimulation. These results demonstrate that
the eorts made to identify the optimal position for lead placement were
successful.
The complexity associated with the study of mechanisms of actions of DBS is
evident from the description in section 2.4.3. It is therefore not surprising that
comprehensive knowledge about it remains elusive. In this doctoral work, the
results of the anatomical analysis in sections 5.1, 6.1 and 7.1 show that the
region between the thalamus and the STN seems to be the ideal target for DBS
to treat ET and PD patients. Anatomically, this region is densely packed with
bre tracts. These information can be used to improve the understanding of
the mechanisms of action of DBS by analysing it in the context of previously
proposed hypotheses.
9.2 General Discussion
9.2.1 Symptom Evaluation during DBS Surgery
Various benets of using the accelerometer based method to evaluate tremor
and rigidity were identied during their use in DBS surgeries. The statistical
features correlated with and can reliably estimate the changes in symptoms.
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The relative evaluation with respect to baseline recorded immediately before
suppresses the inuence of variations in symptoms due to factors other than
electrical stimulation. The results of the clinical study show that quantita-
tive symptom evaluation is more sensitive than the subjective clinical methods.
Higher sensitivity over conventional method enables the clinicians to better
detect changes when baseline severity is very low. Additionally, the eective
stimulation amplitudes identied through quantitative methods are lower com-
pared to conventional methods, resulting in enlarged therapeutic windows and
inuencing lead placement. More importantly, these benets are achieved with-
out elongating the surgical procedure, without hindering the routine clinical
evaluation and without any discomfort to the patient.
There are certain requirements to the proper function of the proposed methods.
Acceleration sensors are inuenced by gravity and all axes will contain some
component of this inuence based on the orientation of the sensor.267 This
inuence can be suppressed by calculating the magnitude of the acceleration and
lter this constant value in data using a high-pass lter.84 Another important
aspect to consider is the duration of baseline data: a minimum of 5 seconds is
necessary for the method to function properly. In absence of sucient baseline
data, the baseline recorded before the previous stimulation test can be used. One
signicant dierence between tremor evaluation method and rigidity evaluation
method is that quantitative tremor evaluation can completely replace the routine
visual evaluation during the surgery but the rigidity evaluation cannot. The
rigidity evaluation method by design relies on the evaluator to perform the
passive movements and calculates changes in rigidity indirectly. In this regard,
the method is proposed as an assistive tool, which does not lessen its utility in
any way as indicated by the results of the clinical study.
9.2.2 Anatomical Targets for DBS Lead Implantation
The incomplete understanding of the pathophysiology of PD and ET as well
as that of the mechanisms of action of DBS causes the need to compare e-
ciency of dierent target structures in reducing the symptoms to identify the
best one. Research studies comparing STN-DBS with GPi-DBS for PD pa-
tients7,99,195,234,240,244,248,250,252,296,298,307,341,359,362,378 and VIM DBS, STN
DBS or PSA DBS for ET patients17,31{33,133,146,214,242,270,271 are plentiful,
most of which compare the eects of chronic stimulation in one target struc-
ture with another. Studies have shown that some therapeutic eect of DBS
may be due to neuro-plasticity i.e. adaptations in the brain's structure and
function due to the introduction of DBS leads. As these eects cannot be esti-
mated, they restrict the results of studies comparing chronic stimulation eects
for identifying the ideal target structure. A possible solution to overcome this
limitation is to use the intraoperative stimulation tests' data for comparison as
done in the current work. An additional benet in using our data is the use of
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quantitative symptom evaluation data during intraoperative tests.
The results of the anatomical analysis of rigidity patients (Section 5.1) show that
the sensorimotor part of the STN (dorso-lateral or anterior-superior-lateral53)
may not be the ideal target for such patients. In terms of stimulation current
amplitude, STN requires the least amount of current compared to ZI and FF.
But in 30 (46.875%) out of 64 stimulation test positions in the STN, adverse ef-
fects were induced. Other studies have had similar results in chronic stimulation
through DBS leads implanted inside the STN.13,20 In comparison, stimulation
in the ZI and FF had signicantly lower occurrence of adverse eects (around
20%) with only a small increase in the stimulation current amplitude to reduce
rigidity by the same amount. Various other studies have also suggested the role
of ZI and FF in the therapeutic eect of STN-DBS.112,132,302,380 These results
collectively suggest to target the superior and lateral border of the anterior STN
near ZI and FF for optimal outcome of DBS.
In a similar way, the VIM may not be the ideal target based on the results of
data analysis for the ET patients who underwent VIM DBS (Section 6.1). Of
the 6 anatomical structures which were compared in this study, stimulation in
the VIM needed the most current amplitudes on average for 75% reduction in
tremor and had the second highest chances of adverse eect occurrences. In
comparison, the superiorly located VO and InL had lower occurrences of adverse
eects while the PLR needed only half as much stimulation current amplitude
for same reduction in tremor. Apart from these results based on the location of
the stimulating contact only, in the study presenting the method of simulating
electric eld distribution to estimate the spatial eects of stimulation (Section
7.1), the data generated was also analysed to study the therapeutic eect of
VIM and the surrounding structures. The results concurred with those of the
rst study indicating that the VIM may not be the only structure responsible
for the therapeutic eects. Other published works also echo our results. Many
papers indicate that stimulation in the PSA305 that includes the ZI,63,103,133 the
PLR331,352 and FF is either as good as or even better than VIM in suppressing
tremor. Reports indicating role of VO48,352 and the DRTT124 in suppressing
tremor have also been published.
9.2.3 Data Visualization for DBS Lead Placement
The success of DBS as a therapy depends heavily on the position of the lead
with respect to the target structure. The percentage of patients having subop-
timal outcome because of malpositioned lead and undergoing corrective surgery
is reported between 1% and 8% at the same centre.92,94 In a report253 of unsat-
ised patients who consulted a dierent center than the one they were operated
in, 46% of them had malpositioned leads. To study the eect of using quanti-
tative tremor evaluation and assistive rigidity evaluation on the choice of lead
placement, the results of the data analysis were provided to the surgical team,
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only post-operatively however and not at the time of choosing the position for
lead placement as the clinical studies were approved for observational purposes
only.
Out of the 26 lead placements in the tremor study (Section 4.2), the surgical
team would have chosen dierently for 15 of the implantations if the accelerom-
etry results could have been considered. In the case of rigidity evaluation study
(Section 5.1), the choice would have been dierent for 12 out of the 14 cases.
To the best of my knowledge, no other published literature in the eld of DBS
has reported such comparison. The only studies that have some relevance to
these results, in my opinion, are those that used quantitative methods to eval-
uate symptoms during post-operative programming of the IPG, the results of
which also support the use of sensor based method over current clinical prac-
tices.140,233,280
An important note for the choice of lead placement for the tremor study is
the stark dierence in this choice between the two centers (CHU, Clermont-
Ferrand: 15 of 18, Inselspital Bern: 0 of 8). These dierences can be attributed
to the dierence in the surgical procedure and the criteria for choosing the nal
implant position. The team at CHU, Clermont-Ferrand tests 5 to 10 positions
per trajectory and chooses the position within a group of positions with large
therapeutic windows. On the other hand, the team at Inselspital tests 2 to
5 positions per trajectory and implants the lowest contact of the DBS lead
at the deepest position with a large therapeutic window. Nevertheless, these
dierences emphasize the need to test any intraoperative system in multicentre
study to understand the inuence of variations in the surgical procedure. They
do not in any way suggest that one procedure is better than the other.
The results of the improvement map study demonstrates that visual analysis of
intraoperative stimulation test results can also potentially alter the lead place-
ment choice. Certainly, as the improvement maps used quantitative tremor
evaluation data, the inuence on the nal implant position is due to both tech-
niques. It is not possible to condently determine which of the 3 choices (based
on clinical evaluation, based on accelerometer data or based on improvement
maps) is better for such limited sample data. One possible way to judge it
would be by comparing it to the position of the chronically stimulated DBS lead
contact. But such a comparison presents its own challenge in terms of unknown
changes due to neuro-plasticity, brain-shift, worsening disease, etc. In order to
investigate this further, a clinical study with a large cohort is necessary.
One limitation of the improvement map method in its current state is that it can
only be applied post-operatively. Nevertheless, a few modications can enable
it to be used intraoperatively. The brain model that is required to simulate the
EF distribution can be generated right after the acquisition of the necessary MR
images, which, in the case of CHU Clermont-Ferrand, is a day before the surgery.
On completion of the planning, the trajectory and stimulation test positions
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can be identied in the brain model. During the surgery, eective stimulation
current amplitudes can be identied using the accelerometer method and used
to simulate the EF. At the end of stimulation tests, the improvement maps can
be calculated from the consolidated EFs fairly quickly (maximum 5 minutes) and
visualized to identify the best position for the lead placement. The practical
requirements and the feasibility of implementing the improvement maps in this
way are being discussed with the research partners involved.
An important discussion concerning the visualization is about spatial accuracy.
Since the visualization involves multiple datasets, their individual inaccuracies
have a cumulative eect on the nal visualization. As most of the information
for the improvement maps is sourced from the patient images, their spatial
dimensions and accuracy play a major role. MRI acquisition can cause image
distortion due to magnetic eld inhomogeneities,339 e.g. in frame identication,
but can be corrected using software. Image registration of MR with CT has been
suggested to reduce distortion errors,376 but studies have found that registration
errors are higher than distortion errors.251 High resolution stereotactic MRI
acquisitions can eliminate registration errors while limiting distortion errors.383
The surgical planning data also has uncertainties. The trajectory for example,
can be aected by brain-shift168,235 i.e. displacement and/or deformation of
the brain during intracerebral procedures.326 Additionally, the planning software
interpolates the outline of the anatomical structures, but these outlines can only
be exported after being assigned to the dimensions of an image dataset.
The FEM simulations of EF distribution to estimate the spatial eect of stim-
ulation also have their limitations. Variations in the tissue conductivity values,
voltage drop at the electrode-tissue interface and the lack of experimental vali-
dation of the models are some of them. Exhaustive discussion of all the limita-
tions associated with the simulations can be found elsewhere.11 Certainly, the
quality of the image data signicantly aects the outcome of simulations as the
patient-specic nature relies on the image data used for creating the conduc-
tivity matrix for the brain model. Overall, it is clear that the resolution of the
patient images play a large role in dening the quality of the visualization. In
their current form, the datasets are based on the pre-operative CT (0.59 mm
x 0.59 mm x 1.25 mm) as it has the highest resolution among the images ac-
quired. In comparison to the diameter of the exploration electrode (0.55 mm)
and the DBS lead (1.27 mm), from a purely engineering point of view, this im-
age resolution can be used to create visualization with limited spatial accuracy.
However, considering the positive results of the adverse eect maps and the
simplicity oered by the improvement maps, the clinical utility of the tool has
more signicance than the strict engineering perspective, especially in absence
of alternatives. Nevertheless, the spatial accuracy can certainly be improved
by acquiring higher resolution images, which was not possible for the current
retrospective application.
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9.2.4 Mechanisms of Action of DBS
The successful results of DBS as a treatment for movement disorders were not
replicated when it was applied to other neurological diseases. One of the various
reasons for this lack of success is the partial understanding of the mechanisms
by which DBS produces the therapeutic eects. Since the rst successful DBS
surgery, a signicant amount of research has been undertaken to understand its
mechanisms of action. Experiments have been performed to know if stimulation
inhibits or excites neurons, aects the neuronal soma (cell body) or projections
(axons and dendrites) or both, and inuences one structure only or the whole
basal-ganglia-thalamic circuit. Through the results of these experiments, re-
searchers have collected information to better understand the mechanisms of
action of DBS.
It is evident from the published literature reviewed in Section 2.4.3 that a com-
plete understanding of mechanisms of actions of DBS is elusive and will require
extensive research in numerous areas. The anatomical analysis of the data col-
lected in this doctoral work and the visualization in the form of improvement
maps can be related to the known hypothesis of mechanisms of action. The
results of the analysis indicate that the region between the ventral thalamus and
the subthalamic nucleus i.e. PSA containing the PLR, ZI and FF is the most ef-
fective for tremor and rigidity suppression. Detailed tractography analysis of the
PSA105 has shown that bres connecting primary motor cortex, supplementary
motor cortex, pallidum, ventro-lateral thalamus, brainstem and others condense
together and pass through this region. Connections to the VO and the VIM
are also reported. In this context, eective stimulation in the PSA could be
attributed to the stimulation of these ber tracts and consequently stimulat-
ing the neurons in the terminating structure. In terms of questions related to
the mechanisms of action, these results suggest that DBS activates ber tracts
which alter the ring pattern of the functional circuit towards a healthier state.
Nevertheless, these implications have low statistical condence as they are based
on data collected from few patients.
9.3 Perspective
The eorts made in the current doctoral work have introduced new technologies
to the intraoperative stimulation tests for DBS. In addition, there are a few
tasks that can further enhance the DBS therapy through technology. One such
opportunity is to use the accelerometer based quantitative evaluation methods
during pre-operative examination of patients. This could simplify the task of
neurologists to judge if a patients needs to and is able to undergo the surgery
to fully benet from the therapy. The use of quantitative symptom evaluation
can also be extended intraoperatively during MER. This resultant data would
allow correlation between neuronal ring and/or LFP with symptom changes to
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better study the pathophysiology of the underlying disease. Furthermore, the
use of quantitative symptom evaluation during post-operative IPG programming
to identify best stimulation parameters as well as during short- and long-term
follow-up examination would also benet the neurologist and the patients. It has
been shown that sensor-based algorithmic programming of IPG was successful in
identifying therapeutic stimulation parameters.140 To further automate the task
of IPG programming, techniques to evaluate other symptoms like bradykinesia,
gait disturbances, etc. as well as adverse eects of stimulation will have to be
developed and tested. Further research is necessary to bring these solutions
from the lab to routine clinical practice.
Apart from researching new techniques, one important task to realize the full
benets of the quantitative tremor evaluation and the assistive rigidity evaluation
methods is to conduct a clinical study with the ability to use the results for lead
placement and then compare the choices to a control group. Results in this
thesis have shown that therapeutically eective simulation amplitudes identied
through quantitative methods are lower. Certainly such a study needs to be
spread across multiple clinical centers and include a large number of patients
to be able to draw statistically condent conclusions. Such a large study also
provides an opportunity to use the improvement maps during the surgery for
choosing the lead placement. In addition, the data collected can be analyzed
with respect to anatomy, not only based on the location of the electrode, but also
using the patient-specic EF simulations. The results can be used to identify
the best target structure for dierent pathologies and learn more about the
mechanisms of actions of DBS.
Future research endeavours should also consider the current trends in clinical
environment. One such aspect is the rise in number of DBS surgeries per-
formed using general anaesthesia. As new lead designs allow more exibility,
experienced DBS neurosurgeons exhibit the intention to place them with fully
anaesthetised patients to simplify the surgery for the patients. New techniques
have to be designed and tested which can optimize lead placement under general
anaesthesia to assist the neurosurgeons in improving the surgical outcome.
Chapter 10
Conclusion
This doctoral work successfully demonstrates that the DBS surgical procedure
can be improved by using new techniques. The accelerometer based methods to
evaluate changes in tremor and rigidity have been shown to overcome the sub-
jectivity of currently used symptom evaluation methods and are more sensitive
to small changes in the symptoms. The new methods also allow quantitative
comparison of the role of dierent anatomical structures in the therapeutic eect
of stimulation. The results show that stimulation in the posterior subthalamic
area containing the elds of Forel, the Zona Incerta and the Prelemiscal Radia-
tions results in signicant suppression of tremor and rigidity at low amplitudes
without inducing severe adverse eects. Furthermore, for ET patients, the com-
bination of quantitative tremor evaluation with estimation of spatial eects of
stimulation through electric eld simulations showed that other thalamic nu-
clei as well as bre tracts surrounding the ventro-intermediate nucleus may also
be the responsible for therapeutic eects. Apart from this, the improvement
maps method has shown that the use of patient data during the surgery can
be improved. The summarized visualization of intraoperative stimulation tests
can signicantly simplify the task of lead placement. As a consequence of the
optimization of DBS surgery through these methods, signicant benets for
patients can be anticipated. The reduction in the therapeutically eective stim-
ulation current amplitude achieved by application of these methods can reduce
stimulation induced adverse eects and potentially lengthen the battery life of
the IPG. These methods can also benet the DBS therapy in general as they
can be used to enhance the understanding of mechanisms of actions. The en-
hanced knowledge can be used to develop better hardware as well as to treat
other neurological diseases using DBS.
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